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1. A review of the literature has shown that the major soluble antigens in amniotic
fluid at term are of serum type, and that of these antigens albumin, transferrin and
group-specific component are mainly of maternal origin. It was not clear whether this
conclusion applied to the protein in amniotic fluid earlier in gestation, nor had
extensive studies been made into the nature of the non-serum protein in amniotic fluid.
The object of the work presented in this thesis was to investigate the nature and origin
of the soluble protein in amniotic fluid throughout pregnancy.
2. An immunological investigation showed that when rabbits were immunised with amniotic
fluid, the majority of their immune response was directed against serum protein. The
major antigens in the fluid were found to include albumin, -antitrypsin, group-specific
component, and transferrin.
3. A method was developed for phenotyping group-specific component (Gc) in amniotic
fluid and in serum by antibody-antigen crossed electrophoresis. Maternal serum and
amniotic fluid was collected from each of 56 pregnancies at between ten and thirty-eight
weeks of gestation, and in each case the Gc phenotype of the fluid was the same as the
maternal phenotype. In 11 of these cases, a sample of fetal serum was also obtained,
and in four cases in which the fetus was discordant from the mother, the Gc phenotype
of the fluid was the same as the maternal phenotype. From this it was concluded that
the majority of the Gc in amniotic fluid was of maternal origin, from ten weeks of
pregnancy onwards.
4. The concentrations of albumin, a.-antitrypsin, Gc, and transferrin were measured in
amniotic fluid and in maternal and fetal serum. The concentration patterns of the four
proteins in amniotic fluid were very similar and maximal concentrations were found between
twenty and thirty weeks, showing a general similarity to the total protein concentration.
When the concentrations of the individual proteins in amniotic fluid were expressed as
ratios of the concentrations in maternal or fetal serum, a general similarity was found
between the ratios of albumin, -antitrypsin, Gc, and transferrin. These concentration
ratios were much less than that found for a-fetoprotein. From this it was concluded
that the albumin, -antitrypsin, and transferrin in amniotic fluid were mainly of
maternal origin from about ten weeks of gestation onwards.
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1. A review of the literature has shown that the major soluble antigens
in amniotic fluid at term are of serum type, and that of these antigens
albumin, transferrin, and group-specific component are mainly of maternal
origin. It was not clear whether this conclusion applied to the protein
in amniotic fluid ealier in gestation, nor had extensive studies been
made into the nature of the non-serum protein in amniotic fluid.
he object of the work presented in this thesis was to investigate the
nature and origin of the soluble protein in amniotic fluid throughout
pregnancy.
2. An immunological investigation showed that when rabbits were
immunised with amniotic fluid, the majority of their immune responce
was directed against serum protein. The major antigens in the fluid
were found to include albumin, -antitrypsin, group-specific component,
and transferrin.
5. A method was developed for phenotyping group-specific component
(Gc) in amniotic fluid and in serum by antibody-antigen crossed electro¬
phoresis. Maternal serum and amniotic fluid were collected from each
of 56 pregnancies at between ten and thirty-eight weeks of gestation,
and in each case the Gc phenotype of the fluid was the same as the
maternal phenotype. In 11 of these cases, a sample of fetal serum
was also obtained, and in four cases in which the fetus was discordant
from the mother, the Gc phenotype of the fluid was the same as the
maternal phenotype. From this it was concluded that the majority of
the Gc in amniotic fluid was of maternal origin, from ten weeks of
pregnancy onwards.
4. The concentrations of albumin, -antitrypsin, Gc, and transferrin
were measured in amniotic fluid and in maternal and fetal serum. The
concentration patterns of the four proteins in amniotic fluid were
very similar and maximal concentrations were found between twenty and
thirty weeks, showing a general similarity to the total protein
concentration. Then the concentrations of the individual proteins
in amniotic fluid were expressed as ratios of the concentrations in
maternal or fetal serum, a general similarity was found between the
ratios of albumin, -antitrypsin, Gc, and transferrin. These
concentration ratios were much less than that found for a-fetoprotein.
From this it was concluded that the albumin, -antitrypsin, and
transferrin in amniotic fluid were mainly of maternal origin from
about ten weeks of gestation onwards.
5. iabbit antisera against amniotic fluid were absorbed with adult male
human serum to search for antigens of non-serum origin in amniotic
fluid. After a considerable course of immunisation, antibodies
against two proteins were found. An ag-protein was found in amniotic
fluid and decidua throughout pregnancy, and in amnion and chorion
early in pregnancy. The protein was absent from maternal and fetal
serum. Because the protein was consistently found in decidua both by
antibody-antigen crossed electrophoresis and immunofluorescence,
decidua was thought to be an origin of this protein. A p-®obility
protein was also found. This was present in maternal and fetal serum
at concentrations similar to those in amniotic fluid. Comparisons of
the concentration gradient of this protein with that of Gc and
a-fetoprotein suggested that the j3-protein in amniotic fluid was
mainly of non-serum origin«at least up to thirty weeks of pregnancy.
6. During the course of concentration gradient studies on amniotic
fluid a-fetoprotein, it became apparent that this fetal seruia protein
might be of value for the prenatal diagnosis of anencephaly. This
possibility was examined in 22 pregnancies leading to anencephaly or
anencephaly combined with spina bifida, where it was possible to get
amniotic fluid in the third trimester. In these cases the concentrations
of a-fetoprotein in the amniotic fluid were found to be grossly elevated
above control levels.
In five cases of spina bifida after thirty-two weeks, the concentration
of a-fetoprotein in the amniotic fluids were indistinguishable from
the controls. However, a single fluid was fortuitously obtained at
13 weeks of gestation from a hysterotomy where the fetus had a myelocele
spina bifida. In this case the concentration of a-fetoprotein in the
fluid was over 4 times as great as the highest normal control.
These results suggested that it will be nossible to diagnose anence¬
phaly prenatally early enough to carry out termination of pregnancy.
Such a conclusion may not hold in the case of spina bifida, where there
is considerable variation in the extent of the lesion.
7. Investigations were made into the specific activities of a-1,4-
glucosidase, hexosaminidase, acid phosphatase, and the heat-stable
and heat-labile fractions of alkaline phosphatase.in amniotic fluid.
Various specific activity patterns were found during gestation, none
of which were similar to the protein concentration in amniotic fluid.
Particularly notable were the specific activity maxima found in the
cases of heat-labile alkaline phosphatase and a-1,4-glucosidase between
thirteen and eighteen weeks of gestation, and for the alkaline and acid
phosphatases at term. The gradients of the enzyme specific activities
between aEiniotic fluid and maternal or fetal genua were compared with
proteins known to be of maternal or fetal serum origin (using Gc and
o-fetoprotein, respectively). The analysis showed that the enzymes
studied could not be regarded as being simply of serum origin
throughout pregnancy.
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INTRODUCTION
1 • -he Medical uses and, notentials of .rarxiotic Fluid inalysis
1though amniocentesis was first suggested and performed by
LamfcLin 1831 and by Henkel in 1919» the technique did not acquire
practical value until the 1950's. Bevis (1950, 1953, 1956) was
the first to claim that the severity of haemolytic disease of the
newborn (rhesus isoimmunisation) could be predicted from the
concentration of iron or of bilirubin in the amniotic fluid. This
claim was confirmed by alker (1957), Kackay (1961), and Liley
(1961, 1963) and amniotic fluid analysis became increasingly used
for estimating the severity of isoimmunisation during pregnancy.
At the present time, transabdominal amniocentesis is carried out on
cases at risk for rhesus isoimmunisation between about twenty weeks
of gestation and term (.alker, 1970). The bilirubin concentration
in the fluid is usually measured by spectrophotometry (hiley, 1961),
and the concentration used to monitor the disease.
The successful diagnosis of rhesus disease, together with the
relatively low risks of transabdominal amniocentesis (icrimgeour,
1972) stimulated attempts to diagnose other genetic and non-genetic
conditions prenatally. The first prenatal genetic analyses in man
were made by 3err (1955) uchs and Riis (1956) and James (1956), who
showed that the sex of a fetus could be predicted from the sex-chromatin
of uncultured amniotic fluid cells. Riis and Fuchs (1960) also
suggested that chromosomal karyotypes could be made from cultured
amniotic fluid cells, although it was not until 1965 that the first
successful report was made by Klinger (1965). Ilore extensive work
was made by teele and Breg (1966) and Jacobson and Barter (1967),
the latter workers identifying a d/d translocation carrier in utero.
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These studies enabled Nadler (1968), Valenti and Kehaty (1969) and
Valenti, 3cutta and Kehaty (1968) to carry out prenatal chromosome
studies in cases which were at high ri3k for Down's syndrome.
Nailer (1968) reported the first prenatal diagnosis of Down's syndrome
which was followed by therapeutic abortion and subsequently confirmed
by cytogenetic analysis of fetal tissue. Since these initial reports,
cytogenetic studies on cultured amniotic fluid cells have become
routine in several centres, providing screening facilities for cases
at high risk for chromosome aneuploidy, and facilities for sex
determination in cases where the mother is a possible or proven
carrier of an X-linked condition.
The adrenogenital syndrome was the first inborn error of meta¬
bolism to be diagnosed in utero. Jeffcoate et al (1965) showed that
this disease could be diagnosed shortly before birth by measuring the
concentrations of pregnane-diol and 17-ketosteroids in amniotic fluid
supernatant. The ability to diagnose this disease at the earliest
possible titie is important as affected infants respond best to
treatment during the first few days of life. The work of Jeffcoate
et al (1965) was confirmed by Tuchs (1967) and Nicholls (1969),
although Merkatz et al (1969) and New (1970) found that the technique
could not be used successfully in early or mid-pregnancy. Further
developments, such as a more rigorous classification of the adreno-
*
genital syndromes may increase the precision of prenatal diagnosis,
while the injection of hydrocortisone into the fetus (Nicholls 1970)
may also provide a means of treatment in utero.
*
adrenal hyperplasia cype I is accompanied by the most severe changes
in steroid metabolism, and therefore could be regarded as the most
likely type to be diagnosed by amniocentesis; yet it was a case of
type I disease that Merkatz et al (1969) attempted unsuccessfully to
diagnose in this way. It should be born in mind, however, that mild
and severe forms of adrenal hyperplasia type I have been described
(Galal et al 1969).
New (1970) attempted the prenatal diagnosis of a case of adrenal
hyperplasia type / (UcKusick 1971).
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Subsequently, it has been shown that cell-free amniotic fluid
could be used to diagnose Tay Sachs disease renatally (O'Brien et al
1971; Iriedland ot al 1971), and perhaps also methylmalonic acidaemia
(Morrow et al 1970). Nadler and Messina (1969) also claimed that
Fompe's disease could be diagnosed by supernatant analysis, but in a
further paper this was refuted (Nadler et al 1970). Matalon and
et al (1970) made similar claims in the case of Hurler'a syndrome,
however, further work by Brock et al (1971) and then by Matalon,
Dorfraan and Nadler (1972) denied this. It is fairly clear that the
majority of inborn errors of metabolism are best diagnosed prenatally
by studies on cultured amniotic fluid cells (Brock, 1972). fhe
limitation of this approach li s in whether the disease is expressed
in cultured cells.
Apart from the diagnosis of rhesus isoinmunisation, there are a
number of diagnostic problems in obstetrics which have benefited or
might benefit from amniotic fluid studies. ince most of these
problems are more physiological than genetic, experiments on the
supernatant of .amniotic fluid (and possibly also on uncultured cells)
becomes the approach of choice. Many attempts have been made to
devise amniotic fluid teats which would provide reliable estimates
of fetal maturity, and thus define the optimal time for delivery.
In this field, the established approach has been to measure the
concentrations of lipid staining cells in the amniotic fluid, together
with the concentrations of electrolytes, urea and creatinine (Brosens
and Gordon, 1966; Chan et al 1969; Lind et al 1969; rfyatt et al
1969; Lind and Billewicz 1971; Gauthier et al 1972;
However, it must be concluded that, at present, the precision
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of these methods available fall considerably short of that required,
if they are to be of clinical value. The narrow
selection of amniotic fluid constituents which have been studied so
far probably accounts for the lack of progress in this field.
One of the reasons for needing a reliable estimate of fetal
maturity, is to avoid the delivery of babies who are liable to
respiratory distress syndrome. his 3/ndrome is partly due to an
absence of the low surface-tension 'surfactant' lipids from the
pulmonary alveolar surfaces (vdams et al 1965; Chu et al 1965).
This causes a disproportionate increase in the surface-tension of the
smallest alveoli, which forces the air out and causes alveolar collapse
( est, 1970). Thus, a number of workers have studied the supernatant
lipids of amniotic fluid, in order to see if surfactant-type lipids
(lecithins) could be found. The work of Biezenski et al (1968) and
Nelson (1969) showed that such lipids were present, and that they
could be of pulmonary origin. ecent work by dluck et al (19T1) and
Thagwanari et al (1972) suggests that the measurement of amniotic fluid
lecithin : sphingomyelin ratios are of value in predicting the
immediate liability of a fetus to respiratory distress syndrome when
delivered.
he pregnancy of the diabetic mother is particularly difficult
to manage during the last two months, owing to the high risk of sudden,
quite unheralded fetal death after about thirty-eight weeks of gestation
(Farquahar, 1965; aird, 1969). To counter this problem, the babies
of diabetic mothers are delivered between thirty-six and thirty-eight
weeks. This measure results in an increased incidence of premature
babies, some of which are severely affected ith respiratory distress
syndrome. If the concentrations of lecithin and sphingomyelin in
5.
amniotic fluid prove to be of value for diagnosing the liability of
these babies to respiratory distress syndrome, then an important
advance will have been made. However, there is a clear need to be
able to monitor the progress of the pregnancy of the diabetic mother
in order to gain warning of impending fetal death. No advance has
been made along these lines, partly because the cause of death is not
understood (see Baird, 1969), but also because the studies to date
have concentrated on the measurement of insulin (for example) in
maternal blood. .ide-ranging empirical studies on amniotic fluid
would clearly be of value here but the limited knowledge of amniotic
fluid solutes has so far prevented this.
A further potential of amniocentesis lies in the prenatal diagnosis
of congenital malformations. A number of attempts have been made to
find tests which could diagnose anencephaly and spina bifida, though
little success has been made to date. A further discussion of this
problem is found on pp.72-73.
Further advances in the use of amniocentesis for the diagnosis
and management of abnormal pregnancies, depend to a considerable
extent on gaining a further insight into the biology of amniotic fluid
macromolecules, and especially of protein. Protein has the advantages
of a relatively low rate of diffusional turnover, and considerable
tissue specificity. Knowledge of the quantitative and qualitative
protein changes which occur in the amniotic fluid during pregnancy
would provide:
1. An increased range of amniotic fluid measurements, which could be
tested for clinical potential.
2. Data which may throw light on the manner in which protein enters
6.
the amniotic fluid, and in particular the extent to which the protein
in amniotic fluid is of maternal or fetal origin.
* * #
The following sections review the embryology of the human
amniotic cavity, and the maintainance and turnover of the amniotic
fluid. Then, the quantitative and qualitative nature of human
amniotic fluid supernatant protein is discussed, with special
reference to work which sheds light upon its origin. This review
allows a number of distinct problems to be posed, and investigations
into these are reported and discussed in the following sections.
2. ,'he ■jabryology of the janiotic Cavity
From very early in gestation until birth, the human fetus is
surrounded by amniotic fluid. This fluid lies within the amniotic
cavity which appears by the end. of the first week of gestation as a
space within the inner cell mass of the blastocyst (Hertig and lock,
1945). By the second week (Fig.1a), the amniotic cavity separates
the epidermal surface of the embryonic disc from the extracmbryonic
mesoderm. The extraembryonic mesoderm develops within the blastocyst
cavity to fill the spaces found between the troohoblast and the amnion,
the edge of the bilaminar disc, nd the primary yolk sac (Hertig and
Rock, 1941; Hamilton and Boyd, 1960). Soon after this, most of the
mesoderm soon degenerates and only remains as a covering of cells
over these tissues (Pig. 1b). The fluid space which results from
this degeneration is known as the extraembryonic coelom (Hamilton,
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Boyd and Mossaan, 1964), and by about fifteen days, the embryo is
suspended in die coeloia, being connected to the trophoblast simply
by a connecting (umbilical) stalk. t about this stage the embryo
undergoes neurulation (Fig.ic), and is covered on its epidermal surface
by the amniotic cavity and on its endodermal surface by the primary
and then the secondary yolk sacs. Soon, (Fig.id) the amnion grows
over the developing head, tail and sides of the embryo and closes in
upon the connecting stalk and the secondary yolk sac. This constricts
the yolk sac un,il part of it is included in the embryo (to develop
into the gut and allantois), and the remainder lies outside the embryo
as the yolk sac (Hamilton, Boyd and Moasman, 1964).
Fig.2a is a diagram to show the arrangement of the conceptus at
about ten weeks of gestation. Fig.2b shows the membranes, placenta,
and umbilical cord of a ten week fetus. The amniotic cavity has
been filled with water, and the extraembryonic coelom is clearly
visible between the amniotic and chorionic membranes. The yolk
sac can also be seen in the coelom. Further expansion of the
amniotic cavity between ten and fourteen weeks of gestation leads
to the obliteration of the extraembryonic coelom, so that in the
later stages of pregnancy it is represented only by the space
between the amnion and chorion, and contains the remnants of the
yolk sac.
Up to about ten weeks of gestation, the conceptus is implanted
in the wall of the uterus and is surrounded by parietal uterine
decidua. Burin; this time the trophoblast (chorion) is covered
with villi which become vascularised as they grow into the parietal
decidua. However, during the third and fourth months of pregnancy
figure 1 Diagrams to illustrate the development of the amniotic
cavity. Details are found on pp.6-7.
a. The embryo during the second week of gestation
b. The development of the extra embryonic coelom
c. Growth of the amnion over the head fold of the embryo
d. Growth of the amnion over the ventral surface of the
























. i rure 2 The conceptus at ten weeks of gestation. For details
see p.7.
a. Diagram of a ten week fetus, drawn to show the arrangement
of the amniotic cavity and the extra-embryonic coelom.
b. Dissection of the membranes of a ten week fetus. The
fetu3 is out of sight at the top of the umbilical cord.
The open amniotic sac has been filled -with water, and
the extraembpyppjc coelom is seen as the space between
the pale amniotic membrane, and the glistening vascular
chorion lying behind and to the left. Note the
location of the yolk sac in the extraembryonic coelom.
EXTRA-EMBRYONIC AMNIOTIC CAVITY
a
Figure 3 The relations between the amniotic fluid, the maternal
serum and the placenta. Maternal blood can penetrate the spaces (s)
between the placental ^xlli and flows against the chorionic plate.
The arrows show the direction of flow. See discussion on pp.104-105.





the conceptus grows to occupy the entire uterine cavity. At this
stage the trophoblastic villi which are adjacent to the implantation
site develop into placental tissue, whilst the others atrophy. Thus
by the end of the fourth week of pregnancy the amniotic cavity is
bounded by the placental and the reflected membranes, with the placenta
and uterus, respectively, as deeper relations. /ig.3 is diagram
showing the relations between the placental membranes, the placental
villi, the maternal and fetal blood spaces and the decidua. The
effect of these relations on the nature of amniotic fluid solutes is
discussed on pp.104-105.
3. Amniotic Fluid Volume and Turnover
a. Volume
'The volume of amniotic fluid is known to increase from less than
30 ml at eight weeks to about 100 ml at fourteen weeks and 300 ml at
eighteen weeks of gestation ( agner and Fuchs, 1962; Rhodes, 1966;
Abramovitch, 1968; hillibrand, 1969; Lind, 1970; Nelson, 1972).
It is not clear what the volumes are between twenty and thirty weeks
but by dye dilution studies on fifty-nine normal pregnancies from
thirty-seven weeks of gestation onwards, lliot and Iman (1961)
showed that maximal amniotic fluid volumes occurred at about thirty-
eight weeks (in nine cases the mean = 1032 ml and the range = 533-1512 ml)
and that volumes declined thereafter to a mean of 250 ml at forty-three
weeks. Oadd (1966) used similar methods to show that between thirty-
two and thirty-seven weeks the volume ranged from between 450 and
1100 ml with no apparent trend; whereas after thirty-seven weeks
volumes fell, to lie between nearly zero and 500 ml at forty-three weeks.
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A number of studies have thrown light on the factors which
control the rate of amniotic fluid turnover. Hutchinson et al
(1959) have shown that there is direct exchange of water between the
amniotic fluid and both the mother and the fetus from twelve weeks
of pregnancy until term. .hey calculated that the respective water
fluxes in and out of the amniotic fluid (irrespective of source) were
about 75 ml/lor at twelve weeks, 131 ml/hr at twenty weeks and 412 ml/hr
at term. The fluxes of ater into the fluid from the mother and the
fetus were approximately equal, except in a single case studied at
twelve weeks, /here the contribution from the mother was thirty times
that from the fetus. lthough this data suggests that the rater in
amniotic fluid turns over very rapidly, this probably occurs by the
simple exchange of rater between the amniotic fluid and the surrounding
tissues. Of considerable interest is the extent to which the turn¬
over occurs as discrete net fluxes of ater across individual tissues,
since it is by the management of these fluxes tiv.it'the total volume of
the amniotic fluid will probably be controlled. Net fluxes of water
may occur across semipermeable membranes under the influence of
hydrostatic or osmotic pre; sures, or they may occur as irreversible,
•bulk' transfers of water, as occurs for example in fetal micturation
and swallowing. The following sections will discuss the extent to
which various fetal tissues and functions contribute net fluxes of
water either into tnd out of the amniotic fluid, and the extent to
which these individual fluxes control the total volume of the amniotic
fluid. Because of the paucity of published data, a detailed
examination is only possible for the most advanced stages of pregnancy.
A subsequent section will outline the possible factors which operate
earlier in pregnancy.
b. Factors affecting amniotic fluid volume and turnover toward term
i. Fetal :'/wallowing
It iias been clear for many years that the fetus can swallow
amniotic fluid. Davis and Potter (1946) and cott and tfilson (1957)
pointed out that fetal swallowing must be the cause of the lanugo
and amniotic fluid cell debris which is found in the faeces of new¬
born babies, and of the radio-opaque material found in the gastro¬
intestinal tract after amniography. Pritchard (1965) measured the
131
bulk turnover of amniotic fluid by injecting I labelled albumin
51
and Cr -labelled red cells into the amniotic cavity about twenty-
four hours before delivery. He found that the volume of fluid
swallowed by normal babies at term was between 210 ml and 760 ml per
24 hours, the mean volume being 450 ml per 24 hours. This was in
close agreement with the findings of Rosa (1951 )» suggesting that
fetal swallowing alone could bring about the complete turnover of
the amniotic fluid in two to three days (assuming an amniotic fluid
volume of less than about 1.5L, Elliot and Inman, 1961; 3add, 1966
and Gillibrand, 1969).
In a di3cussioa on the role of fetal swallowing in the control
of liquor volumes, bramovitch (1970) pointed out that the rate of
water turnover (Hutchinson et al 1959) is far in excess of the rate
of fetal swallowing at term (Pritchard, 1965)* From this he
suggested that swallowing may play a minor role in the control of
liquor volumes. However, most of the water turnover in amniotic
fluid is probably due to the diffusion of water in and out of the
amniotic sac, across passive tissue membranes. Although net fluxes
11.
of water can occur across such membranes under the influence of
external hydrostatic and osmotic pressures, the membranes themselves
are unlikely to be able to regulate these fluxes beyond gross changes
in permeability. Conversely, fetal swallowing may occur at variable
rates, and is an unbalanced process which causes a net efflux of
water from the amniotic fluid. Swallowing may therefore be of
considerable regulatory importance, even th ugh its contribution to
the total rate of water turnover is small.
A number of studies have shown that abnormally large volumes of
amniotic fluid (polyhydramnios) occur more frequently in cases of
fetal malformation, and it has been suggested that in many of these
cases, the malforsaation prevents normal volumes of liquor being
swallowed in itero. Jeffcoate and Scott (1959) surveyed the records
of 169 patients with polyhydramnios and found that in 54 (32 ) of the
cases there was evidence of defective fetal swallowing. Of these
54 cases, 34 were anencephalic or iniencephalic, 16 had gastro¬
intestinal atresias or other similar obstructions, and 4 had hydrops
fetalis which was accompanied by gross oral oedema. In a similar
recent study, Gadd (1970) found that 24 of patients with polyhydramnios
had an anencephalic baby, and 5 had babies with obstructions of the
alimentary tract. Teffcoate and ,cott (1959) suggested that the
anencephalic and iniencephalic fetuses were unable to swallow, either
because their brain malformation was extensive enough to interfere
with the neural control of swallowing, or because the cervical
abnormality was severe enough to cause mechanical obstructions to
swallowing. 'hey suggested that the cases of anencephaly which were
not associated with polyhydramnios were mild enough to permit swallowing.
12.
McLain (1963) injected radio-opaque material into the amniotic
sac to observe the rate of fetal swallowing, and found the rate
to be reduced in cases of polyhydramnios. The swallowing rates
of anencephalic fetuses have also been measured directly. Pritchard
(1965, 1966) observed that in six cases, the rate of swallowing was
between 0 and 13 ml per 24 hours. -bramovitch (1970) found that in
six out of eight cases the rate of swallowing was less than 24 ml per
24 hr., whilst in the two other cases there were rates of 79 and
237 ml per 24 hr. These data show clearly that the rate of swallowing
is severely reduced in most cases of anencephaly.
Abraraovitch (1970) found no correlation between the rate of
swallowing of anence halic fetuses and the volume of their respective
amniotic fluids, and suggested that fetal swallowing played little
part in the production of polyhydramnios. However, it must be added
that the measurements of swallowing were made after the excessive
volume of liquor had been established, so that a role for swallowing
in the genesis of polyhydramnios cannot be ruled out. Nevertheless,
it may be that the increased volumes of amniotic fluid are due to the
transudation of cerebro-spinal fluid (CSP) or other fluids out of
the exposed brain. In this case, the volume of amniotic fluid might
still bear some relation to the severity of the lesion, as has been
suggested by Teffco. te and Scott (1959); however, this would not
so much be due to defective swallowing, as to the extent to which
the brain was exposed. otter (1961) considers it unlikely that
CSF would materially contribute to the fluid volume; however, it
would not necessarily be prevented by the collagen membrane which
Benirschke and iicKay (1953) found to be covering the exposed parts
13.
of the anencephalic brain. Evidence which supports the possibility
of fluid transudation from the brain is discussed on p.80.
Few studies have been made 011 the physiology of polyhydramnios
associated with normal fetuses. ritchard (1966) measured the
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swallowing rates in three such fetuses at term, by injecting Cr
labelled red cells into their amniotic fluid. He found that two
fetuses swallowed normal quantities of amniotic fluid, 'whilst the
third swallowed much less than normal. This suggested that poly¬
hydramnios in normal fetuses may either be due to oversupply of
amniotic fluid water, or to a reduced rate of swallowing. However,
work by Hutchinson et al (1959) on two cases of polyhydramnios at *
term, suggests that the situation may be more complex. Although
there was a reduction in the rate of transfer of water from the
amniotic fluid into the fetus, there was also a marked reduction
in the rate of exchange of rfater across the placenta between the
mother and the fetus. They found that although more water than
usual was pa3sin - out of uhe fetus into the fluid, the rate of water
efflux from the fluid into the maternal serum was at least as great
a3 in the control patients at term. The causal connection between
the reduced w iter fluxes between the two circulations and the genesis
of polyhydramnios remains unsolved,
ii. Fetal Urine
' bramovitch (1970), discussing the extent to which fetal urine
may be considered as a major source of amniotic fluid, pointed out
that no firm conclusion was possible, since no clear evidence
existed on the rate of voiding in utero. He suggested that at
term the fetus might void 450ml/24hrs in order, perhaps, to balance
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the effect of swallowing. However this may well be an overestimate,
as it ignores other sources utilising hydrostatic energy (e.g. umbilical
cord transudation). The situation early in gestation is still less
clear. Urine has been found in the fetal urinary bladder from
eleven weeks of gestation onwards (Abramovitch, 1968, 1970), though
attempts to deduce voiding rates from bladder capacities are
hazardous. Jeffcoate and cott (1959) reviewed reports of oligo¬
hydramnios associated with agenesis or obstruction of the fetal
urinary tract. In a total of 295 cases of severe urinary tract
anomaly, there was "firm or presumptive" evidence of oligohydramnios
at delivery in 100 cases. In the majority of the remaining cases,
no reference to the volume of amniotic fluid -was made. 'here have
been cases of renal agenesis reported in which there were normal or
large volumes of liquor. However, in three such cases (.Jeffcoate
and Scott, 1959; Bain and cott, 1960) the fetus was anen- or inien¬
cephalic, and thus the water may well have been associated with the
cranial rather than the urinary lesion. Oespite these exceptions
(see Abramovitch, 1970), cases of bilateral renal agenesis and
urinary tract obstruction have been reported with normal volumes of
liquor and no other detectable abnormality. Abramovitch (1970)
has pointed out that the additional liquor may be due to changes in
the permeability of the umbilical cord and the fetal membranes, or
to other apparently minor changes associated with renal agenesis,
such as hypoplastic lungs (potter, 1961). alterations in the fetal
swallowing rate must also be considered,
iii. Umbilical Cord Transudation
The radioactive tracer experiments of Hutchinson et al (1959)
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and of Plentl (1961) showed that the umbilical cord can transfer water
from the fetal circulation into the amniotic fluid. hese conclusions
confirmed those of Runge (1927, 1929), Runge et al (1928), and were
later amplified by Feliks (1968a, b). Feliks showed that water and
a variety of small molecules could permeate the cord, and from his
data it may be calculated that the cord passed 30-40 ml water per
hour into the amniotic fluid at term under the influence of fetal
blood pressure. Feliks (1968b) also found that the permeability of
the cord for water and for other small molecules (except chloride)
increased as the cord diameter increased, and suggested that this
was due to the thicker cords being more hydrated. In subsequent
investigations, the degree of cord hydration was studied, and
6U~\c( (OaJtef
Feliks * suggestions -ere supported (: atrick^ 192f<}). The notably
thick umbilical cords, which are commonly found in infants of
cvyc*. U3cilVa.ec
diabetic mothers, are also very hydrated (Patrick^ and it
may be that the well-known association between maternal diabetes
and polyhydramnios is due to a change in umbilical cord permeability.
Parry and bramovitch (1970) investigated the possibility that
the umbilical cord might regulate water exchange between the fetus
and the amniotic fluid by studying the cord's histology. hey found
that the cells on the surface of the cord were relatively unspecialised
in appearance, and that gaps occurred between the 'type I' cells
which occur particularly at the fetal and of the cord. They
suggested (as did 'ait, 1875 -1376) that much of the water exchanged
passed through these gaps, and that the cells on the surface of the
cord played little role in controlling this exchange. Parry and
ibramovitch pointed out that the endothelium of the cord vessels may
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be of importance in regulating water exchange.
iv. ,ater -'luxes across she : etal .kin and jgsmbranes
It is thought that, in the absence of hydrostatic pressure
gradients, not fluxes of water across membranes are always associated
with active sodium transport (Ussing, 1964; tein, 1967). Phis
sodium transport is usually, but not always associated with an
electrical potential difference across the membrane. Thus the
finding that at term there is no potential difference across the
amnion (darby, 1957; liellor et al 1969) strongly indicates that
this tissue cannot transport salt and water actively. Observations
made on early samples of .amnion by Lind et al (1972) produced similar
results. Lind et al (1972) also made direct studies on the transport
of sodium ions across fetal skin and amnion by radioisotope flux
measurement. They concluded that no active transport of sodium occurs
across these tissues during the second trimester of pregnancy.
Collectively, these data indicate very strongly that the fetal akin
and amnion are not able to regulate the flux of water between the
amniotic fluid and other compartments.
:-'he recisio:; of Influx o"ulutio~ at :erm
The number of possible net sources of amniotic fluid water
raises the question of whether there is any inherent precision in
the flux rates from individual sources. One as-yet unremarked
observation suggests that there is considerable precision, although
the location of its control is not clear. At term, Lind et al
(1969) and Roopnarinesingh and Korris (1970) have both found a
close correlation bet\*een the concentrations of creatinine in
amniotic fluid and in maternal serum, despite the concentration in
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amniotic fluid boing 2~5 times that in maternal scrura. Hinee fotal
urine is the major source of amniotic fluid creatinine, it follows
that the concentration of creatinine in maternal oerua controls the
concentration i amniotic fluid via the fetal serum and urine. rhe
concentration of creatinine in amniotic fluid i3 unlikely to control
that in maternal oerun, since "the difference in volumes of the two
compartments is so great. :his suggests that the rate at which
the fetus excretes creatinine is closely regulated (probably by the
glomerular filtration rate). \ further implication of this finding
is th«t there is a closely controlled relationship between the quantity
of creatinine voided and the rate of supply of water from both the
urine and from other sources (e.g. umbilical cord). This particularly
applies at term, ;hon the bulk turnover of amniotic fluid is relatively
rapid. If the net influx of water into the amniotic fluid wa3 very
variable, then no proportionality would be found between the creatinine
concentrations in the maternal serum and the amniotic fluid.
c. 'purees of u.r<fotic fluid v.^or in the first .-elf oi pregnancy
All the evidence cited above refers to she latter half of
pregnancy, olyhydraianioa is not usually detectable early in
pregnancy; and in cases of renal ..genesis, it is not clear whether
the oligohydranni: of late pregnancy was present before twenty weeks.
Thus, the association between renal agenesia and oligohydramnios may
not bo used ts evidence for a major fetal urinary contribution to
amniotic fluid early In pregnancy. Although urine has been found
in the bladders of fetuses from eleven weeks of gestation onwards,
(ibramovitch, 1968, 1970), there is no direct evidence of the rate
at which urine i voided. Calculations suggest that between 7 and
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17ml are voided per 24 hours, however the premisses upon which the
calculations were based are arguable (AbramovjStch, 1970). Between
seventeen and twenty-one weeks of gestation, the concentration of
sodium and chloride in amniotic fluid is approximately twice that in
fetal urine, and nearly equal to that in fetal and maternal plasma
(Abramovitch, 1970). However, this does not argue against fetal
urine as a major net source of amniotic fluid water, because the rate
of 3odium chloride influx from other sources has not been fully
investigated.
Lind and ytten (1970) and Lind et al (1972) have claimed that
amniotic fluid before twenty weeks of pregnancy is "an extension of
the fetal extracellular space" and that its volume and other character¬
istics are controlled by the fetus. However, it is disputable
whether there is evidence to support this claim. The fact that there
is a close correlation between the volume of amniotic fluid and the
fetal length or weight cannot be used to argue that the fetus controls
the volume and composition of amniotic fluid.
Lind et al (1972) rightly point out that some net influx of water
into the amniotic sac must occur to counteract the efflux of -water
resulting from the hydrostatic pressure of the uterus on the amniotic
3ac. .'he net influx must also balance the effect of fetal swallowing,
although this is a much smaller factor than at term ( ritchard, 1966;
i'.braaovitch, 1970). However, it is not clear that there is a net
flux of water from the fetus into the amniotic fluid in addition to
the voiding of urine. ince Lind et al (1972) were unable to find
in vitro evidence that a net flux of water might occur as a result
of sodium transport across the fetal skin and membranes (p.16 )» it
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may be that fetal sources of water which are independent of fetal
urine only enter the amniotic sac under the hydrostatic force of the
fetal blood pressure. hether the fetal blood pressure is
sufficiently high enough early in pregnancy to cause a significant
contribution i3 not known.
It is possible that the placental membranes raight provide a
pathway for not water transport. The energy for this transport
would come from the pressure of maternal blood circulating against
the chorionic plate, between the roots of villi. The development of
the placenta and its membranes, together with possible changes in the
maternal placental circulation might be responsible for some of the
increase in fluid volume during the first sis months of pregnancy.
1though the point has not been investigated early in pregnancy, it
seems very likely that the hydrostatic pressure gradient across the
placental membranes due to the maternal circulation under the
chorionic plate will exceed that across the fotal skin, so that this
maternal source is worthy of some consideration. Some indirect
evidence will be liscusaed later (p.118 ) which. suggests that
permeability changes occur in the fetal membranes during the first
six months of pregnancy.
4. Amniotic fluid , rotoin
a. uantity
The protein in amniotic fluid may be considered as existing in
a number of different forms. It may be part of an intact cell
(e.g. Nelson and -mery, 1970), or it may be a free cellular organelle
(. -alafaky and "adlor, 1971), or it may be soluble protein. This
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review is concerned with the soluble protein in human amniotic fluid,
although in many of the papers cited cellular organelles have not
been stringently removed by centrifugation.
Cantarow et al (1933) showed that the mean protein concentration
in term amniotic fluid was less than one tenth of that in maternal
serum. Derrington and Soothill (1961) compared the concentrations
of various serum proteins in amniotic fluid at term with the concen¬
trations found in maternal and fetal serum. They found that the
amniotic fluid : maternal serum ratios for albumin ranged from 1,/12
to 1/40} for transferrin (siderophilin) : 1/12 to 1/56} for
tf-globulin : 1/32 to 1/144; and for caeruloplasmin : 1/64 to 1/128.
The corresponding protein concentration ratios for amniotic fluid :
fetal serum were for albumin : l/tO to 1/64, for transferrin : 1/4
to 1/28, for tf* globulin : 1/56 to 1/192, and for caeruloplasmin :
1/16 to 1/24.
ueenan et al (1970) showed that there were changes in the
protein concentration in amniotic fluid as pregnancy proceeded.
Although there -was a considerable scatter of results, they found that
the protein concentration increased from a mean of 3.5mg/ml at twelve
weeks of gestation to a maximum of 6.6mg/ml at about twenty-five
weeks. After twenty-five weeks there was a marked fall in concen¬
tration to about 3ng/ml at thirty-five weeks. Between thirty-five
and thirty-nine weeks there was little further change in concentration.
Ho consistent changes in the protein concentration were found in
cases of mild or moderate rhesus iso-i.'amunisation, although in very
severe cases more random patterns with some very high values were
observed as pregnaney proceeded. The reasons for the changes in
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amniotic fluid protein concentration were not clear, partly because
the nature of the protein had not been adequately studied. Queenan
et al (1970) suggested that the fall in protein concentration after
twenty-six weeks was due either to fetal swallowing or to dilution
following an increase in amniotic fluid volume.
Gitlin and Biasucci (1969) have measured the concentrations of
various serum proteins in a small series of amniotic fluids before
term. However, the data are not extensive enough to allow a firm
conclusion to be drawn about the quantitative behaviour of serum
proteins in amniotic fluid.
b. Me rum origin of amniotic fluid protein
Paper, disc, and cellulose-acetate electrophoresis have shown
that the mobilities of the major proteins in amniotic fluid are
similar to those in serum, and various authors have claimed that the
protein in amniotic fluid ia either of maternal or fetal serum origin
(see Table 1). All the studies in Table 1 reported amniotic fluid
protein bands corresponding to serum albumin, and , (3, and ^"-globulin.
The a,g globulins in amniotic fluid were present in very low concen¬
trations, and were best detected by cellulose-acetate electrophoresis
(Wild, 1961), or by concentrating the fluid prior to paper electro¬
phoresis. 'The majority of the work -was carried out on fluids taken
between thirty-six weeks of gestation and term. Only McKay et al
(1958) and Brzezinski et al (1964) studied earlier samples.. In
most of the stxidies, the electrophoretic patterns were scanned by
an integrating densitometer to express the percentage of the total
stained protein which was found in each band. In this way it wa3
established that the percentage of albumin in amniotic fluid protein
exceeded that in maternal serum (Table 1). Immunoelectrophoresis
TABLE 1
Electrophoretic studies on Jimiotic fluid protein
Author
*




1st 2nd 3rd Term
Barbanti 1956) PE y y y Similar to MS
Palliez et al 1956) PE y Amniotic epithelium
secretion
HcKav et al 1958) PE . 7 AF AsG >MS suggest
maternal origin of
protein
Mentasti 1959) FME y y y ^S/A^ after 6 month
suggest fetal serum
origin
Abbas & Tovey 1960) PE
Dialysis
y AF AsG >MS
AF At G = MS dialysate
Strebel 1960) IBs 3 4 3 12 Serum protein in AF
Derrington &
3oothill




40 AF AsG > MS
Brzezinski et al 1961) PE 23 AsG of F'S >AF> MS
MBE .'.fetal origin
Viergiver et al 1962) PE 1 13 AsG of PS >AFP>MS
Brzeainski
et al
1964) MBE 3 11 AsG of AF>FS.Bis-
albuminaemia in fetus
and AF indicates fetal
origin - see text p.33
Heron 1966) PE 4 103 AF AsG ratio increases
from 1.0 at 36 wks. to
1.8 at 43 wks.
Usategui-G-omez
et al
1966) DE 12 Serum Protein in F
von Kleist et al 1968) IEa -12 2 2 Serum and non-serum
proteins
Castelaso-Ayala 1968) PE 28- Serum protein : in




Author Method No. of amniotic fluids studied Conclusion
durin-; each trimester
1 st 2nd 3rd Term
Vernier ot al (1969) IEs 9 A:GofAF>KS
Fischbacher & (1970) IEs Y Serum protein in AF
uinlivan
Key
DE a Disc Electrophoresis
FME = Free micro-electrophoresis
IEs = Immunoelectrophoresis using antisera
against human serum
lEa = Immunoelectrophoresis using antisera
against amniotic fluid
= number unspecified











using antibodies against human serum protein confirmed that the major
amniotic fluid proteins were indeed serum proteins (strebel, 1960;
Derrington and Soothill, 1961; Vernier et al 1969; Fischbacher and
Quinlivan, 1970). However, it remained a possibility that there were
non-serum proteins in amniotic fluid, which were not detected by the
insensitive methods of paper or cellulose acetate electrophoresis,
and would not be detected by Immunoelectrophoresis using antisera
against human serum protein. A number of immunological studies
have been made to examine this possibility.
c. Ilon-aerum protein in amniotic fluid
Derrington and oothill (19G1) raised rabbit antibodies against
term amniotic fluid protein, and absorbed the resultant antiserum
vfith human sorum to remove the antibodies against human a crura protein.
Ihey then tested the absorbed antiserum against human amniotic fluid
by Immunoelectrophoresis to search for non-serum proteins. Because
they found no residual precipitin lines, Derrington and Soothill
concluded that the vast majority of protein in term amniotic fluid
vfa3 of serum type. It fell to Salmon et al (1962) to describe the
first non-serum protein in human term amniotic fluid. She origin of
this protein was shown by immunofluorescence to be the epithelial
cells of the amnion. Subsequent studies showed that this protein
had an mobility (Lambotte and Salmon, 1962; Lambotte, 1966), and
that it was a glycoprotein with an unusually high content of reducing
sugar (Lambotte and Ilhlenbruck, 1966; Lambotte and Sosselin-Rey, 1967).
A similar protein was found in bovine amnion, and the unusual nature
of these glycoproteins prompted Lambofcte and Uhlenbruck (1966) to
call them 'uaniomucoids.
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A specific amnion protein of a -mobility has also been found in
rabbit amniotic fluid and in neonatal rabbit sera up to the twentieth
day of life (Lambotte, 1963), though this protein was not detectable
in maternal sera. Of considerable interest is the finding of
Lambotte et al (1963) that rabbit -amnion protein will evoke an
antibody response when injected into the mother rabbit. Further,
Lambotte et al found 3ome aultiparous animals who had developed
antibodies against rabbit -amnion protein in the absence of
experimental i aunisation. "his observation prompted speculation
about the role of such immune phenomena in the genesis of congenital
abnormality and abortion. Lambotte (1965) immunised a number of
adult female rabbits with rabbit amniotic fluid protein and counted
the number of still-births which occurred in subsequent pregnancies.
In the immunised group of rabbits, 64.5 of fetuses were stillborn,
whereas the rate in primaparous control rabbits was 0, , and in
multiparous control rabbits was 4.4 . Fetal death could also be
brought about by injecting a control pregnant rabbit with serum from
a sensitised rabbit. Fetal death was unaccompanied by visible
congenital abnormalities, and those fetuses which wore live born were
apparently normal. However, it is not clear that this observation
can be simply applied to the case of the multiparous rabbits who
have spontaneously acquired antibodies against amniotic fluid protein,
since in these cases the rate of fetal death was not linked to the
presence of the antibodies.
A similar immunological study of the non-serum proteins in
human amniotic fluid was made by von Kleist b al (1963). These
workers studied twelve fluids of between six and sixteen weeks
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gestation, two fluids between sixteen weeks and term, and two samples
of amniotic fluid at term. Some, or all of these samples were used
to immunise two rabbits, and the resultant antisera were absorbed with
human serum and tested for antibodies against non-serum protein.
Four non-serum protein precipitin lines were detected by immuno-
electrophoreais. One mobility protein was identified as
-fetoprotein. Two a^-proteins were found in late liquor samples
and were found to be present in amnion. A ,3-mobility protein wa3
also found, though this waB shown to be due to contaminating haemoglobin.
These preliminary studies used relatively insensitive qualitative
iramunoelectroohorotic methods to detect new antigens. There is a
clear need to extend these studies, using more sensitive and quantitative
techniques. This will enable a further understanding of the factors
causing the changes in amniotic fluid protein concentration observed
by ueenan et al (1970), and will provide potentially important data
on the contribution of tissue-specific antigens to the amniotic fluid
of normal and abnormal fetuses,
d. Origin of the scrum proteins in amniotic fluid
i. :~imple quantitative studies
A number of quantitative and qualitative studies have been made
on the origins of the serum proteins in amniotic fluid. McKay et al
(1953) pointed out that the increased proportion of albumin in the
fluid was typical of the protein of the interstitial fluids, and
concluded that a maternal serum origin was likely during the first
trimester. Abbas and Tovey (i960) reasoned that if the serum
protein in amniotic fluid was of maternal origin, then it must enter
the amniotic 3ac by diffusing through the fetal membranes. They
therefore asked whether the differences between the maternal serum
and the amniotic fluid patterns were due to the diffusion process.
They found that at term, the pattern of amniotic fluid protein was
very similar to that obtained by dialysing maternal serum through the
fetal membranes, and concluded that the amniotic fluid might be a
simple dialysate of maternal serum. However, as ild (1961) has
pointed out, the equivalent experiment of diffusing fetal serum
through the surface of the fetus (umbilical cord) has not been
carried out, so that a fetal contribution is not excluded. Indeed,
because the percentage of albumin in fetal serum protein i3 greater
than in maternal serum (McKay et al 1958} Brzezinski st nl 1961),
Brzezinaki et al (1961) thou^t that the protein in amniotic fluid
was of fetal origin.
Mentasti (1959) was among the first to suggest that the protein
in amniotic fluid resembled fetal serum protein more closely than
maternal serun protein. Using free microelectrophoresis he found
that after the sixth month of pregnancy, there was an increase in
the percentage of ^globulin and a decrease in the percentage of
albumin in both fetal serum and amniotic fluid protein. No such
change was detected in maternal serum. Jhis finding has not been
re-examined, and more recent vrork on the origin of albumin and
•^globulin in amniotic fluid suggests that the conclusion is
questionable (.Derrington and oothill, 1961; ditlin et al 1964).
Jild (1961) found a correlation between the concentrations of
bilirubin and protein in amniotic fluid, and suggested that since
the bilirubin was of fetal origin, the albumin (which binds the
bilirubin) must also be of fetal origin. He suggested that the
umbilical cord, was the most likely route for the complex to enter the
amniotic sac. It must be added that in severe cases of rhesus
disease, this proportionality is not found as there is an increase in
the ratio of bilirubin s protein (Morris et al 1967; Fort, 1971).
Although /lid's observations are of considerable interest, it has yet
to be demonstrated that bilirubin actually passes out of the fetus
bound to albumin. It is fairly clear that most of the bilirubin in
amniotic fluid and fetal serum is unconjugated (see Fort, 1971) and
that about 99i is bound to albumin, (Odell et al 1969} liandelbaum
et al 1967). However, the covalent linkage between albumin and
bilirubin is not strong. Bilirubin may be displaced from the protein
by low pH, anionic drugs, and some naturally occurring anions,
including bile acids and fatty acids (see Odell et al 1969). If
the umbilical cord i3 a major source of amniotic fluid bilirubin,
then the polyanionic mucopolysaccharides of harton's jelly may
displace bilirubin from the albumin. If this occurs, the bilirubin
will pass much more quickly into the amniotic fluid than will
albumin, because of the differences in molecular 3ize. Once in the
amniotic fluid, the bilirubin would again be able to bind to albumin,
irrespective of the protein's origin.
Derrington and foothill (1961) argued that if sorum proteins
entered the amniotic fluid by ultrafiltration, then proteins of
similar molecular weight would diffuse into the amniotic fluid at
approximately the sane rate. Thus the concentration ratio of such
proteins in amniotic fluid would be similar to the ratio in their
serum of origin. Comparison of the concentration ratio in amniotic
fluid \irith the ratio in maternal and fetal serum should therefore
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provide an indication of the origin of the amniotic fluid proteins,
provided that the ratios in maternal and fetal serum were sufficiently
different. They therefore compared the ratio of transferrin
(siderophilin) : albumin and the ratio of caeruloplasmin : /-globulin,
and found that the ratios in term amniotic fluid were significantly
more similar to the ratios in maternal serum than to the fetal serum
ratios. They concluded that at term these proteins were more
likely to be of maternal rather than fetal origin.
Usategui-domes et al (1966) expressed the concentrations of
transferrin and caeruloplasmin in amniotic fluid as percentages of
the total protein, and compared the percentages in amniotic fluid
with those in the maternal and fetal serum. They found that the
percentages of the two proteins in amniotic fluid were very similar
to those in maternal serum, and over twice as great as the percentages
in fetal serum. Prom this they concluded that the proteins were of
maternal origin. Hoxfever, a similar pattern was not found for other
serum proteins, and although this may be explained on the bases of
molecular weight, other interpretations could be advanced.
Of considerable interest i3 a preliminary report on the
haemopexin and albumin in amniotic fluid. Haemopexin is a
(3-glycoprotein which binds free haem in the serum. Jxuller-Eberhard
and Bashore (1370) found that in cases of ix isoimmunisation, the
ratio of haemopexin : albumin in amniotic fluid fell during severe
fetal haemolysis. The concentration of haemopexin in adult and
neonatal serum falls when haemolysis occurs for any reason
(ji'uller-Bberhard et al 1968; Bears, 1969). 'his is believed to
occur as a result of the haenopexin-haen complexes being removed from
the senna by the liver (Kull&r-Eberhard et al 1969). It is not
clear at present whether the change in amniotic protein ratios found,
in severe Kh disease are due to haem in the amniotic fluid precipi¬
tating kaemopexin, or whether the ratio change is caused by changes
in the serum. The latter possibility may be more likely, and is of
interest as it poses the question of whether amniotic fluid haemopexin
is of maternal or fetal serum origin. since starch gel electro¬
phoresis has failed to reveal genetic variants of human haemopexin
(htewart and Lovrien, 1971)» quantitative studies will have to be
made on the concentration charges of haem and haemopexin in fetal and
maternal serum.
a-Fetoprotein has been detected in amniotic fluids between six
and thirteen weeks by Gitlin and Boesman (1966) and throughout
gestation by Sepp&lS. and iuo3lahti (1972). This fetal 3erum protein
is synthesised in the fetal liver, yolk sac and gastrointestinal
tract from the sixth week of gestation (Gitlin and Boesman, 1967;Gitlin
et al 1972), and since the concentration of a-fetoprotein in
maternal serum is much lower than that in amniotic fluid (Gitlin and
Boesman, 1966; Ruoslahti and Seppala, 1972), it has been suggested
that the protein must enter the amniotic fluid direct from the fetus.
However, although it is not clear how much of a contribution the
yolk sac makes to the ---fetoprotein in amniotic fluid, what con¬
tribution it does make after 10 weeks of gestation will be independent
of the fetus, since the vitelline vessels have been obliterated by
this time. Gitlin and £0soman (1966) found that the ^fetoprotein
in fetal urine was often greater than that in the amniotic fluid
early in gestation, and suggested chis was a major source of the
protein. They pointed out that if urine was a major source, then
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alternative sources were probably contributing albumin to the amniotic
fluid, because the concentration ratio of albumin to a-fetoprotein in
amniotic fluid was 12 to 80 times greater than that in fetal urine.
This discrepancy in relative concentrations is even more significant
if the yolk sac is contributing .^-fetoprotein to the amniotic fluid.
However, it is not clear that the fetus contributes urine to the
amniotic fluid at this early stage of pregnancy (p. 17), and the
albumin and :>»fetoprotein nay diffuse out of other fetal tissues at
different rates. Of considerable interest is the finding of a
large concentration gradient for o-fetoprotein between the fetal
serum and the .amniotic fluid. G-itlin and Boesman (1966) found this
to be of the order of 182 : 1 to 625 : 1 between nine and thirteen
weeks of gestation. This may indicate the relative impermeability of
the fetal tissues to the flux of fetal serum protein into the amniotic
fluid.
Casper and Benjamin (1970) have reported that, whilst they could
detect iBimunoreactive insulin in amniotic fluids from twenty weeks of
gestation until tern, none was present in the 3ingle fluid sample
studied at sixteen weeks of pregnancy! They suggested that the
appearance of insulin in the amniotic fluid between sixteen and
twenty weeks of gestation was due to the onset of insulin secretion
by the fetal pancreas. however, insulin has been detected in fetal
plasma as early as eleven weeks of gestation (.'.dam at al 1969)? and
by fifteen weeks the concentration in fetal plasma exceeds that in
maternal plasma (Thorell, 1970). Thus, the failure to find insulin
in a single sample of fluid at sixteen weeks of gestation does not
constitute evidence that the insulin in amniotic fluid is of fetal
origin.
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Casper and Benjamin (1970) also found that insulin was absent from
the amniotic fluids of three fetuses who died in utero during the third
trimester of pregnancy. From this, they argued that the insulin in
amniotic fluid was "mainly or entirely fetal in origin". However,
insulin is a labile molecule, prone to loss of activity by reduction
of its disulphide bonds (Buse et al 1962; Katzen et al 1962).
Furthermore, the placenta i3 known to contain potent insulinase
activity (Goodner et al 1959), and it may be that the absence of
insulin in the fluids of dead fetuses is due to insulin degradation
(this is especially likely as the fetuses had been dead in utero up
to 3 weeks before amniocentesis). This possibility could have been
simply investigated by adding insulin to the amniotic fluid sample
and testing the effect of incubation at 37°C; it is not clear that
this was tested by their recovery experiment.
In a further attempt to study the relationship of the amniotic
fluid insulin to that in maternal serum, Casper and Benjamin measured
the insulin in single samples of amniotic fluid taken from third
trimester patients before, and at various times during oral glucose
tolerance tests. They claimed that a peak in the concentration of
insulin in amniotic fluid only occurred at one hour after the test
dose, whilst that in maternal serum lasted over three hours. However,
the elevation of the mean insulin concentration in amniotic fluid one
hour after the test dose was due mainly to the very high levels in two
of the six fluids studied. Further observations are needed to clarify
this point. If a concentration peak does occur at this time, then
the decline during the second hour provides evidence of the lability
of amniotic fluid insulin.
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It has been shown that glucose and tolbutamide have much greater
effects on the neonatal serum insulin concentration if the mother is
diabetic (Baird and Farquhar, 1962; Velasco and aulsen, 1969;
Cole et al 1970). Thus, if the data of Casper and Benjamin (1970)
on the changes in amniotic fluid insulin concentrations are supported,
comparison of the fluid insulin responses to glucose and tolbutamide
loads in normal and diabetic mothers may throw light on the origin of
amniotic fluid insulin.
Human placental lactogen has been found in term amniotic fluid
and in maternal serum, but is virtually absent from umbilical cord
blood ('Pal lberg et al 1965). As this protein is thought to be
synthesised only in the placenta it must enter the amniotic fluid by
diffusing through the placental or reflected membranes. The relative
concentrations of the protein in amniotic fluid and maternal serum
have not been measured (seppElE, personal communication),
ii. Evidence from genetic, immunological and radioisotopic markers
The use of genetic variants is one of the methods of choice
for investigating the origin of a protein in amniotic fluid. The
method was first used by SeppalE, Ruoslahti and Pallberg (1966) to
determine the origin of transferrin in amniotic fluid. These
workers studied the transferrin (Tf) phenotypes in amniotic fluid and
maternal and cord sera from pregnancies at term. In twenty-seven
cases the Tf phenotypes in the maternal and cord sera were both
concordant for the common type : CC, however, in two cases there was
discordance between the maternal and fetal phenotypes and in both
cases the amniotic fluid Tf phenotype was that of the mother.
Similar work was carried out on the a.^ group-specific component (Gc)
by Ruoslahti et al (1966) and Usategui-Gomez and Morgan (1966).
The frequency of variants is much higher for 0c than for Tf so that
it is easier to find feto-maternal discordance. Both groups of
workers found that in term amniotic fluid, the Gc phenotype was that
of the mother. The haptoglobin (Hp) in amniotic fluid must be
raaintainly of maternal origin since it is absent from' 90 of fetal
sera (scliultz and Herenens, 1966), However, Usategui-Gromez et al
(1966) showed that haptoglobin was only present in term amniotic
fluids when the maternal phenotype was 1-1. They pointed out that
the Hp 2-1 and 2-2 forms have higher molecular weights than Hp 1-1,
and that this may have prevented them from entering the amniotic sac.
The effect of molecular weight on protein permeation will be further
considered on p.
The ABH antigens are known to occur in amniotic fluid (Putkonen,
1930; Freda, 1953; Przestwor, 1964; Turowska and Bromboszcz, 1967;
Harper et al 1971). In a series of twenty-two term pregnancies,
Freda (1958) found that the fetal blood group antigens were expressed
in the amniotic fluid when the fetus was a secretor and the maternal
antigen was expressed when the mother was a secretor. Both pheno-
types were usually expressed when there was discordance for the
blood group antigens if both mother and fetus were secretor-positive.
frzestwor (1964) and Turowska and Bromboszcz (1967) found that the
occurrence of blood group substances in the amniotic fluid was
correlated with the fetal secretor phenotype. In a recent study
of sixty-seven pregnancies between nine and twenty-four weeks of
gestation, Harper ot al (1971) found that the phenotype of soluble
blood group substances in the amniotic fluid was determined by the
fetus, and their presence controlled by the fetal secretor phenotype.
The reason for the discrepancy between the results of Freda (1958)
and Harper et al (1971) is not clear. It may represent a difference
between amniotic fluids early and late in gestation, or it nay be that
the technique of Harper et al (1971) was not sensitive enough to detect
a maternal contribution.
Because the secretor locus is linked to that of myotonic dystrophy
(Mohr, 1954; Renwiek et al 1971) it has been suggested that linkage
analysis could be of importance for the prenatal diagnosis of myotonic
dystrophy (Renwick, 1969). However, linkage analysis will be useful
in only about 10-15 of pregnancies at high risk (Renwick, 1969;
Tmith, 1972), and about 10 of the diagnoses made xd.ll be erroneous
because of recombination.
Using a rather insensitive method, Brzezinski et al (1964)
claimed to have found a case of fetal bisalbuminaemia in which the
amniotic fluid contained the variant albumin, whilst the maternal
serum did not. Because the variant protein was said to be clearly
evident in the fetal and fluid samples, it was suggested that the
albumin in amniotic fluid was of fetal origin. ho fetus in this
case was in the sixth month of gestation, and the extra albumin
band appeared on electrophoresis as a small superimposed peak close
to the normal albumin peak. However, no evidence was provided that
it was antigenically related to albumin, and unfortunately no paternal
serum was available to show that the trait was heritable. Further,
although electrophoresis showed that the amniotic fluid also had an
unusual protein peal: in a similar position to that of the albumin
variant in serum, there were only two protein peaks of slower mobility,
and one of these was also superimposed on the albuinin peak. This
pattern was very different from that of other amniotic fluids, which
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all showed the globulin peaks as three separate entities well behind
albumin. For these reasons, the claim of Brzezinski et al (1964)
is based on unsatisfactoiy evidence. It may be that other explana¬
tions underlie their findings, and this is further discussed on p.58
It would be laborious to attempt to repeat the work of
Brzezinski et al (1964), as bisalbuminaemia is a rare genetic variant,
but another approach has been successful at term and could be developed
further. Dancis et al (i960, 1961) and Gitlin et al (1964) labelled
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albumin with I , and injected it into women at three and nine
months of pregnancy, respectively. They both found that the
concentration (counts per ml) of labelled albumin in amniotic fluid
was less than in fetal or maternal serum; however, Gitlin et al
(1964) showed that the specific activity of the albumin (counts per
mg albumin) in term amniotic fluid was 3-5 times greater than that
in fetal serum. If the amniotic fluid albumin had been of fetal
origin its specific activity would not have exceeded that in fetal
serum; thu3 a substantial fraction of the albumin in amniotic fluid
at term must be of maternal origin.
The specific activities of albumin and of ^-globulin in amniotic
fluids at three months gestation were less than those found in
corresponding maternal and fetal sera (Dancis et al 1960), and the
same was found for 7 S fl". -globulin (i.e. Fc fragments) at term
(Gitlin et al 1964). Although these results may indicate that the
.specific activities measured by Dancis et al (i960) were cpr: per
mg protein. Jhe individual concentrations of albumin and if-globulin
were not measured.
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proteins are of fetal origin, they are compatible with the hypothesis
of a maternal origin. Early in pregnancy the proteins may diffuse
more slowly into the amniotic fluid than into the fetal serum, so
that the specific activity of albumin in an amniotic fluid at three
months may be lower than in the fetal serum. At term the rate of
'bulk' turnover of amniotic fluid is far greater than at three months
(see section on fetal swallowing), whilst the amniotic fluid protein
concentrations are similar (Queenan et al 1970). Thus at term there
must be a rapid flux of protein into the amniotic fluid; this may
account for the high specific activity of albumin found in amniotic
fluid at term by Gitlin et al (1964). Evidence will be presented
on the concentration of serura proteins in amniotic fluid which may
indicate that the permeability of the membranes are lowest early in
pregnancy (p.117).
Radioactive labelling experiments may not be necessary for
investigating the origin of amniotic fluid Ig G, since specific
serotypes may be measured. However, the mere measurement of the
titres of Rh-antibodiee (TTsategui-Gomez and Stearna, 1969) or of
poliomyelitis antibodies (Lipton and >teigman, 1957) is not
sufficient, because the concentration of Ig G in amniotic fluid
(at term) is much less than in the fetal and maternal sera (Berrington
and Soothill, 1961). If the titre of a specific Ig G antibody in
amniotic fluid was expressed as a fraction of the total Ig G in the
maternal and the fetal sera, a more meaningful result would be
obtained. It must be stressed that the radioactive or immune
labelling experiments described above can only prove that the majority
of a protein is of maternal origin since the protein is injected into
or synthesiaed in the mother. Since the direct injection of
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radioactive protein into the human fetus is out of the question, the
use of genetic markers and tissue specific proteins are the only direct
ways of searching for fetal serum proteins in the amniotic fluid.
e. The selective effect of molecular weight on the serum proteins
present in amniotic fluid
Molecular weight is probably the major physical parameter
determining whether a serum protein can permeate into the amniotic
fluid. However, the shape and surface properties of the protein
will also control its relative concentration. Pre-albumin, albumin,
a.|-antitrypsin, o^-caeruloplasmin, group-specific component,
haptoglobin 1-1 , haemopexin, transferrin, ^ -globulin, plasminogen,
Ig and Ig A are all serum proteins which have been detected in
amniotic fluid (strebel, 1960; Gitlin and Biasucci, 1969; Muller-
Eberhard and Bashore, 1970). The heaviest of these proteins is
a^-caeruloplasmin, which has a molecular weight of approximately
160,000 (Schultz and Heremans, 1966). In contrast, -lipoprotein
(mol. wt. : 435»000), a^ macroglobulin (mol. wt. : 820,000),
6
(3-lipoprotein (mol. wt. : 3.2 x 10 ), o^-macroglobulin (mol. wt. :
820,000), and Ig M (mol. wt. : 1 x 10^) are absent from the fluid
(Strebel, 1960; Gitlin and Biasucci, 1969).
It Is clear that the majority of the haptoglobin in amniotic
fluid is of maternal origin, and that only the Hp1-1 form enters the
fluid in quantities detectable by disc electrophoresis (see p. 32:
Usategui-Gomez et al 1966). Phis may be accounted for by the
*
abbreviation: aol. wt. = molecular weight; data from Schultz and
Keremans (1966).
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differences in molecular weight. The molecular weight of Hp 1-1
is 35,000 (.Tayle and Boussier, 1955), whereas Hp 2-1 and 2-2 form
6
polymers of molecular weights up to 1 x 10 (tTsategui-Gomez et al
1966} Siblett, 1969).
The finding that the fetal secretor phenotype is expressed in
the amniotic fluid (p.32 J Harper et al 1971), is of interest not
only for it3 medical genetic implications, but al30 for its
biological ones. Secretor positive individuals are believed to
secrete soluble blood group substances from most exocrine glands
(see Glblett, 1969). Human endometrium and parietal decidua are
secretory tissues (see Hamilton et al 1964-)» and well be
expected to secrete blood group substances (Freda, 1958). However,
it appears from the genetic studies early in gestation that the
maternal phenotype is not expressed in detectable quantities in the
amniotic fluid. The i*eason for this may be that the molecular
weights of the soluble blood group substances are about 300,,100
(Oiblett, 1969), and thus do not easily cross the fetal membranes.
The fetal tissue of origin of these substances remains unsolved.
f. loutea of entry for serum protein into the amniotic fluid
i. The fetal membranes
This is the only pathway available for proteins which enter
direct from the maternal serum or the uterus (e.g. haptoglobin and
group-specific component). It xfould seem that the placental (a3
opposed to reflected) membranes may transmit much of the maternal
serum protein found in amniotic fluid, because maternal blood flows
freely against the chorionic plate (Fig.3). However, in vitro
studies have 3hown the placental and reflected portions of the amnion
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are equally permeable to albumin (darby, 1957).
Keiffer (l926)and Palliez et al (1956) claimed that the amniotic
epithelium secreted lipids and possibly other material into the
amniotic fluid, though the in vitro work of darby (1957) suggests
131that the permeation of I albumin through the membrane occurs
merely by passive diffusion through pores in the amnion. Phe
permeability of albumin through the amnion was found to be about
0.013 times that of sodium and chloride ions and 0.026 times that of
creatinine (darby, 1957). The possible contribution of amnion
protein to the amniotic fluid i3 discussed on pp.23-24.
ii. Fetal entry routes
Possible routes include the urine, the gastrointestinal, buccal
and bronchial secretions, the umbilical cord and the fetal skin.
However, although there is evidence to support the use of some of
these routes, the size of their contribution is not known. Albumin
and a-fetoprotein have been found in fetal urine between six and
thirteen weeks of gestation, and the possible significance of the
high fetal sex*um s amniotic fluid concentration .gradient for a-feto-
protein has been discussed on p. 29 . dastrointestinal and bronchial
secretions are known to contain some serum protein (Schultz and
Heremans, 1966) and may contribute protein towards terra. This may
especially apply to lung secretion, since evidence frora amniotic fluid
lipids suggests that pulmonary secretion occurs toward term
and Potter and Bohlender, 1941).
It is not clear whether serum protein permeates through the
human umbilical cord into the amniotic fluid, despite the interesting
speculations of /lid (1961). However, fluorescent antibody staining
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ha3 shown senua protein to be present in human Jharton's jelly at
term (Bardawil, Toy and Hertig, 1958), and albumin has been shown to
pass through sheep cords in vitro (Barcroft, Danielli, I-larper and
Mitchell, 1944).
The concentration of the proteins in fetal serum does not
remain constant during gestation, and this must be considered when
discussing a possible fetal contribution to the serum protein in
amniotic fluid. Gitlin and Biasucci (1969) found that the concen-
tration of fetal serum ^-immunoglobulin, p^-globulin, Q esterase
inhibitor, transferrin, haemopexin, and Og-toacroglobin increased
linearly by about ten-fold between ten and about thirty to forty
week3 of gestation, and a similar five-fold increase was found for
albumin (Gitlin and Boesman, 1966). At term, the concentrations
of these proteins were approximately the same as in maternal serum.
However, Gitlin and Biasucci (1969) found that some protein concen¬
trations remained uniform from early in gestation (-antitrypsin),
or increased by only two- to three-fold (c&eruloplasmin, plasminogen)
or actually fell ( -lipoprotein, and possibly $ l-immunoglobulin).
In the case of only three proteins were the concentrations in fetal
serum greater than in internal serum. These proteins were albumin
(hendenhall, 19 70), .^-microglobulin (Gitlin and Biasucci, 1969) and
a-fetoprotein (Gitlin and Boesman, 1966). Only in the case of
a-fetoprotein was the concentration gradient appreciable, and this
serum protein is the only one for which clear evidence of a fetal
contribution into the amniotic fluid exists.
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5. Enzymes in Amniotic Fluid supernatant
Table 2 summarises the enzymes which have been studied in
amniotic fluid at the various stages of pregnancy. Some of the studies
were made either to carry out prenatal diagnoses of inborn errors of
metabolism, or to enquire into the origin of amniotic fluid enzymes.
Most of the studies, however, were made in the hope that way3 of
monitoring fetal distress or prematurity might emerge. The work
in the latter category was rarely thorough enough for there to he
any hope of success.
The recent studies of O'Brien et al (1971) and Friedland et al
(1971) have shown that Tay-Sachs disease may be diagnosed in utero
between the fifteenth and twenty-3ixth weeks by measuring the specific
activity of the A form of hexosaminidase in amniotic fluid supernatant,
as well as cultured and uncultured cells. The initial attempt to diag¬
nose Pompe's disease prenatally by measuring a-1, 4-glucosidase in
amniotic fluid was encouraging (Nadler and Messina, 1969); however
subsequent studies (iiadler, Bigley and Hug, 1970) showed that normal
a-1, 4-glucosidase activity may be present in the amniotic fluids of
fetuses affected with the disease. However, the limited quantity of
control data makes it difficult to assess the biological significance
of this finding. Pluharty et al (1971) have reported that the a—1,
4-glucosidase in amniotic fluid is less sensitive to inhibition by
turanose than is the enzyme deficient in ompe's disease. They
also found that the fluid enzyme was more labile, and that its pH
optimum was more neutral. The turanose inhibition and pH profiles
were confirmed by Salafsky and Nadler (1972). These studies strongly
suggest that the a-1,4-glucosidase in amniotic fluid is not the same
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as that which is absent in bompe's disease, though it must be added
that these kinetic differences may be due to the very different
protein environments of the crude extracts used in the enzyme studies.
A few quantitative studies have been made into the origin of
amniotic fluid enzymes. Galafsky and Hadler (1971) have attempted
to study the particle binding of enzymes in amniotic fluid supernatant.
They subjected two amniotic fluids from the second trimester of
pregnancy to differential centrifugation, and claimed that over 35
of the alkaline phosphatase and a-1 ,4-glucosidase in amniotic fluid
was particle bound, whereas only 6 of the hexosaminidase was bound,
fet, although electron microscopical analyses showed that sub¬
cellular organelles were present in amniotic fluid, it is not clear
that the enzymes were located within these particles, rather than
being merely adsorbed either onto their surfaces, or onto the
surfaces of the general rissue fragments present.
Geyer and jchneider (1970) have measured the specific activities
of a number of enzymes in term amniotic fluid and in various fetal
tissues. On the basis of the relative enzyme specific activities,
ieyer (1970) suggested that the enzymes in amniotic fluid came from
amnion. However, the lactate dehydrogenase and malato dehydrogenase
isoenzyme patterns did not fully confirm this.
The possibility that serum might constitute a source of amniotic
fluid enzymes as well as other proteins has not been thoroughly
examined. Tornqvist et al (1971) found that during the second
trimester of pregnancy the specific activity of the diamine oxidase in
amniotic fluid is somewhat less than in maternal serum, whilst at
term there was no significant difference. The specific activity of
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the enzyme in fetal serum was considerably less than in either
maternal serum or amniotic fluid. Arainoguanidine is an inhibitor
of diamine oxidase, and the same workers injected 0.2 mg/xg of this
intra-muscularly into the mothers in ten individual pregnancies
during the second trimester. They found that there was a ten-fold
decrease in enzyme specific activity in the maternal serum, and a
five-fold decrease in the amniotic fluid. The significance of these
results is not clear, since the inhibitor may have entered the amniotic
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TIi . OF JHL- ■ JUDY
The introduction has reviewed work showing that the major
soluble antigens in amniotic fluid at term are of serum type,
and that of these antigens albumin, transferrin, and group-
specific component are mainly of maternal origin. However,
it is not clear whether this conclusion applies to the proteins
in amniotic fluid earlier in pregnancy. Likewise, little is
known about the nature and origin of non-serum protein in
amniotic fluid.
The object of the 'work presented in this thesis was to
investigate the nature and origin of amniotic fluid protein
throughout pregnancy. It was also an intention to examine
any finding which might appear to be of value for the prenatal
diagnosis of fetal disease.
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IMUNOLOGICAL STUDIED ON THf: .Nl) ORIGIN
01'' -RIO .IC r LUIS PROTEIN
MTakiAL-. .i<!.> KG JHODS
a. Introduction to the measurement of antibody-antigen complexes
A variety of direct and indirect methods can be used to observe
antibody-antigen reactions in vitro. The selection of an appropriate
method depends partly on whether quantitative or qualitative data
are needed; and also on the solubility of the antigen, the complete¬
ness of the antibody (i.e. its ability to form insoluble antibody-
antigen complexes in vitro). and the required sensitivity. The
major methods fall into one of two categories. In the first, the
insoluble antibody-antigen complexes are studied in 1ram thick agar
or agarose gels. In the other, the quantity of antigen available
to complex with antibody is measured indirectly, by measuring either
the extent to which it competes for antibody binding sites with a
purified, radiolabelled standard form of the 3ame antigen (radio¬
immunoassay) , or by measuring the amount of complement which is
fixed during the formation of immune complexes between the antigen
and immunoglobulins A and G.
In agar or agarose gel systems, the antibody-antigen complex
exists as a precipitate which may be stained with protein stains
after the soluble protein has been washed out with saline. The
basic requirements for this approach is a soluble antigen ( so that
it can diffuse through the gel), and a complete antibody (so that the
immune complexes are insoluble and thus form visible precipitates).
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One of the simplest gel precipitation methods is the double diffusion
method of Quchterlony (1943) which is used mainly for studying the
structural relationships between antigens using antisera of limited
specificity. In this method, the antibody solution (antiserum) and
appropriate antigen are placed in separate well3 at between 5mm and
2cm apart in agar (or agarose) gel. An immune precipitate occurs
after the antibody and antigen have diffused through the gel to meet
each other. The position of the precipitate line depends upon the
relative mobilities and concentrations of the proteins. Too high
a concentration of antigen will result in the non-appe. .ranee of a
precipitate, since most immune complexes are soluble in antigen excess.
In the case of horse antibodies the complex is also soluble in antibody
excess, but this is not true of rabbit or sheep antibodies.
Multiple reactions in the double diffusion system are indicated
by the number of precipitation lines between the antigen and anti¬
serum wells. In 3uch cases it is usually not possible to make
detailed studies on the individual bands without the aid of Immuno¬
electrophoresis (Grabar and .illiam3, 1953; Scheidegger, 1955).
The principle of Immunoelectrophoresis is the same as in double
diffusion, except that the antigens are first separated out by
electrophoresis. ..fter the electroshoretic step, the antiserum i3
then poured into a small trough "which is cut in the gel close beside
and parallel to the protein tract. The antibodies then diffuse into
the gel and complex with antigen to form arcuate precipitates which
approximately describe the concentration locus along one 3ide of the
antigen spot in the gel. The individual precipitates of different
proteins cross over each other without interference (being reactions
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of non-identity). Because the complex forms close to the outer
border of the antigen, the precipitate's outer edge is usually
smooth. Its inner edge is also smooth because the precipitate is
soluble in antigen excess. Rather sharper lines can be obtained
if horse antiserum is used, since the immune complexes are soluble
in both antibody and antigen excess.
Unlike the Ouchterlony and imaunoelectrophoretic methods, there
are gel systems which are quantitative, or both quantitative and
qualitative. ,/ith the exception of Oudin's diffusion velocity
method (Oudin, 1$M8), they employ the following principle. A small
zone of antigen is allowed to migrate (by either diffusion or electro¬
phoresis) into a gel containing antibody. This migration results in
a spreading of the antigen and a successive lowering of its concen¬
tration in the gel. 'lien the antigen concentration is low enough
for it not to be in excess, the antibody will complex with it and
precipitate. Thus the area contained within the precipitate increases
in proportion to the quantity of antigen present, provided a standard
concentration of antibody is present in the gel. This i3 the basis
of the radial immunodiffusion test (Mancini et al 1965) in which the
sample is placed in a small well in the antibody gel, and diffuses
radially to form a ring precipitate around the well during the following
3 days.
In multivalent systems, radial immunodiffusion is not appropriate,
because the many concentric precipitates are difficult to distinguish.
Antibody-antigen crossed electrophoresis (Ressler, 1961; Laurell,
1965; 1966; Freeman and Smith, 1970) resolves this problem, by first
separating the antigens by electrophoresis into a track in a simple
agarose gel without antibody. An agarose gel containing antibody
Figure 5 Diagram to show the development of iinrune precipitates
in antibody-antigen crossed electrophoresis. See pp. 46-47.
;.'he top diagram shows the hypothetical distribution of four antigens
after a sample has been subjected to electrophoresis in the first
dimension. The antibody gel has been laid on the right-hand side
of the plate, and the system is now ready for the second dimension
electrophoresis in the direction marked by the arrow. The strip of
gel outlined by the dashed lines either side of the stippled antigen
is considered in the lower diagrams.
The lower diagrams show the migration of the 3tippled antigen into
the antibody gel at various times. The crosses show the areas in
which antibody-antigen precipitation is prevented by the excess of




is then laid beside the antigen track, and the antigens are driven
into the antibody gel by further gentle electrophoresis (the so-
called second dimension step) in a direction perpendicular to the
first electrophoretic step (the so-called first dimension step).
As an antigen migrates into the antibody gel (Pig. 5 ) the low
concentration of antigen in front does not precipitate with antibody
because the antibody-antigen complexes are dissolved by the majority
of the antigen which follows (this occurs in the regions marked by the
crosses in the diagramatic tracks of Fig. 5 )• Because of this
process, the antigen only precipitates when most of it is spread out
in a thin rocket-shaped band. The area under this band is directly
related to the antigen concentration, and indirectly proportional to
the concentration of antibody in the second dimension gel. Fig.5
shows that the majority of the antigen is involved in the formation
of the rocket-shaped precipitate. 'his should be contrasted with
the immune precipitate of immunoelectrophoresis which involves only
a fraction of the total antigen present. It is this feature that
makes quantitative antibody-antigen crossed electrophoresis (AACE)
far more sensitive than immunoelectrophoreais.
Both gel methods are of considerable importance, as they allow
electrophoretic studies to be made on genetic protein variants.
AACE also permits individual proteins to be measured with confidence as
separate peaks in agarose gel. Complement fixation, on the other hand,
is a more sensitive method although it cannot be easily used to study
individual proteins in the absence of monovalent antisera. It can,
of course, be used to search for tissue specific antigens by using
absorbed antisera. Radioimmunoassay is of no value in the search for
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new antigens, since it requires a purified radio-labelled standard form
of the antigen to be available. It is of most value when well
characterised antigens (e.g. hormones) are to be measured at low
co ncent rations.
b. Preparation and injection of antigen, collection and adsorption
of antisera
Amniotic fluid was obtained from three sources. Zamples from
early in gestation were taken from hysterotomy sacs, and those from
about 20-38 weeks were taken by amniocentesis at the clinic for
patients with rhesus iso-immunisation. Collections of amniotic fluid
at term were made using an amnioscope during artificial rupture of the
membranes. The specimens of amniotic fluid were centrifuged at 125g
for 10 rnins., and were then concentrated x 10 by pressure filtration
at 4°C using Sartorius membrane filters (pore size:5-i5(j.) *30 p.s.i.
During the concentration procedure a thick deposit of amniotic fluid
solute accumulated on the filter and this was vigorously resuspended
before the material was stored at -20°C.
Adult male New-Zealand white, and Dutch-cross rabbits were
injected subcutaneously with 0.5 - 1.0 ml of x10 concentrated amniotic
fluid at approximately three weekly intervals. The first three
injections were dispersed in Freund's complete adjuvant (oifco).
A week after the third injection, the rabbits were bled from an ear
vein, and the antiserum was tested against amniotic fluid by Immuno¬
electrophoresis and MCE. ,<hen antibodies of sufficient strength
were present in the rabbit sera, injections were spaced to maintain
TABLE 3
Tank buffer Gel buffer
Diethylbarbituric acid 13.8 g 11.07 g
Na barbitone 87.6 g 70.07 g
Ca lactate 3.84 g 10.24 g




Final concentration of nethiolate in buffer
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the yield of antibody.
To search for antibodies against non-serum proteins using AACE,
the antisera against amniotic fluid were absorbed with pooled adult
(male) human 3Qrum. The following routine was used. To 15 ml
of rabbit antiserum was added 20; >1 pooled adult human serum (PAHS).
This was then centrifuged at 12,000 g for 10 mins at 4°C, and the
supernatant was removed. To this supernatant was added 40pl PAHS,
and the mixture was recentrifuged. This was repeated with respect¬
ively 80j.il, 120i.il, and 150|il of PAHS; and thereafter with about
8 cycles of 150ul PAHS. This gradual increase in PAHS concentration
ensured that all the complete anti—PAHS antibodies were removed by
the centrifugation. If the entire 1.61 ml PAHS had been added at
once, some of the complete anti-PAHS antibodies would probably have
been in antigen excess and so would not have precipitated. The
methods for testing the completeness of the adsorption process is
outlined on p.52.
c. Imrgunoelectronlicresis
Immunoelectrophoresis wa3 carried out in 1 agar gels on 76 mm
glass microscope slides by the method of Hirschfeld (1959,1960,1962).
The concentrations of the buffer systems actually used in the gels
and in the electrophoresis tanks are 3hown in Table 5 . However,
the stock solution of gel buffer was made at double the final concen¬
tration. The agar gel was then made by boiling 2 gm of agar per
100 ml of water for 10 minutes, and then adding an equal volume of
double strength gel buffer at 65°C.
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d. Antibody-antigen crossed electrophoresis (aice)
AACE was carried out using barbitone-calcium lactate buffer
systems of the final concentrations shown in Table 3. vgarose
gel at a final concentration of 1 were made up in the same way as
agar gels, except that the 2 agarose/H^O solution was boiled for
approximately 45 minutes (at room pressure). After the equal volume
of double strength stock gel buffer had been added and mixed, 10ml
aliquots of the final gel solution were poured onto individual 5.25
inch square glass cover slides (Xodak) and allowed to set on a
levelling table. The remainder of the liquid agarose gel was put
in a stoppered tube in a water bath at 60-61°C.
If two-dimensional AACE was to be carried out, a single well
of between 1.5 and 8pl capacity was punched in one corner of the gels
after they had set (Pig. 6a). A wider bore Pasteur pipette made a
suitable punch. The gels were then placed in Abandon (Kohn) tanks
either on specially fitted cooling plates, or in a 4°C cold room.
The tanks were filled with the appropriate buffer (Table 3 ) and the
gels were connected to the tank buffers by filter-paper wicks. The
sample-wells were then loaded and electrophoresis was begun in the
1st dimension at 6 v/cm along one margin of each gel (Fig. 6 a).
If the gels were laid on cooling plates in tanks at room temperature,
their surfaces were slowly flooded by condensation occuring above them.
This was avoided by suspending a long glass plate about 7 mm above
the gels.
After about 2-j hours, the first dimension electrophoresis was
stopped, and the gels were removed from the tank3. The gel to the
side of the first dimension protein track was removed and replaced
Figure 6 Antibody-antigen crossed electrophoresis (AACE)
a. Two-dimensional Ai.CE : 1st dimension. The arrow
shows the direction of the electrophoresis toward
the anode.
b. Two-dimensional AACE : 2nd dimension. The antibody
gel has been laid beside the 1st dimension track, and
electrophoresis is carried out toward the anode in
the direction of the arrow.
c. Cne-dimensional AACE. Eany wells are cut in agarose
gel, just behind the antibody gel. Electrophoresis
i3 carried out in the direction of the arrow.
for details see pp.50-51.
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with, a volume of antiserum gel in proportion to the volume of gel
removed. (Fig. 6 b). The antiserum gel was made by adding a volume
of antiserum to the liquid agarose gel which had been incubated at
60-61°C. The proportion of antiserum depended upon its specific
antibody titre, although, proportions in excess of 40 were difficult
to use. After the second dimension gels had set, they were returned
to the electrophoresis tanks for the second dimension electrophoresis.
This was carried out for over 15 hours at 1.5 t/ch in a direction
. I'll. 1DICULAR to the first (Fig. 6 b), so that the proteins migrated
toward the anode into the antibody gel.
For single dimension AACE, the first dimension electrophoresis
step was unnecessary, usually because a monospecific antiserum was
available. Thus, up to thirteen sample -wells could be cut behind
the antibody-gel, as show in Fig. 6c. Electrophoresis in the
second dimension was then carried out as usual at 1.5 v/cm.
\t the end of the second dimension electrophoresis, the gels
were removed from the tanks and immersed in several changes of
physiological saline for between 24 and 48 hours. The gel3 were
then drained, and numbered by slipping numbered pieces of paper
between each gel and its glass plate. Filter-paper was then placed
on top of each gel, which were then dried into a tliin transparent film
either at room temperature, or at a temperature less than 60°C. The
dried gels were stained using 1;. amido black in 50 : 40 : 10 methanol :
water : acetic acid. The gels were destaxned in the 3ame solvent
without amido black, and were then dried.
For quantitative studies, the areas under the individual protein
curves were measured by planimetry, using a light box and transparent
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millimetre squared, graph paper. Linearily studies were carried out
on all the proteins measured, and these are reported in the individual
sections following.
e. Testing the completeness of antibody absorption using AAC-...
After an antiserum against amniotic fluid protein (for example)
had been absorbed with adult serum, it was tested by AACE against
amniotic fluid, to search for non-serum proteins in amniotic fluid.
* when such proteins were found, it was important to show that they
were not serum proteins which were precipitating because the antiserum
had not been completely absorbed. 'This was tested by one or two-
dimensional AACE, and is illustrated in Fig. 7. A known volume
of the amniotic fluid sample was run both alone, and also with an
excess of the absorbing antigen (i.e. adult serum) in the same well.
Finally, the absorbing antigen was run alone. If the size of the
precipitate found for the amniotic fluid sample was unaffected by
the addition of an excess (8-1Opl) of absorbing antigen, and if no
peaks were found when the absorbing antigen was run alone, then the
amniotic fluid antigen was regarded as being of non-serum type.
figure 7 Testing the completeness of antibody absorption by
two dimensional AACE,
labbit antibodies against hypothetical tissue extract A have been
absorbed with serum, and Fig.7a shows that two proteins (a and (3) are
detected when a known volume of extract A is tested against the
absorbed antiserum by AACE. In Pig.7b the same volume of extract
and a sample of serum are placed in the same well, and subjected
to AACE. The result is that the a peak increases in height whilst
the p remains as in,Fig.7a. This suggests that the antibodies
against the a-protein have not been totally absorbed, and this is
supported in Fig.7c where the addition of serum alone into the
origin well results in a'protein peak.
By the same reasoning, the |3 protein is not found in serum.
7
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JII MAJOR ..HTIG.Nn IN JIIilOTIC i'LUID
a. Introduction.
It is not clear whether the major antigens in amniotic fluid
before term are of 3erum or non-serum type. To investigate this
question, amniotic fluids from various stages of pregnancy were
concentrated and were injected into rabbits. The following sections
describe the nature and quantitative behaviour of the major amniotic
fluid antigens to which the rabbits responded.
b. Materials and cthods
i. Rabbit antisera ware raised against x 10 concentrated amniotic
fluids from various stages of gestation, using the methods summarised
on pp. 48-49. 'Table 4 summarises the number of amniotic fluids
injected, together with their corresponding gestational ages.
Antibody-antigen crossed electrophoresis (AACE) was used to study
the specificities of the immune responses. Pull methods for AACE,
and for the absorption and testing of the rabbit antisera are given
on pp. 50-52.
ii. Identification of antigens
Commercially produced monospecific antisera were obtained from
Behringwerke i(5 for the identification of -lipoprotein, -antitrypsin,
a.j- easily precipitable glycoprotein, a,,- H3 glycoprotein, group-
specific component (Gc), and haetaopexin. Group specific component
also showed it3 characteristic heterogeneity (Pig. 18), and a.-
lipoprotein was usually associated with a rapidly migrating degradation
product. Albumin and transferrin were identified by their characteristic
positions, and by their relatively intense precipitates.
JABLE4-
ummaryoftherabbitsin.iect -dwithamniot cfluidpr tein,and,ofthappear cea t bodyspecifities
Rabbit
Breed.
AntigenMaintenanceajorn ib dypecif city Injecteddos (average)Nature
limeof appearance
"Minorntib dypecificity Naturerimeofappear¬ ance(months)*
3(+).5(+ +) 4(+),6 - 5(++) 5(++) 6(++) 6(-) 4(-)(seenoteB)
5V4 6X1 6M6 5X5
5 6
DutchCross Hew Zealand hite
Amnioticfluid atterm,con¬ centratedx10 Amnioticfluid frombetween12 and20weeksof gestationcon¬ centratedx10 .Amnioticfluid frombetween20 and24weeksof gestationcon¬ centratedx note(a)
10
57weekhydram¬ niosspecimen, normalbaBy delivered
1ml/20dayserumprotein
4-6weeks 6-9weeks 7-9weeks 6-8weeks 7-8weeks 6-7weeks
Ja2-decidualprotein |(3-protein rci2-decidualprotein "\p-protein (3-protein nonedetected
5-6weeksnonedetect d o^-decidual nonedetected
4(0 -(seenoteC)
Notes FT"* (B)(c)
Mainlyfromhysterotomya24we ks. Injectionsstoppedafter4monthsbec usola kantige Injectionsstoppedafter5months
(_.)—Antibodiestdetecte . (+)=Antibodiesjustdetected,btooweakf r detaileds udi s. (++)=i.ntibodie3detectableinquantitiesjus adequatefordetail ds udi sbyAACE. (+++)=intibodiespresentinquant tiesadequate fordetailedstudiesbyAACK.
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iii• uantitation
The concentrations of albumin, a,j-antitrypsin, (Jc, and
transferrin were measured in amniotic fluid, in maternal and fetal
sera, and in fetal urine by two dimensional AACE, using experiment¬
ally induced rabbit anti-amniotic fluid antisera. Adequate peaks
were obtained for these serum proteins by using a 4cia wide second-
dimension gel which contained 10-15 antiserum.
Between 2 and 4il of amniotic fluid, and 1-2pl of 1/10 saline-
diluted maternal serum and term fetal serum were used for each gel.
Fetal sera obtained early in gestation were diluted up to 5 times
with physiological saline.
The areas under the peaks were measured by planimetry. Fig.8
shows that the areas under the peaks for albumin, c,^-antitrypsin, Gc,
and transferrin were proportional to the volume of amniotic fluid
added. The concentrations of albumin, -antitrypsin and transferrin
were calculated from a 'technicon* standard scrura. Gc was expressed
2
in arbitrary units (mm ) as no standard was available.
■if
.'igure 3 Linearity tests for serum proteins by AACB.
Varying volumes of amniotic fluid were subjected to MCE, and
the areas under the protein precipitates (ordinates) were plotted
against the volume of amniotic fluid applied (abscissa), for each
protein.
Alb = Albumin
AT = a,j -antitrypsin





The antisera which had been raised in rabbits against amniotic
fluid were tested by AACE. Fig. 9 a shows the precipitation lines
which -were observed when a sample of amniotic fluid of twenty-four
weeks of gestation was studied by MCE, using antiserum from a
rabbit which had been immunised with the same fluid. Fig. 9 b shows
the pattern observed in the case of a maternal serum at nineteen weeks
of pregnancy using the same antiserum. A number of distinct
precipitates were found, each corresponding to a separate protein.
In order to prove that all the amniotic fluid proteins visible in
Fig. 9 a were of serum type, the antiserum was absorbed with pooled
adult male human 3erum. When the absorbed antiserum was tested by
AACE against amniotic fluid, none of the precipitates shown in Fig.9a
were present. This result was found in all the antisera studied,
and indicates that the majority of the antibodies raised against
amniotic fluid react with serum protein. !Ion-serum antigens could
only be detected by using higher concentrations of antiserum, and
these are described on pp. 66-71.
The strongest precipitates were identified as albumin, -anti¬
trypsin, and transferrin by position and by the use of specific
antisera. ag-Group—specific component (Gc) was also found to be a
prominent protein, showing characteristic heterogeneity (Fig.18).
A number of unidentified proteins were al30 detected by AACE using
rabbit anti-amniotic fluid antisera. Email quantities of easily
precipitable a.-glycoprotein, a2-0S glycoprotein, haenopemin and
the component of complement, were also identified by specific
antisera, or, in the latter case, simply by its degradation product.
tabu: 5
The mean concentrations of the major serum proteins in amniotic flu:
expressed as ratios of their mean concentrations in maternal and fc
serum, both early in gestation and at term.
13-18 weeks
of gestation At Term
ms//vF p*/af ms/af fs/af
Albumin 9.6 3.2 25 27
^-Antitrypsin 18 4.4 55 17
GrC 15 2.1 32 15
Transferrin 14 2.0 47 15
MS = Maternal serum
fs = Fetal Serum
af = Amniotic fluid
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The concentrations of albumin, -antitrypsin, Gc, and trans¬
ferrin were measured in amniotic fluid by AACE and are shown in Figs. 10
- 13. The concentrations of all four proteins rose linearily from
ten to twenty weeks, after which there was a plateau followed by a usually
rapid fall in concentration between thirty weeks of gestation and term.
The mean concentration ratios for these proteins between the maternal or
fetal serum and the amniotic fluid are summarised in Table 5 . The
table shows that the protein concentrations in the sera exceed that in
the amniotic fluid, and that the gradient between the fetal serum and
the amniotic fluid is less than that between the maternal 3erum and
the fluid. It is also clear that these gradients increase during
gestation. To investigate possible relationships between the concen¬
trations of the proteins in amniotic fluid with those in maternal serum,
the respective concentrations of albumin, -antitrypsin, and trans¬
ferrin were expressed as a ratio to the Gc concentration and the
ratio for each protein in amniotic fluid plotted against that for each
protein in maternal serum (Figs. 14-16). By expressing the protein
concentration as a ratio to Gc some of the variation of the data is
reduced, as the measurement is independent of amniotic fluid dilution.
Figs.14-16 show that in each case there is a correlation between the
relative concentrations of the proteins in amniotic fluid with those
in maternal serum.
d. Discussion
In this study, rabbits were challenged immunologically with
amniotic fluid from various stages of gestation, in order to determine
the nature of the amniotic fluid protein. The fact that the majority
Figure 9a MCE of a sample of 24 week amniotic fluid using
antiserum from rabbit 1 (fable 4).
Figure 9b MCE of a sample of maternal serum from a patient in
the 19th week of pregnancy.
A = Albumin
AT « Antitrypsin
Lp = a,.j -Lipoprotein
Gc * Group-specific component
Tf = Transferrin
 
Figure 10 Ihe concentration of albumin in amniotic fluid,
measured by two-dimensional MCE. Concentrations expressed in mg/ml.
Figure 11 fbe concentration of -antitrypsin in amniotic fluid,




A = 'rteficiai Rupture of Membranes, Noruel
pregnancy
e


































Figure 12 The concentration of group-specific component in
amniotic fluid, measured by two-dimensional AACE and expressed in
arbitrary units.
Figure 15 The concentration of transferrin in amniotic fluid,
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Figure 14 The ratio of the concentration of albumin : Gc in
maternal sera, plotted against the ratio of albumin : Gc in their
respective samples of amniotic fluid.
Figure 15 The ratio of the concentration of -antitrypsin : Gc
in maternal sera, plotted against the ratio of -antitrypsin : Gc


















Figure 16 The ratio of the concentration of transferrin : Gc in
maternal sera, plotted against the ratio of transferrin : Gc in their




of AAC.. precipitates were abolished by adsorbing the anti-aaniotic
fluid antisera with adult human serum suggests that the majority of
the 'complete' rabbit antibodies reacted with aerum proteins. Figa. 10
-15 show that before about thirty-five weeks the concentrations of
four of the major serum proteins in amniotic fluid change in a manner
similar to those of the protein concentration measured by the biuret
( ueenan et al 1970) and Lowry methods (Fig. 48). the fact that
after thirty-five weeks the fluid protein concentration remains
approximately level, whilst the concentration of albumin and the
other serum proteins continue to fall (Figs. 10-13 )» suggests that
there is an increasing contribution of non-serum protein into the
amniotic fluid after thirty-dive weeks. :,nzyaological evidence
has been put forward (pp. 114-116) for a tissue contribution to the
protein of amniotic fluid, both early and later in gestation, though
no immunological evidence has so far been found (pp. 117-118) to support
this.
The origin of the serum proteins in amniotic fluid has been the
subject of a number of enquiries. At term, the tudies on amniotic
fluid albumin, 1c, haptoglobin, transferrin and IgA leave little
doubt that there is a major maternal contribution at this time (pp.51-34).
Yet, conflicting evidence exists for the seruxa protein early in
gestation. Gritlin and Doesman (1966) reported a-fetoprotein to be
present in amniotic fluid and fetal urine In fetuses up to thirteen
weeks of gestation. They showed that the ratio of albumin : a-feto-
protein in fetal urine was less than that in amniotic fluid, suggesting
that there was an alternative (perhaps maternal) source of the
amniotic fluid albumin. Their findings have been extended in this thesis
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(Fig. 35). However, Brsezinski, Sadovski and Shafrir (1964) have
suggested that the albumin in amniotic fluid is of fetal origin.
They claimed to have found a case in which a normal mother had a
bisalbuminaemic fetus, which expressed its extra albumin band in both
fetal serum and amniotic fluid. These observations were made by
descending boundary electrophoresis: a non-specific technique which
could offer no evidence that the extra protein peak was a variant
form of albumin. Significantly, the fluid in question appeared to
be lacking {3 and ^-globulins. The major (3-globulin in amniotic
fluid is transferrin, and in our experience (Fig. 13) this protein is
invariably present in fluids at six months of gestation. It is
therefore unlikely that the (3-globulins were absent, and probable
that they were present in the most slowly migrating protein band.
This being so, the and a^ bands would be displaced to lie close
behind albumin so that these three bands would become superimposed.
Such antefacts of migration rate can occur as a result of protein
concentration procedures, and would produce novel protein patterns.
The following section (pp.61-65) shows that the 9c in amniotic
fluid is of maternal origin throughout gestation, and that it enters
the fluid by crossing the amnion and chorion. The close similarity
between the concentration pattern of amniotic fluid Gc and the
patterns of albumin, ct^-antitrypsin, and transferrin, suggests that
all four proteins are mainly of maternal origin throughout gestation.
Two other lines of evidence support this suggestion.
Table 5 shows the concentration gradients for the serum proteins
between the sera and the amniotic fluid. Karly in gestation, the
concentration ratios lie between 9.6 and 18, and these gradients
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increase to between 25 and 47 at term. The rather smaller gradient
found early in pregnancy is found for all the proteins, including Gc
which is known to be of maternal origin (pp.61-65)* contrast,
cu-fetoprotein (AFP) has a fetal serum : amniotic fluid ratio of
-X-
about 200 s 1 at between 15 and 18 weeks of pregnancy. This is
despite the fact that AFF is detectable in early fetal urine, whereas
the other serum proteins, except albumin, are not detectable in urine
by AACE.
An experiment was carried out to test the possibility that the
four ma.jor 3erum proteins in amniotic fluid were mainly of maternal
origin between twenty and thirty weeks of gestation ( when their
concentrations in amniotic fluid are maximal). The concentrations
of albumin, -antitrypsin and transferrin in maternal serum and
amniotic fluid were expressed as a ratio of the Gc concentration in
the respective samples. Figs.14-.16 show that there was a positive
relationship between the protein ratios in the respective maternal
sera and amniotic fluid samples. Thus, variations in the concen¬
trations of maternal serum proteins result in similar changes in the
amniotic fluid proteins. In all three cases, there was an approximate
1 : 1 proportionality between the relative protein concentration
changes in maternal serum and amniotic fluid. 3uch a proportionality
was also found by Derrington and Soothill (1961) for the transferrin :
albumin and ceruloplasmin :^-globulin relationships between maternal
serum and amniotic fluid at term. Collectively, these findings
suggest that a large proportion of the amniotic fluid serum protein is
of maternal origin. In the light of the genetic studies on Gc, it




However, the presence of albumin in fetal urine (ditlin and. Boesman,
1966; and Fig. 33) and in umbilical cord (p. 3^ shows that this
protein may have dual origin early in pregnancy.
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THE ORIGIN OF AMNIOTIC FLUID GRQUf- IP CIFIC COKPOIEHT
a. Introduction
Although it has been shown that the majority of the protein in
amniotic fluid is of serum type, it is not clear whether it'is of
fetal or maternal origin before term. Group-specific component (Gc)
is a polymorphic ag-globulin which is present in amniotic fluid
throughout gestation (Fig.12). The relatively high frequency of
heterozygotes for Gc has made thi3 an ideal candidate for genetic
studies into the origin of serum proteins in amniotic fluid, and it
has already been shown that the Gc in amniotic fluid at term is of
maternal origin (Ruoslahti et al 1966; Usategui-Gomez and Morgan, 1966).
;.his section describes an investigation into the origin of the Gc in
amniotic fluid before term, by comparing the Gc phenotype of the fluid
with that of the corresponding maternal serum.
b. Introduction to Methods
Group-specific component (Gc) was first identified imrauno-
electrophoretically by Eirschfeld (1959) because of its characteristic
heterogeneity in human serum. It is a polymorphic glycoprotein,
1 2
with two common alleles Gc and Gc . The frequency of heterozygotes
for Gc (Gc 2-1) is relatively high in most populations (Giblett, 1969)
being approximately 38, in Edinburgh (p.65). herum pheno typing for
Gc is usually carried out by immunoelectrophoresis (iiirschfeld, 1959;
Reinskou, 1963) or, more occasionally, by starch gel or acrylamide gel
electrophoresis (Beam et al 1964; Kitehin and Bearn, 1966). However
none of these techniques are quantitative, and difficulties can arise
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when the Gc is in low concentration or substantially degraded (Kerstrjrfm,
1963} Herstrbm et aj 1964). Previous phenotyping studies on the
Gc in term amniotic fluid have employed Immunoelectrophoresis and
have used concentrated fluid (Ruoslahti et al 1966; Usategui-Gomez
and Morgan, 1966). In our hands, immunoelectrophoresis could often
be used for reliable Gc phenotyping of amniotic fluid (see Fig, 17)
but each sample had to be run three or four times for results of
acceptable quality. uite frequently, samples of fluid were found
which produced consistently uninterpretable patterns, because the Go,
o,j-antitrypsin and albumin precipitates became continuous. As this
effect /as probably an artefact due to the concentration procedure,
an alternative method of phenotyping was developed. AACE was the
method chosen, since Gc was detectable using 2-4pl of unconcentrated
amniotic fluid (Fig. 9a). The reasons for the increased sensitivity
of AACE compared to imaunoelectrophoresis are discussed on p.47
It has previously been pointed out that antigen-antibody crossed
electrophoresis (AA.CB) shows Gc as a heterogeneous protein (Eitchin,
1965; Weeke, 1970).
c. Development of AACL for phenotyping Gc
AACE wa3 carried out at 4°-8°C on 3.25 inch square glass plates
using a 1; agarose gel and the buffer systems of Hirschfeld (i960)
as described on p.50. In routine experiments, the sample was electro-
phoresed in the 1st dimension for up to 2-^ hours at 6v/'cm, along one
margin of the gel. After this, the gel beside the protein track
was replaced with 1, agarose gel containing 5-15 of rabbit antiserum
(anti-amniotic fluid). The second dimension electrophoresis was then
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carried out perpendicular to the first at 1.5v/cm for over 15 hours.
Pig.18 shows the immune precipitates of the three common Gc
phenotypes obtained by AACE. In these experiments, 2j_tl of amniotic
fluid was placed in the antigen well and run in the 1st dimension for
2 hours at 6v/cm. No rapidly migrating (a^) components of Gc were
found in any of the amniotic fluids tested, though these were often
found in haemolysed sera, as has been previously reported by
Nerstr^m (1963) and Nerstr/dm et al (1964). Pigs. 19 a and jg b show
the Gc pattern obtained from such a sample. The aj- Gc degradation
product is clearly visible, and prolonged electrophoresis in the 1st
dimension was needed to separate it from the ag-Gc proteins. However,
after 2y hrs at 6v/em, the anodal end of the gel began to shrink,
presumably as a result of endosmosis. This vaused the cathodal
protein trails of albumin and the a^-proteins which are visible in
Fig.19 a. To prevent this, the 1st dimension electrophoresis was
interrupted after 2^ hrs and the gel ahead of the albumin band was
replaced with fresh gel solution. After this had set, the electro¬
phoresis was continued for a further 2^ hrs, after which the second
dimension gel was poured in the usual way. Tig. 19 b shows that the
gel-replacement technique prevented the albumin and a^-protein trails,
and simplified the phenotyping of the Gc protein.
These results show that AACE is a potent tool for carrying out
Gc phenotyping in the presence of haemolysis, or when the concentration
of Gc is as low as, for example, in amniotic fluid. Concentrated
amniotic fluid seem3 to be an ideal antigen for eliciting a multivalent
rabbit antiserum with relatively high titres of anti-Gc antibodies,
.his is probably because the majority of soluble amniotic fluid
Firaire 17 Gc phenotyping of amniotic fluid by iminunoelectrophoresi s ,
10 x concentrated amniotic fluid was studied using the methods on p„49.
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Figure 18 Sections of AACE gels showing the three common Gc
phenotypes (arrowed peaks).
Figure 19 Fetal serum proteins subjected to prolonged AACE.
Run (a) was carried out without 1st dimension gel replacement;
1 2.
run (b) was made with gel replacement. Note Gc and Gc peaks,














The number of pairs studied in which concordance or discordance for
Gc phenotype was found between the amniotic fluid and maternal serum,
broken down according to gestational age and maternal Gc phenotype.
Gestation Concordant pairs Discordant pairs
weeks Maternal Gc phenotype ,11 phenotypes
1-1 2-1 2-2
10-18 11 8 2 0
19-27 5 5 2 0
28-38 14 8 1 0
Phenotype frequency .54 00t<-\• .09
TABLE 7
Showing the Gc phenotype of the amniotic fluid in cases of discordance
between maternal and fetal serum.
Case Gestation Gc phenotype
Maternal serum Amniotic fluid Fetal serum
1 15 1-1 1-1 2-1
2 16 1-1 1-1 2-1
5 16 1-1 1-1 2-1
4 24 1-1 1-1 2-1
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antigens are those of serum protein (berrington and Soothill, 1961;
Von Kleist et al 1968; see pp.53-60) whose molecular weights are
mainl/ less than about 170,000 (see pp.36-37# and Usategui-Gomez et al
1966). Since Gc has a molecular weight of about 50,000 (Schultze
and Heremens, 1966) it will be enriched in amniotic fluid relative
to the higher molecular weight proteins, and will therefore occupy
a greater proportion of the rabbit's immune response when obtained
from amniotic fluid rather than from serum.
d. Results
The Gc phenotypes observed in amniotic fluid and maternal
serum are shown in Figs. 18-19. fable 6 shows that concordance
of phenotype was found in all of the fifty-six maternal serum-amniotic
fluid pairs studied. Amongst the cases summarised in the top line
of Table 6 were eleven in which a sample of fetal serum was
available for phenotyping. In four of these cases, discordance
was found between the fetal and maternal phenotypes, and in each case,
the phenotype of the amniotic fluid Gc was that of the mother (fable 7)
Fig. 19a and b both show the fetal serum phenotype in case 2 in
Table 7» the amniotic fluid phenotype in this case is shown in the
top panel of Fig. 18.
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e. Discussion and Conclusions
Polymorphism studies on Gc protein have shown that the protein
in fetal serum is synthesised by the fetus from ten weeks of gestation
onwards (Helartin et al 1965). Thus, in cases where the fetal
phenotype is discordant with the mother's, the amniotic fluid Gc
would be concordant with the maternal phenotype if it is of maternal
origin, but discordant if it is of fetal origin. In the latter
case, the expected frequency of discordance between the fetal and
maternal phenotypes is equal to the heterozygote frequency in the
population (Slandt-Johnson, 1971). Prom the frequency of hetero-
zygotes (Table 6 ) approximately 38/- discordance in at least one of
the gestational groups is expected if there is a major fetal contri¬
bution to the Gc of amniotic fluid. Table 6 shovrs that no
discordant cases were found. Furthermore, in four cases between
ten and eighteen weeks of gestation, in which the fetal phenotype
was known to be discordant from the maternal type, discordance was
found between the fetal and amniotic fluid nhenotypes.
From these results it is concluded that throughout gestation the
Gc in amniotic fluid is of maternal origin, and that it enters the
fluid by passing through the placental or reflected membranes. This
finding sounds a cautionary note for any attempts to carry out prenatal
diagnoses of genetic disease either by direct screening of serum
proteins, or by linkage analysis using serum protein polymorphisms.
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ITOH-BKRUM AHTIGEN3 IN AMNIO JIG FLUID
a. Introduction
Although it is clear that the major antigens in amniotic fluid
are of serum origin (pp.53-60), the search for minor antigens is of
importance since some of them may be tissue specific, and would
therefore provide a way of measuring the contribution of a particular
tissue to the protein in amniotic fluid. Previous immunological
studies on the non-sorum proteins in amniotic fluid have been carried
out by Lambotte and colleagues and von Kleist et al (1968) (see pp.22-24).
These workers found and a2 amnion-specific proteins in amniotic
fluid by using immunofluorescence and Immunoelectrophoresis, although
they made no attempt at quantitative studies. In the experiments to be
described in this section, rabbit antisera against human amniotic fluid
were absorbed with serum, and the antibodies against non-serum protein
*
were sought by AACE .
b. Materials and Rothods
Rabbits were immunised with amniotic fluid according to the
schedule on p.48 and Table 4. After the rabbits had been bled, the
antiserum was absorbed with pooled adult male human serum as described
on p.49. The resultant absorbed antiserum was then tested against 10x
concentrated and unconcentrated amniotic fluid by AACE. The method
for AAGE is described on p.50.
Many of the antisera had very weak antibodies against non-serum
antigens, so that high concentrations of antiserum had to be occasionally
used in the second dimension AACE gel. This necessitated prolonged
Antibody-antigen crossed electrophoresis
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washing of the gel, and sometimes resulted in distortions of the second
dimension gel. To prevent the distortions confusing the results of
quantitative studies, a number of standard antigen preparations were
run in each gel, and tests were made to ensure that the areas under the
immune precipitates were proportional to the quantity of the antigen
applied to the gel. Such tests are reported in the results,
c. results
As noted in Table 4, antibodies against non-serum protein in
amniotic fluid appeared considerably later than those against serum
protein. Only three rabbits developed antibodies against non-serum
proteins in concentrations which were of use for specificity studies.
AACE was used to investigate the specificities of these antisera, using
amniotic fluid as antigen. In two antisera (5Y4, 6X1, see Table 4)
two precipitates were found when amniotic fluid was used as antigen (Fig.20).
After three months, the antibodies to the more cathodally migrating
protein virtually disappeared in rabbit 5Y4, whilst the antibodies
against the anodal protein became stronger. Fig.21 a shows an AACE
experiment to investigate the mobility of the anodal protein using 5Y4
antiserum absorbed with pooled adult human male serum. To compare
the mobility of the anodal protein with serum protein, an immunoelectro-
nhoretic run has also been carried out in agarose gel beside the 1st
dimension of the AACE run. The mobility of the anodal protein is close
to that of Gc 1-1, and it was therefore referred to as an o^-protein.
Fig. 21a is also noteworthy as two precipitates are visible: one under
the other. This was not found in other samples of amniotic fluid
(see Fig. 21b).
Figure 20 Two dimensional AACE of amniotic fluid (lO(jl) using
absorbed 5Y4 antiserum. The first dimension was carried out for
50 minutes. Two peaks were found, the most anodal is labelled a
and the slower migrating is labelled p.
The arrows indicate the direction of the anode for the first and
second dimensions.
 
Figure 21 The mobility of the a-protein in amniotic fluid,
tested by two-dimensional AACE using absorbed antiserum 5Y4.
a) Shows the mobility of the a-protein compared with
an Immunoelectrophoresis slide of serum protein.
The immunoelectrophoresis was carried out in the
agarose of the AACE plate, parallel to the first
dimension run, and was therefore under identical
conditions. After the first dimension step,
the immunoelectrophoresis gel strip was removed
to allow the pouring of the antibody gel.
After the strip had been removed, an imrnuno-
electrophoresis trough was cut in it in the
usual way. The mobility of the a-protein
corresponded to Oc 1-1, and it was therefore
called an ag-protein
b) AACS of the o^-protein using absorbed 5Y4 anti¬












It was essential to show whether the -protein was a serum protein,
and this was tested by two-dimmensional MCE in Fig.22. The absence
of a precipitate when term maternal serum was run alone (track c) shows
that the absorption of the antiserum was complete, and that the protein
is not detectable in maternal serum at term.
Experiments were next carried out to investigate the possible tissue
origin of the ag-protein in amniotic fluid, by making 30 w/v saline
extracts,from various tissues and running the samples against absorbed
antiserum in MCE. -Protein was found in two samples of uterine
decidua obtained at sixteen weeks of pregnancy (at hysterotomy), and
in a sample of decidua at term (obtained at caesarian section). The
protein was also found in traces in amnion and chorion early in gestation
(15-18 weeks), however, it was not detectable in these tissues at term.
The protein was not detected in maternal or fetal sera at any stage of
pregnancy, or in umbilical cord, placenta, or in fetal 3kin and liver.
Fig.23 shows a two dimensional AACE in which an extract of 16 week
decidua and amniotic fluid are run separately (tracks a and c respectively)
and together (track b). The increase in peak height in track b indicates
a reaction of identity. If the proteins in the two samples had not
been identical the two precipitates would have been found separately
in track b.
Immunofluorescent studies were made to attempt to see if the
u^-protein was located within the cells of the decidua. The method of
indirect fluorescent labelling was employed, using FITC-labelled sheep
anti-rabbit -globulin (Burroughs V/ellcome). The labelled sheep
antibodies were used to locate the regions in which the specific rabbit
anti-Og-protein antibodies had been Bound to the surface of frozen
sections of decidua. The control sections were exposed to the serum
of rabbits which had not been immunised. hen the sections were
viewed under the fluorescent microscope, fluorescence was only found
in the slides which had been exposed to the rabbit-ag-protein antibodies,
virtually none was visible in the controls. A clear green fluorescence
was found in the former sections in about 20-40,' of cells, and the
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distribution of staining did. not correspond to the edges of the uterine
glands. This experiment was carried out on two samples of decidua
(Obtained at 16 and 40 weeks gestation respectively), and showed that
the Og-protein was located within the cell3 of the decidua. However,
no photographs were available of the results, and the data was very
limited owing to the shortage of the strong 5Y 4 antiserum which was
used in these experiments.
After about six months of immunisation, the antiserum against
c^-protein became strong enough to carry out quantitative measurements.
One-dimensional AACE was used, with an antibody concentration of 18
in the second dimension gel. Fig. 24a shows that the area under the
precipitate is proportional to the volume of amniotic fluid added.
The relative concentration of the o^—protein was therefore measured
in a number of amniotic fluids, using 4-8|il of fluid per well. The
results (Fig. 24b) show that the concentration of o^-protein in
amniotic fluid is maximal between twenty and thirty weeks of gestation.
The second protein found in amniotic fluid using absorbed antiaera
was mentioned briefly on p.67 and was shown in Fig.20. Its mobility
was tested by AACE and wa3 compared with a parallel immunoelectrophoretic
run in agarose gel. The protein was found as an asymmetric p—mobility
peak, migrating a little ahead of transferrin (Fig.25). The antiserum
used in all the studies on the (3-protein was obtained from rabbit 6H6 some
seven months after the initial immunisation. 'The strength of the antiserum
and the quantity of (3-protein in amniotic fluid was only great enough to
2
produce small AACE peaks of up to 30mm area, which stained up clearly
but rather faintly. The intensity of the peak could be improved only
by increasing the percentage of antiserum in the antibody gel, and
this reduced the peak area to an extent that made detailed studies
impossible.
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The specific antiserum was tested for the completeness of
absorption in the usual way (Figs. 7, and 22) and it was found that the
addition of adult male human serum to amniotic fluid caused no detectable
increase in the size of the amniotic fluid protein peak. However, vihen
the serum was subjected to AACE by itself, a very small precipitate was
found,yet the protein was present in maternal 3erum and fetal sei*um at
much higher concentrations. It was also detected in 30,= saline extracts
of fetal liver, chorion, and placenta. It was not detected in amnion,
umbilical cord, or skin; nor was it present in washed adult or fetal red
cells.
Quantitative studies were made on the (3-protein by one dimensional
AACE. 6-10|J. of amniotic fluid were placed in the wells and 3,
absorbed antiserum in the antibody gel. Fig.2b shows that the height
of the (3-protein peak increased in proportion to the quantity of
amniotic fluid in the well. However, the peaks stained weakly and
the system was therefore less than ideal. Figs. 27a and b show the
relative concentrations of the (3-protein in amniotic fluid and in
maternal and fetal sera. Although the data is not extensive, the
concentration of (3-protein in amniotic fluid and maternal serum is
maximal between about eighteen and thirty weeks of gestation. The
concentrations of (3-protein in maternal serum were slightly greater
than in amniotic fluid until about thirty weeks, when the difference
became more apparent. The concentration of the (3-protein in the sera
of three non-pregnant adults did not exceed 3 units when expressed in the
units of Figs.27a and b.
figure 22 Testing the absorption of serum 5Y4 by AACE.
run a) 6jil of 30 w/v decidual extract
b) M " " " " + 8j_il serum
c) 8|il serum
figure 23 The presence of c^-protein in decid.ua, demonstrated
by two-dimensional AACE. 6;j1 of 30» w/v extract of decidua, and
8(il of 20 week amniotic fluid were used.
23
higure 24a Measurement of the -protein concentration by one
dimensional AACE. i'he graph shows that there vfas a proportionality
between the volume of amniotic fluid added and the area under the
immune precipitate.
b) fhe concentration (arbitrary units) of a^-protein in
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Figure 25 The mobility of the (3-protein in amniotic fluid, tested
by two dimensional AACE. This experiment was carried out in parallel wi
that in Fig. 21a and the details are found there. The mobility of
the (3-protein was similar to that of transferrin.
Figure 26 Measurement of the (3-protein concentration by one
dimensional AACE. The graph shows that there was a proportionality





Figure 27 a) The concentration (arbitrary units) of p-protein in
amniotic fluid throughout gestation.
b) The concentration (arbitrary units) of p-protein in
maternal and fetal serum at various stages of pregnancy. The units
in Figs. 27a and b are the same.
• as Maternal serum



















The results show that when the rabbit antisera against amniotic
fluid were absorbed with adult male human serum, two specificities
remained. The faster migrating (anodal) protein had an cu,-nobility,
and was found in amniotic fluid and decidua both early and late in
gestation, and also in amnion and chorion early in gestation. ' The
concentration of the protein in amniotic fluid was maximal at between
twenty and thirty weeks of pregnancy, and the protein was absent from
maternal and fetal sertim. The ag-amnion proteins described by von
Kleist et al (1968) were present at maximal concentrations in term
amniotic fluid. The amnion protein found by Lambotte and colleagues
(pp.22-23) was of -mobility and was therefore only a little more
rapidly migrating than the a^-proteins of von Kleist et al (1968) and
?ig.25. Lambotte and colleagues demonstrated the presence of their
protein in amnion by immunofluorescence, but neither they nor von Kleist
et al invested the possibility of a decidual origin for the proteins.
Is it possible that all three studies have been investigating the
same protein? At present no definite answer is available. The
quantitative behaviour of the a^-protein described here (rig.24b) is
different from that described by von-Kleist ot al (1968). The
absence of the -protein from term amnion and chorion (p.68) is
probably not complete, but as the concentration must be below that
detectable by MCE, this suggests that the protein is not identical
to that described by Lambotte and colleagues.
The studies on the a2-protein in this thesis have shown that it
is present in uterine decidua both early and late in oregnancy.
Although this suggests that the decidua is a source of o^-protein,
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it does not rale out alternative sources in the membranes. This is
because a tissue synthesising a protein need not store it intra-
celiularily at any appreciable concentration. In vitro studies
using radio-active amino acids would be essential for a final decision
on the source of this protein. At present the -protein described
in thi3 the3i3 is referred to as a^-decidual protein only because it
was consistently found in decidua, and because iaaunofluorescent studies
showed it to be located within the cells of this tissue.
The p-mobility protein described in the results was difficult to
study because it as present in low concentrations. A fluid protein of
similar mobility was found to be haemoglobin by von Kleist et al (1968);
however, the protein described here was absent from washed adult and
fetal red cells, and must have a different identity. The origin of
the (3-protein ha3 not been determined. Before thirty weeks it is
|PP
present in maternal and fetal serum at concentrations not greatly in ^ y
/ -i J
excess of the concentrations in amniotic fluid. This is rav ^
to the concentration gradients of amniotic fluid proteins which are
known to be of serum origin. Table 7 shows that the gradient for Gc
(known to be of maternal origin) increases from a mean of 15 at
thirteen to eighteen weeks to a mean of 32 at term; and calculations
(p.77) show that the gradient for a-fetoprotein (fetal serum origin)
is in the order of 1:206. This data suggests that much of the
j3-protein in amniotic fluid is synthesised somewhere in the tissues
surrounding the amniotic fluid, and this hypothesis has been supported
by the finding of p-protein in placenta and chorion. Yet, the
theoretical difficulties in determining the tissue origin of a protein
(see above) make a conclusion impossible from the present data.
71b
The major problem in attempting to search for antigens of non-
serum origin in amniotic fluid lies in the weak nature of the
rabbits' immune response to them. Longer periods of immunisation,
together with complement fixation methods may increase the potential
of this type of study.
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THB PREMTAL DIAGNOSIS OF ANEriC :: H uff AM) EPIHA BIFIDA
a. Introduction
Anencephaly and spina bifida cystica are the most common of the
congenital malformations of the central nervous system, with a
combined incidence of up to 7 in a thousand in the U.K. (blwood,
1970} Renwick, 1972). The risk of either disorder is increased to
1 in 20 in a family where there is already an affected sib (Carter
et al 1966) and to 1 in 10 or above in a family where there are two
affected sibs (Carter and Roberts, 1967). One of the prerequisites
of antenatal diagnosis, the identification of pregnancies with
enhanced risks, is thus satisfied. The other prerequisite, a
marker molecule which will indicate an affected fetus early enough to
allow termination of pregnancy, has so far not been found. Various
attempts have been made before now to find marker molecules in
amniotic fluid which would indicate the presence of fetuses with
anencephaly and/or spina bifida (Lambert and Pennington, 1965;
Emery et al 1972; Hall, 1972). Cassady and Cailliteau (1967),
Lee and Wei (1970), and Stewart and Taylor (VfJ3§.) have all reported
that bilirubin or a bilirubin-like molecule with an extinction
coefficient at 450 nm is present in the amniotic fluid surrounding
anencephalic fetuses at or near term. This finding suggested that
enhanced leakage or transudation of fetal blood components was
occurring either directly into the fluid or into the fluid via the
C.S.P,, and that detection of fetal blood components in the fluid
might be of use for the prenatal diagnosis of anencephaly. This
possibility gains extra support from the indications that in anen¬
cephaly, the vascular tissue on the floor of the skull is virtually
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exposed to the amniotic fluid (Willis, 1958).
For any such blood components in amniotic fluid to be of diagnostic
use, they would have to be known to be of fetal rather than of
maternal origin. Thus, a-fetoprotein (AFP) was the obvious protein
to study. It was a simple matter to test this hypothesis by
comparing amniotic fluids from normal and abnormal fetuses, since
methods had already been developed to study the AFP concentration
gradient between fetal serum and amniotic fluid.
Originally discovered by Bergstrand and Czar (1957), AFP is
virtually an exclusive product of the conceptus, being synthesised
in the yolk sac, liver and gastrointestinal tract from as early as
six weeks of gestation (Gitlin et al 1972). It i3 known to reach
maximum concentration in fetal serum at about 13 to 15 weeks and then
to decline towards term (Gitlin and Boesman, 1966). It has been
detected in amniotic fluid throughout gestation (Gitlin and Boesman,
1966; Adinolfi and Gardner, 1967; epp&ld and Ruoslahti, 1972),
although its low concentration at term lead to the failure of
Smith ot al (1971) to find it.
The following sections report an investigation into the concen¬
trations of AFP in the amniotic fluids of normal fetuses and of
fetuses affected with a variety of CNS malformations. The most
common of these malformations was unencephaly.
b. Materials and Hethods
i. Introduction
Immunological assays are essential for the measurement of AFP
concentrations in body fluids. Gitlin and Boesman (1966) used
radial-immunodiffusion and an absorbed rabbit antiserum to measure
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AFP in fetal serum and. amniotic fluid. Phis technique was not
sensitive enough to measure the concentration of AFP in amniotic fluid
at term with confidence. The highly sensitive technique of radio¬
immunoassay has recently been applied to the measurement of AFP in
amniotic fluid and also maternal serum by Ruoslahti and Seppdld (1972)
and SeppElh and Ruoslahti (1972).
The relative insensitivity of radial-immunodiffusion and the
considerable technical difficulties (p.48) of radio-immunoassay lead
us to develop a technique for measuring AFP by antibody-antigen crossed
electrophoresis (AACE). After this had been developed a similar
technique was reported by N^rgaard-Pedersen (1972).
ii. Materials
Samples of amniotic fluid were obtained either at termination of
pregnancy, or at delivery, or by transabdominal amniocentesis. They
were centrifuged for 5 minutes at 125 g, and the clear supernatants were
removed. These supernatants were stored at -25°C for periods up to
3 years. Since the effect of prolonged storage on AFP is not known,
each sample from a pregnancy leading to a congenital malformation was
matched with a control sample of the same approximate gestation, which
had been stored for an equivalent length of time. Congenital mal¬
formations were classified as anencephaly (with or without spina
bifida), spina bifida and hydrocephaly (with or without spina bifida).
Most of the control samples were obtained from terminations of
pregnancy or from amniocenteses carried out during the management of
rhesus-incompatible pregnancies.
iii. Methods
AFP was measured by one-dimensional antibody-antigen crossed
electrophoresis using rabbit anti-serum which was initially kindly
provided by Dr J.V. Clark and subsequently bought from Behringwerke AG.
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Since these antisera were monospecific, it was not necessary to
carry out the initial electrophoretic step of 2-dimensional AACE.
The commercial antiserum was used at a final concentration of 0.25/j
in a agarose gel. Amniotic fluid (5-15 pi) was placed in the
sample wells and electrophoresis carried out overnight. The
sensitivity limit of the assay was about 1 pg/ml, though values
under 3 pg/m1 were somewhat unreliable. Absolute values of AFP
were calculated with reference to a standard supplied by Professor
0. Abelev. If a Behringwerke standard is used the values in
Figures 1 and 2 must be multiplied by 0.7. Protein was measured
by the method of Lowry et al (1951).
The concentrations of AFP in fetal serum and urine were
measured in the sane way as for amniotic fluid, except that in the
case of fetal serum a prior dilution of between x50 and x100 was
carried out with physiological saline.
Fig.28 shows that increases in AFP concentration in the samples
causes a smooth linear increase in the area under the precipitates.
At least two standard AFP samples were run in each MCE plate in
order to provide internal standards.
c. iesuits
.uniotic fluid .v-Petoprotein concentrations in normal and
abnormal pregnancies
Fig.29 shows the concentration of AFP found in normal amniotic
fluids between eleven weeks of pregnancy and term. Maximal concen¬
trations were found in amniotic fluid at 13 v/eelcs of gestation, and
these declined rapidly between 15 and 20 weeks. Subsequently there
was a 3teady fall in concentrations, so that the quantities of AFP in
amniotic fluids at term were close to the minimum detectable by AACE.
The mean concentration of AFP in the control fluids from the period
25 to 42 weeks of gestation was 3.1 ps/ml the range being from 0 to
10.5.
In 22 pregnancies leading to anencephaly or anencephaly combined
with spina bifida, where it was possible to get amniotic fluid in the
third trimester, the concentrations of AFP in the fluid were grossly
elevated. All were above 12 pg/ml while 3ome ranged as high as
200 pg/ml (Fig. 30, In another 9 •anencephalic' pregnancies where
fluid was obtained only after 35 weeks gestation, the distinction was
less clear though 5 of the samples had strongly raised AFP concentrations.
In five spina bifida cases after 32 weeks (three of which were
associated with hydrocephaly) the concentration of AFP in the amniotic
fluids were indistinguishable from the controls. However, a single
fluid was fortuitously obtained at 13 weeks of gestation from a
*
hysterotomy where the fetus had a myelocele spina bifida. In this
case the concentration of AFP in the fluid was 350 (jg/'ml, which was
over 4 times as great as the highest normal control (Fig.3l).
Since many of the control samples used in this study were
obtained from pregnancies past 20 weeks in which there was a risk of
rhesu3 incompatibility, it was important to establish what effect this
had on amniotic fluid AFP concentrations. Two pregnancies were
studied where at least four successive amniocenteses had been necessaiy
to monitor fetal status. In both the degree of isoimmunisation was
*
personal communication from Dr M.K. Nelson whose careful studies of
abortion material made this observation possible.
TABLE 9
a-Petoprotein concentrations in amniotic fluids from pregnancies in
which the fetus was affected wit£ various conditions. Gestation







Rh isoimmunisation necessitating three post¬











Rh isoimaunisation necessitating two intra¬ 25 0.8
uterine and three post-natal exchange trans¬ < 26 1.3
fusions. Live-born infant progressing well. 27 1.2
K. 28 1.3
Rh isoimmunisation necessitating intra¬
uterine exchange transfusion. Stillbirth.
24 2.2
Rh isoimmunisation. Hydrops fetalis. Still¬
birth.
27 6.5
Rh isoimmunisation. Stillbirth 35 1.7
Rh isoimmunisation (anti-E). Stillbirth 29 0
Duodenal atresia. Live birth. 36 4.2
Renal hypoplasia. Neonatal death. 21 5.1
Stunted embryo. Termination. 12 34.2
Rubella contact. Termination. 22 4.9
Ectopia vesica. Termination. 16 25.6
Sxomphalos. Termination. 10 13.7
Diabetic mother. Hydramnios. Normal infant. 35 2.0




sufficient to require postnatal transfusions, and in one of the
pregnancies intrauterine transfusions had also been necessary. In
neither case was there any indication of a raised AFP level (Table g)f
nor was there in four cases of rhesus isoimmunisation leading to
intrauterine death. A variety of other conditions where there
seemed a possibility of elevated amniotic fluid AFP were tested,
but in none was an abnormal level found (Table g)#
a-Fetoprotein in maternal and fetal serum and in fetal urine
AFP was not detectable in any of the maternal sera obtained at
the delivery of normal or anencephalic babies. The limit of
sensitivity of the method used was 1.0 pg/ml.
Fig. 32 shows the concentration of AFP in fetal sera and urine
from various stages of gestation. Between 13 and 18 weeks of
gestation, the concentration of AFP in fetal serum ranged between
0.54 and 10.8 mg/ml, with a mean of 7.6 mg/ml. During the same
period, the concentration of AFP in amniotic fluid ranged between
21.8 and 87.2 ixg/nl, with the mean value being 36.9 fig/ml. Thus the
mean AFP concentration ratio between the fetal serum and the amniotic
fluid was of the order of 206 : 1.
Fig. 33 summarises the ratios of the concentrations of albumin
and a-fetoprotein which were calculated for a number of samples of
amniotic fluid and of fetal serum and urine between thirteen and
eighteen weeks of gestation. Unfortunately in the case of this
figure, no samples of serum, urine, and fluid were available from
the same fetus. However the figure shows clearly that the mean ratio
of albumin to a-fetoprotein is greater in amniotic fluid than in fetal
urine or serum by a factor of 10 or more.
Figure 23 The relationship between the volume of amniotic fluid
subjected to AACE (abscissa) and the area under the o-fetoprotein
precipitate (ordinate).
Figure 29 a-Fetoprotein (AFP) concentrations in amniotic fluid
at various stages of gestation. • Normal samples;A samples obtained
during monitoring of pregnancies at risk for rhesus isoimmunisation,
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Figure 50 The concentration of a-fetoprotein (AFP) in the amniotic
fluid of normal pregnancies, and of pregnancies leading to anencephaly,
spina bifida and hydrocephaly between twenty-five weeks of gestation
and term.
Figure 51 fhe concentration of a-fetoprotein (APP) in the
amniotic fluids of normal pregnancies between ten and twenty five
weeks, and of a pregnancy at thirteen weeks in which the fetus was
affected with a myelocele spina bifida.
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Figure 52 I'he concentration of a-fetoprotein in fetal serum and



















Figure 35 The ratio of the concentration of albumin to the
concentration of a-fetoprotein in samples of fetal serum, fetal urine,















.r- . — ratios, 13 to 18 weeks of^Fetoprotein
Fetal Fetal Amniotic
Serum Urine Fluid
I-'lTure 34 The effect of incubation at 37°C on the concentrations of
a-fetoprotein, albumin, -antitrypsin, group-specific component, and
transferrin.
Dojjs ok j 7 °C
Figure 55 The concentration of albumin in amniotic fluids from
normal and anencephalic pregnancies, measured by one-dimensional MCE.





















Fig.30 shows clearly that in cases of anencephaly during the
third trimester, the AFP concentrations in amniotic fluid greatly
exceed those in matched controls. This suggests that anencephaly
may be detectable by fluid analysis early enough to allow termination
of pregnancy. There are three reasons to support this suggestion.
Firstly, even though there are high concentrations of AFP in amniotic
fluids from normal fetuses before 20 weeks (Fig.29 )» several of the
anencephalic fluids between 27 and 35 weeks of gestation had AFP
concentrations well above the entire normal range. Secondly, in
the single case of spina bifida at thirteen weeks of gestation there
were grossly elevated concentrations of AFP. It must be emphasised
here that there are different types of 3pina bifida, and that myelocele
and total myeloschisis are more likely to be associated with extrusion
of fetal proteins into the fluid them are meningomyelocele, mening¬
ocele or spina bifida occulta. The thirteen week case studied here
was a definite myelocele (personal communication from Dr M.M. Nelson),
whilst the later cases were probably all meningomyelocele or
meningocele. This may indicate that unclosed neural plate malform¬
ations will be diagnosable antenatally. The third reason for
believing that AFP may be of value for the early prenatal diagnosis
of anencephaly lies in the AFP concentration ratio between the fetal
serum and amniotic fluid. It is reasonable to assume that in
anencephaly, the raised AFP concentration in amniotic fluid is due to
the protein diffusing out of the blood vessels in the exposed portions
of the cranial contents. The driving force for this diffusion would
be represented by the normal AFP concentration gradient being the
fetal serum and amniotic fluid. The fact that this gradient is about
79.
200 ; 1 between the thirteenth and eighteenth weeks of gestation
strongly suggests that during this time there would be an elevation
in the concentration of amniotic fluid AFP, provided that a
sufficient cranial lesion was present.
Is it possible that the reduced rates of fetal swallowing in
anencephaly (pritchard, 1965, 1966; Abrumovitch, 1970; p.12)
cause the elevation of AFP concentrations by reducing its rate of
turnover? Although it is clear that AFP is a fairly stable protein
at 37 C (Fig. 34), and that it will therefore be particularly liable
to the effects of bulk fluid turnover, the reduced rate of swallowing
in anencephaly cannot account for the specific alteration in AFP
concentrations. The first reason for this is that the maximum
difference in swallowing rates between normal and anencephalic
fetuses will be presumably at term, since it is then that the normal
fetus is thought to be swallowing at its fastest. Thus, if
the absence of swallowing was the major factor in causing the elevated
amniotic fluid levels, the effect would be greatest at term; yet
Fig.35 shows that the AFP concentrations in anencephalic fluids at
term approach those of the controls. Further evidence against this
theory comes the albumin concentration in amniotic fluid. Because
swallowing is unselective, it would be expected to have the same effect
on similar proteins. ..lbumin and AFP are both fairly stable (Fig.30)
and have similar molecular weights (mol. wt. albumin : 65,000 -
Schultz and Heremens, 1967; mol. wt. of AFP j 75,000, Gitlin & Boesman 1967)
Despite these similarities, there are no great differences between
the concentrations of albumin found in normal and in anencephalic
amniotic fluids (Fig. 34). This indicates that the altered
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concentration of AFP in anencephalic fetuses is not primarily due to
lack of swallowing.
The finding that a specific fetal protein is present in the fluid
of anencephalic fetuses suggests that the protein is transuding into
the fluid either from brain tissue, or from the choroid plexus
(possibly via the CSF), or from the many small blood vessels which
are exposed within the remnants of the cranium. Such protein trans¬
udation suggests that increased leakage of water may also occur. This
may go far to account for the polyhydramnios which is observed in
anencephaly ( s ee p $>. 12-13).
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■ir-fT-r - Iff Ail .T01'IC FLUID: v Study of
Specific Activity Patterns during Pregnancy
a. Introduction
Amniotic fluid analysis has been shown to bo of value in the
prenatal diagnosis of both genetic and non-genetic conditions.
Tay-Sachs disease can be diagnosed between fifteen and twenty-eight
weeks of gestation by measurement of hexosaminidase A in amniotic
fluid (O'Brien et al 1971; Friedland et al 1971). Bilirubin
measurement has become routine for the diagnosis and assessment of
rhesus isoimmunisation (see, for example, Robertson, 1969). and the
measurement of fluid phospholipids has been claimed to be of value in
determining the liability of a fetus to respiratory distress syndrome
at birth (Gluck et al 1971; Bhagwanani et al 1972).
A greater understanding of the origin and quantitative behaviour
of the proteins in amniotic fluid would help in attempting to extend
the diagnostic potential of amniocentesis. This section reports an
investigation into the specific activity patterns of a number of
amniotic fluid enzymes during pregnancy, and discusses their
potential usefulness in the diagnosis of fetal maturity. The factors
which contribute to the changes in enzyme specific activity during
gestation are discussed in a subsequent section.
The enzymes chosen for study were a-1,4-glucosidase, hexosamini¬
dase, acid phosphatase, and the heat-stable and heat-labile fractions
of placental alkaline phosphatase. The lysosomal enzymes a-1,4-
glucosidase and hexosaminidase were of particular interest since
enzymes with their substrate-specificities are absent in Pompe's
disease and Tay achs disease, respectively. Acid phosphatase was
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investigated, because it is also a lysosomal enzyme, and thus its
specific activity pattern could be compared with those of a-1,4-
glucosidase and hexosaminidase. The heat-stable fraction of
alkaline phosphatase is oynthesised specifically in the placental
trophoblast (see Hunter, 1969)* and is often referred to as placental
alkaline phosphatase. This ensyme was included in the study in
order to examine the relationships between the placenta and the
amniotic cavity. The heat-labile (non placental) fraction of
alkaline phosphatase was included out of interest, since the stable
fraction had already been measured.
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b) Materials and I ethoda
i« Amniotic fluid
Amniotic fluid was obtained from three sources. Samples from
early in gestation were taken from hysterotomy sacs, and those from
about 20-38 weeks were taken by amniocentesis at the clinic for
patients with rhesus iso-immunisation. Collections of amniotic fluid
at term were made using an amnioscope during artificial rupture of
the membranes. In all cases, the duration of pregnancy was measured
from the first day of the last menstrual period. All samples which
were visibly contaminated by blood or meconium were excluded from the
series. In the patients having repeated amniocentesis only the
initial specimen .as collected. Specimens with a AOD which fell
outside the k\ , 331 , 332, C1 and C2 zones of Robertson (1969) were
excluded.
The samples of amniotic fluid were centrifuged for 45 minutes
at 27,000 g at 4°C, and the clear supernatant was removed. Enzyme
assays were carried out within two days of the sample being collected,
the material being stored at 4°C during this period,
ii. Routine assay methods
Hexosaminidase was assayed in a system of 0.1 K citrate buffer
pH 4.25, 5.3mM p-nitrophenyl^-acetamido^-deoxy-p-TA-glucopyranooide
and 5j.il of amniotic fluid in a final volume of 0.15ml. Acid phos¬
phatase was assayed in a system of 0.1 M citrate buffer pH 4.9,
10.5mM 'Sigma 104' phosphatase substrate (p-nitrophenyl phosphate),
0.4, formaldehyde and 20-40pl amniotic fluid in a final volume of
0.15 ml. The formaldehyde inhibited any red cell acid phosphatase
present. a-1,4-01ucosidase was assayed in a system of 0.18 M
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citrate pfl 4.9, 12.8mM p-nitrophenyl-c,-D_-glucopyranoside and 10pl
of amniotic fluid, in a final volume of 0.15 ml. Alkaline phos¬
phatase was assayed in a system of 62raM sodium carbonate buffer pH
10.75, l2.5mM HgClg, 32.5mM 'Sigma 104' phosphatase substrate and
5-20j.il amniotic fluid in a final volume of 50pl. To determine the
specific activity of the placental (heat-stable) alkaline phosphatase,
an aliquot of amniotic fluid wa3 incubated at 65°C for 25 minutes, after
the method of Hunter (1969). The difference in specific activity
between the unheated and heated amniotic fluid aliquots represented
the heat-labile alkaline phosphatase. In all assays a control
without amniotic fluid and a control without substrate were included.
The assay solutions were incubated for 2 hours at 37°C under
saturated vapour pressure to minimise evaporation. The reactions
were then stopped by the addition of 0.4M glycine-NaOH buffer pH
10.3, to a final volume of I.Onl. The optical density of the
solutions was measured spectrophotometrically at 400 bjj. The enzyme
specific activities were calculated by subtracting the sum of the
controls from the full systems, and using the molar extinction co-
. a ,
efficient of p-nitrophenol (1.775 x 10 under these conditions) to
express the results in p moles substrate hydrolysed per hour per ml
amniotic fluid. The protein concentration in amniotic fluid was
measured by Lowry'3 method (Lowry et al 1951), and it was used to
calculate specific activity in p moles per hour per gm of protein.
iii. Inhibition of red cell acid phosphatase
Red cell acid phosphatase is a different enzyme from lysosomal
acid phosphatase which is found in other tissues. For example,
whilst the red cell enzyme is polymorphic in humans (Hopkinson et al 1963)
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no such variation is found in the lysosomal form. The activities of
the two enzymes may he differentiated by a number of specific inhibitors.
Neutral formaldehyde is a potent inhibitor of red cell acid phosphatase
(Abul-Fadl and King, 1949), and it was therefore used to differentiate
between the enzymes in this study. Fig.36 a shows the effect of
neutral formaldehyde at various concentrations on the specific activity
of red cell acid phosphatase. 0.4 Formaldehyde was found to almost
completely inhibit the red cell enzyme whilst having little effect on
the acid phosphatase in serum. An experiment v/as therefore made to
find whether 0.4 neutral formaldehyde would selectively inhibit red
cell phosphatase which had been added in varying quantities to an
amniotic fluid obtained at term. Fig£>6 b shows that the effect of
adding formaldehyde to the assay system i3 to selectively inhibit the
red cell enzyme which had been added to the amniotic fluid. although
the inhibition is very strong it is not complete: since the curve in
the presence of formaldehyde still increases with increasing red cell
enzyme. However, the effect of formaldehyde is clearly great enough
to show whether there is a significant red cell enzyme contribution to
the acid phosphatase in amniotic fluid.
The specific activity of red cell acid phosphatase was measured
as the difference between the specific activities of acid phosphatase
in the presence and absence of 0.4 neutral formaldehyde. Fig£7
shows the percentage of acid phosphatase in amniotic fluid which was
of the non-red cell type. There appears to be a small contribution
from red cell enzymes early in gestation, which disappears toward term.
Figure 36 a) The effect of neutral formaldehyde on the activity
of red cell (rc) and serum (s) acid phosphatase.
b) The effect on the activity of acid phosphatase in
amniotic fluid of adding various volumes of red cell ly3ate, assayed
in presence and absence of 4, neutral formaldehyde (4. ECHO). 50pl
of term amniotic fluid was present in all the assays, and 0-20pl of
red cell lysate (at a concentration of /70 v/v) was added, to test
the extent to .-/hich the red cell phosphatase was inhibited.
a
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Figure J7 he specific activity of fornc1-rcsi3tant (non-red. cell )
acid phosphatase in amniotic fluid, expressed as the percentage















iv. The measurement of placental alkaline phosphatase
A number of different forms of alkaline phosphatase occur in
various human tissues (see Suzuki et al 1969), and the increase in
phosphatase specific activity in the serum of pregnant women is
known to be due to the appearance of a placental form (Beck and Clark,
1950; Boyer, 1961; Hchaster et al 1964). Phis placental form of
alkaline phosphatase has been found to be particularly resistant to
heat denaturation (Monaster et al 1964; Hunter, 1969) and to be
particularly strongly inhibited by phenylalanine (Suzuki et al 1969).
These properties have lead to the use of either phenylalanine or heat
to distinguish between the placental and non-placental forms of the
enzyme in pregnant human serum.
xperiments were made to investigate the beet system for measuring
the placental and non-placental forms of alkaline phosphatase in
amniotic fluid. Placental homogenates (in saline) served as a source
of placental alkaline phosphatase and adult male serum as a source of
non-placental alkaline phosphatase. Pig.38a shows the effect of
varying concentrations of DL-phenylalanine in the assay system on the
activity of the placental (p) and the serum (s) enzymes. At 18mM
DL-phenylalanine, the placental phosphatase activity was inhibited
by 75 whereas the male serum enzyme was subject to very little
inhibition.
To test che heat-stability of the enzymes, aliquots of the serum
and the placental extract were either kept at 4°C or were incubated
at between 40 and 80°C for various periods of time. The aliquots
were then tested for phosphatase activity. Fig.38b shows the effect
of 25 minutes incubation at between 47° and 78°C. The serum phos—
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phatase was almost entirely inactivated after 25 minutes at 65°C,
whereas at the same temperature the placental enzyme had only lost
16 of the activity which was found in the aliquot kept at 4°C.
The placental phosphatases are highly labile when exposed to
temperatures above 70°C for 25 minutes.
The heat and phenylalanine sensitivities of the alkaline
phosphatases in amniotic fluid were investigated next. The upper
curve in Fig.58c shows the heat-stability profile of the enzymes
in an amniotic fluid at term. There is a gradual loss of activity
between 4 and 65°C, and a more rapid loss between 70° and 80°C.
If the enzymes in amniotic fluid had similar stabilities to those
in serum and placenta, the loss of activity between 70° and 80°C
should be due to placental alkaline phosphatase, whilst the non-
placental forms should have been inactivated by 65°C. Since
phenylalanine selectively inhibits the placental form, the heat
stability profile could be further investigated by assaying the
enzyme activities in the presence of phenylalanine after the
incubations were ended. Fig.38c shows the heat stability profiles
of amniotic fluid alkaline phosphatases measured in the presence
(-i- $ala) and absence (-0ala) of 13mJT DL-phenylalanine in the assay
system. The curves show that a phenylalanine resistant form of the
enzyme is progressively inhibited between 4 and 65°C, and that the
loss of activity between 70 and 30°C is due to a phenylalanine-
sensitive enzyme. The results are consistent with the hypothesis
that the non-placental forms of alkaline phosphatase in amniotic
fluid are selectively inhibited by incubation for 25 minutes at 65°C.
his incubation period was therefore used to measure the placental
TABLE 1 0
Kichaeli.3 constants and pH optima of the enzymes






total alkaline phosphatase 6.0 10.75
expressed as mM substrate
*
substrate inhibition above 10mII substrate
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fraction of alkaline phosphatase in amniotic fluid and serum. rhe
same system has been used by Hunter (1969) measure placental
alkaline phosphatase in maternal serum. Roopnarinesingh et al (1972)
assayed placental alkaline phosphatase in amniotic fluids at term
using 55°C as the inactivation temperature. This may give an over¬




To ensure that the enzymes were assayed at optimal pH, the
effect of changing the pK was observed for each enzyme. Tig.39
shows the effect of pH on the activities of each enzyme. The pH
optima are summarised in Table 10. Routine assays were carried out
at the pH optima.
ilichaelis constants
To ensure that the enzymes were assayed at optimal substrate
concentrations, the effect of changing the substrate concentration
was observed for each enzyme. Fig.40 shows the relationships
between the substrate concentrations and enzyme activities. Note
that in the case of acid phosphatase, there was inhibition of enzyme
activity at substrate concentrations above10mM p-nitrophenyl phosphate.
Each enzyme was routinely assayed under conditions of saturating
substrate concentrations, except in the case of hexosaminidase, wliere
the sparing solubility of the substrate precluded saturating conditions.
Effect of altering the quantity of enzy.-.e present, or the
length of the aaaay time
For the enzyme assays to the reliable-, there should be a
linear relationship between the quantity of the enzyme added to the
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assay system and the quantity of substrate hydrolysed. There should
also be a linear relationship between the length of time for which an
assay is run and the quantity of substrate hydrolysed. Fig.41 shows
that for each enzyme, the assay systems provided linear results both
in terms of time and the quantity of enzyme added.
Figure 38 Inhibition studies on alkaline phosphatase. Details
on pp.86-87.
(a) The effect of phenylalanine on the enzymes in
placenta (p) and serum (s).
(b) The effect of temperature on the enzymes in
placenta (p) and 3erum (s)
(c) The effect of temperature on the enzyme in term
amniotic fluid, assayed in the presence ( + ala)
and absence (- ala) of 18mK DL-phenylalanine.











Figure 40 The effect of substrate concentration on the activities
of amniotic fluid enzymes. a) Lindwever-Burke plots of hexosaminidase
(Hex) and a-1,4-glucosidase (G-lu). b and c) Mchaelis-Menten plots
of (b) acid phosphatase, and (c) alkaline phosphatase.
 
figure 41a The effect of changing the time of incubation on the
quantity of substrate hydrolysed by (a) hexosaminidase, (b) acid
phosphatase, (c) a-1,4-glucosidase, (d) heat-labile alkaline phosphatase,
and (e) heat-stable alkaline phosphatase. The volumes of amniotic
fluid added to the assays were (a) 5pl» (b) 40j.il, (c) (d) and (e) 10pl.
All the assays were carried out on term amniotic fluid, with the
exception of o-1,4-ylucosidase, which was assayed using a 16 week
sample of fluid.
For assaying conditions see pp. 83-84.
Figure 41b The effect of changing the volume of amniotic fluid
added to the assay systems of (a) hexosaminidase, (b) acid phosphatase,
(c) o-1,4-glucosidase, (d) heat-labile alkaline phosphatase, .(e) heat-
stable alkaline phosphatase.






Figs.42a and b show the patterns of specific activity on
volume and protein bases respectively. A peak of activity was
found between thirteen and eighteen weeks of gestation. After this
period consistently low specific activities were observed.
Heat-Labile Alkaline iho3phataae
Figs.43» and b show the patterns of specific activity on
volume and protein bases respectively. An initial peak in activity
occurred between thirteen and eighteen weeks, and during this time
a close relationship was found between the specific activities of
heat-labile alkaline phosphatase and a-1,4-glucosidase in individual
amniotic fluids (Fig44). Heat-labile alkaline phosphatase was
found at very low levels between eighteen and thirty-six weeks of
gestation, after which there was a considerable rise (accompanied by
a wide scatter), hen enzyme specific activity is expressed on a
protein basis (Fig43b) both peaks of activity are exaggerated, and
the rise toward term occurs earlier.
cid Phosphatase (Fig3.45a and b)
Little change in specific activity per ml amniotic fluid was
observed before about thirty-two weeks. After this time there was
an increase in specific activity, together with considerable variation
between individual values. Fig45 b shows that a minor peak in
specific activity per gm protein occurs between thirteen and eighteen
weeks of gestation, as well as the more obvious peak at term.
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Hexosaminidase (Figs.46a and b)
No clear pattern emerges from the enzyme specific activity per
ml amniotic fluid, although the lowest specific activities are found
before fourteen weeks of gestation. However, Fig.46b shows the
specific activity per mg protein is minimal between twenty and
thirty weeks.
Placental \lkaline hosphataoe (Figs.47a and b)
A gradual increase in specific activity was observed between
ten and thirty weeks, after which the specific activity rose more
rapidly. Between thirty and forty weeks, the specific activity of
placental alkaline phosphatase in amniotic fluid increases by 3 to
3.5-fold. Expression of activity on a protein basis lead to an
exaggeration of the rise in the latter half of pregnancy.
Figure 42 Amniotic fluid a-1,4-glucosidase, expressed (a) per
ml amniotic fluid, and (b) per mg protein, plotted against gestational
age.
ymbols for Figs.42-43* 45-47
■ = Hysterotomy
# = .nniocentesis
A = -rteficial iupture of Hembranes, Normal
pregnancy




















Figure 43 Amniotic fluid heat-labile alkaline phosphatase,














































Figure 44 The relationship between amniotic fluid a-1,4-glucosidase
and heat labile alkaline phosphatase between ten and twenty weeks of
gestation, expressed aa fnaole/hr/ml amniotic fluid.
HEAT LABILE ALKALINE PHOSPHATASE
uu
Figure 45 Amniotic fluid acid phosphatase, expressed (a) per ml
























Figure 46 Amniotic fluid hexosaminidase, expressed (a) per ml














































Figure 47 Amniotic fluid placental alkaline phosphatase, expressed
(a) per ml amniotic fluid, and (b) per gm protein, plotted against
gestational age.
PLACENTAL ALKALINE PHOSPHATASE
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d. Discussion
The results show that complex changes of enzyme specific activity
occur in the amniotic fluid as gestation proceeds. Generally,
hexosaminidase had the highest specific activity in amniotic fluid
and, with the exception of a-1,4-glucosidase, all the enzymes were
at their highest specific activities at term.
Between thirteen and eighteen weeks of gestation, there is a
peak in the specific activities of a-1,4-glucosidase and heat-labile
alkaline phosphatase. he close correlation between the values for
these enzymes in individual amniotic fluids (Fig.44) suggests that
their activity peaks are due to the same developmental event. The
effects of this event are not limited to these two enzymes, for there
is a simultaneous increase in the specific activity of hexosaminidase
and also minor activity peaks for the other enzymes.
Between twenty and thirty weeks of gestation, the specific
activities of a-1,4-glucosidase and heat-labile alkaline phosphatase
fall to their lowest levels, whilst those of the other enzymes remain
unchanged. fter thirty weeks, the specific activities of hexos¬
aminidase and a-1,4-glucosidase remained unchanged, whilst those of
acid phosphatase, placental alkaline phosphatase, and (somewhat later)
heat-labile alkaline phosphatase rise to their maximal levels.
Roopnarinesingh et al (1972) also found that the specific activity of
placental alkaline phosphatase increased during this time, though
these workers used 56°C as their inactivation temperature and so may
have also been measuring a labile fraction of alkaline phosphatase.
The considerable scatter of the specific activities of these
phosphatases at term may be partially due to errors in estimating
gestational age, or to the varying proximity of the onset of labour.
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Such errors would have their greatest effect upon enzymes undergoing
rapid changes in specific activity. Jhe lack of correlation between
the levels of the three enzymes in the individual amniotic fluids
after 37 weeks does not seem to be due to technical problems.
Meconium stained amniotic fluids were excluded from the series as
they contain excessive quantities of(heat-labile)alkaline phosphatase
(Oeyer and .Schneider, 1970). It was possible that the samples of
amniotic fluid obtained at artificial rupture of the membranes were
not typical of the rest of the fluid. This point was investigated
in three patients at the induction of labour. In these patients,
ten consecutive 20 ml samples of amniotic fluid were taken for analysis
while it drained from the amnioscope. In no case was significant
variation found in the protein concentration or in any of the enzyme
specific activities.
In this study no significant correlations were found between
the amniotic fluid protein concentration and the enzyme specific
activities. However, the specific activities on a protein basis
were plotted against gestational age because this caused an exagg¬
eration of the early and late peaks of enzyme specific activity.
This occurs because the protein concentration reaches a maximum at
approximately twenty-five weeks of gestation (pueenan et al 1970;
Pig.48). Although the biological basis of this expression of
specific activity is questionable, the exaggeration it brings about
may be valuable if the measurements are to be used for maturity
testing or other studies during the last trimester of pregnancy.
The patterns of enzyme specific activity reported here show that
complex factors control the composition of amniotic fluid, and the
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possible nature of these factors is dealt with in a subsequent section
(pp. 95-100). let, whatever the biological implications of these
findings, the trends observed during the latter half of pregnancy
suggest that the measurement of enzymes in amniotic fluid may be of
use in the assessment of fetal maturity. In particular, the changes
in phosphatase activity, on both volume and protein bases, appear
to merit further investigation.
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3. POSSIBLE ORIGINS OF AMNIOTIC FLUID 3HZYME5
a. Introduction
A number of studies have suggested, that the majority of the
protein in amniotic fluid is of serum type. Paper electrophoresis
has been used by a number of authors (see Table j ) to show the
similarity between the amniotic fluid protein and 3erum protein.
Berrington and Soothill (1961) immunised rabbits with amniotic fluid
obtained at term, and found by Immunoelectrophoresis that the antibody
response was directed solely toward serum protein. In the work of
von Kleist et al (1968) and that of our own (p.53) rabbits were
immunised with amniotic fluid from various stages of gestation, and
the majority of their immune responses were directed toward serum
protein throughout gestation.
Although proteins of non-serum origin must constitute a minor
fraction of the total amniotic fluid protein, their study is of
interest for a number of reasons. Knowledge of the way in which
local tissues contribute to the fluid may increase understanding of
the formation and maintenance of the amniotic fluid. Secondly, the
identification of proteins which corae from ti. sues of fetal origin
should be of value in the antenatal diagnosis of some genetic disease
(O'Brien et al 1971; 1riedland et al 1971; Brock and Sutcliffe,
1972 a and b) and finally data collected throughout pregnancy may be
useful in the assessment of fetal maturity.
Immunological and ensymological techniques can be used in attempts
to find tissue protein in the amniotic fluid. In the previous section
the activity patterns of a group of amniotic fluid enzymes were
investigated, and it was suggested that these measurements might be
used for the assessment of fetal maturity. In this section, the
biological implications of the results are considered by firstly
discussing the extent to which the enzymes are of serum origin, and
then considering possible tissue origins of amniotic fluid enzymes.
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b. Materials and * ethods
The assay systems used have been described on p.35. The
maternal and fetal sera were diluted respectively up to x10 and x5
with physiological saline before assay. extracts of amniotic fluid
cells were made using the methods of Sutcliffe and Brock (1971).
In order to follow the release of cellular enzyme small serial
samples of the supernatant were collected during the course of
sonication. The maximum specific activities of released enzyme were
used to calculate the ratio of supernatant to cellular enzyme in
samples of amniotic fluid at term.
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c. Results
1. Amniotic fluid protein concentration
Fig.48shows the distribution of protein concentrations in amniotic
fluid found throughout pregnancy. Although there is considerable
scatter of results, there was a rise in mean protein concentration
between ten and twenty-five weeks. The quadratic curve of best fit
was calculated for this period by multiple regression analysis, and
is shown in Fig. 48 . Between twenty-five and thirty-two weeks the
protein concentration falls by half and remains at this level until
term. Fig. 4<£ shows the rate of accumulation of protein in the
amniotic fluid between ten and twenty-five weeks of gestation. It
was constructed by taking the product of the mean amniotic fluid
volume for each weekly period between ten and twenty-five weeks of
gestation and the weekly protein concentration as calculated from the
quadratic curve of best fit. The mean volumes were taken from the
combined data of Wagner and Fuchs (1962); Gadd (1966), Rhodes (1966),
Gillibrand (1969) and ibramovitch (19 6$. The difference between
the products for consecutive weeks was taken as the rate of protein
accumulation per week,
ii. enzymes in serum and urine
The specific activities of hexosaminidase, acid phosphatase,
a-1,4-glucosidase and the heat-labile and placental alkaline phos¬
phatases were measured in maternal and fetal sera, and in fetal urine.
The results are shown in Table 11 The specific activity of heat -
labile alkaline phosphatase could not be measured in maternal serum
at term because of the exceedingly high levels of placental alkaline
phosphatase.
Figure 48 The protein concentration in amniotic fluid supernatant
measured by Lowry's method. The best fitting quadratic curve for the
data between ten and twenty-five weeks of gestation wa3 plotted. '
It is of the form:
P = 1.266S + 0.026G2 - 9.822
*
where P = protein concentration, and G = gestation in weeks .
■ = Hysterotomy
# = Amniocentesis
A = Vuteficial 'iupture of Membranes, Normal pregnancy.
X - " " " Ancephaly.
Figure 49 Histograms of amniotic fluid protein influx calculated
from the regression curve in Fig.48 and the mean amniotic fluid volumes
in the literature. The graphs show the rate of protein influx
expressed per week (a), per week per ml amniotic fluid (b) and per
week per mg amniotic fluid protein (c).
*
Grateful thanks are due to Miss 3. Holloway, B3c., for
computing the quadratic curve of best fit.
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Figure 50 The liberation of amniotic fluid cell enzymes during
3onication. The maximum specific activities were used to calculate
the enzyme specific activities in amniotic fluid.
Figure 51 The decay of enzyme activity in a sixteen week amniotic
fluid incubated at 37°G. the enzymes are placental alkaline
phosphatase (▼ ), heat-*labile alkaline phosphatase (■ ), acid

























Snzymes in Ilaternal and Fetal 3erum and Fetal Urine
Gestation No. hexosamin¬ Acid .Ikaline phosphatase a-glucos-




9-11 10 2.46 0.43 0.54 0.10 .07
1.72-3.42 0.35-0.75 0.42-0.81 0.07-0.12
13-13 11 3.00 0.5 0.65 0.33 .08
2.05—4.08 0.34-0.79 0.39-0.81 0.12-0.32
39-41 16 3.33 0.55 f 11.90
5.21-13.0 0.41-0.78 1 4.60-22.6
Fetal Serum
13-18 10 2.20 0.87 4.43 0.26 0.26
1 .2-7.23 0.40-1.90 2.65-6.7 0-0.66 0.13-0.42
30-38 7 1.28 0.60 2.33 0.3 ..
0.27-1.79 0.44-0.79 1.0-3.54 0-0.45 0.11-0.15
39-41 11 2.2 1.64 2.91 0.38
1.70-3.82 0.70-2.51 1.31-5.23 0.21-0.33
Fetal Urine i'otal
13-13 11 0.47 0.56 0.08 0.03
0.15-0.90 0.28-1.10 0-0.18 0-0.07
22.40 6 0.26 2.20 0.14 0.25
0.05-0.37 0.45-4.33 0.04-0.13 0.10-0.45
Mean and range of observations, expressed a3 pinoles substrate hydrolysed
per hr per ml at 37°C.
•j* ccurate measurement not possible due to high levels of placental alkaline
phosphatase.
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dnzymes in amniotic fluid cells
The liberation of enzyme from amniotic fluid cells during the
course of Bonication is shown in Fig.50. Between 40 and 150 seconds
of sonication were required for maximum enzyme liberation. From
the results the quantity of cellular enzyme was calculated and
expressed as the specific activity of enzyme (mole/hr) per
precipitate from 1ml of amniotic fluid (Table 12). In each case the
quantity of enzyme present in 1ml amniotic fluid supernatant was
measured a3 mole/hr per ml supernatant. The ratio of the supernatant
to cellular enzyme was then calculated. In each case the quantity
of enzyme in the supernatant exceeded that in the cell fraction
(Table 12).
t:\blj-; la
Ratio between the enzyme specific activities in the super¬
natant and cellular fractions of amniotic fluid
Enzyme Case Amniotic fluid enzyme content
*
Supernatant Cella^ Supernatant/Cell Ratio
d 1.44 0.67 2.15
Hexosaminidase e 2.00 0.56 3.57
t 1.45 0.64 2.27
d 0.21 0.02 10.5
Acid phosphatase E 0.24 0.03 8.00
t 0.13 0.03 4.33
d 1.11 0.02 56.0
Heat labile alkaline
E 0.87 0.03 29.0
phosphatase + t 0.75 0.02 37.5
pmole/hr per ml supernatant
^pmole/hr per precipitate from 1 ml amniotic fluid
"t measured as heat labile alkaline phosphatase in supernatant,
and total alkaline phosphatase in cells.
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d. Discussion
Immunological methods have shown that most of the protein in
amniotic fluid is of serum type (Derrington and Soothill, 1961;
ton Kleist et al 1968; p.53). Thus the protein concentration
determined by Lovry's method measures the approximate concentration
of serum protein in the amniotic fluid. Figure#shows that this
protein concentration rose from ten weeks of gestation to reach a
maximum between twenty and thirty weeks, and then declines until
term. These findings are in good agreement with the work of
Queenan et al (1970), who used the biuret method for protein measurement.
In contrast to the protein concentration, the specific activities
of the amniotic fluid enzymes studied in the previous section (p.90)
showed little or no tendency to rise initially and reach a maximum
between twenty and thirty weeks. In most cases we found maximal
enzyme specific activities at term and/or between thirteen and
eighteen weeks of gestation. These obvious differences lead one to
question the extent to which serum can be a major source of these
enzymes in amniotic fluid.
For an amniotic fluid enzyme to be of serum origin, three
conditions must be fulfilled. Firstly, it must be able to pass
into the amniotic sac from the serum. Secondly, its specific activity
pattern during gestation should be predictable from the concentration
changes of other serum proteins in the amniotic fluid. Finally, the
gradient of enzyme specific activity between the serum and the
amniotic fluid should be similar to the concentration gradients of
proteins which are known to be of serum origin.
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i. Molecular "eight
Previous studies (Usategui-Gomez et al 1966; Gltlin and
Biasucci, 1969; see p.36) suggest that serum proteins which
have molecular weights of less than -bout 170,000 can permeate into
the amniotic fluid. Pour of the enzymes studied here have molecular
weights under 170,000. Robinson and Stirling (1968) found the
molecular weight of hexosaminidase to be 100,000. Placental
alkaline phosphatase is dimeric at physiological pB, and has a
molecular weight of 116,000 (jussman and Gottlieb, 1969). The three
forms of acid phosphatase which have been found in human placenta
have molecular weights respectively of 35,000; 105,000; and over
200,000 (Di Pietro and Zengerle, 1967). No data is available for
human o-1,4-glucosidase, however the enzymes purified from bovine
and from rat liver have molecular weights of 107,000 and 114,000
respectively, (Bruni et al 1969; Jeffrey et al 1970). Human heat
labile alkaline phosphatase exists in a number of distinct forms and
has not yet been purified.
ii. The effect of lability on expected enzyme specific activity patterns
Enzymatic proteins are more labile than the majority of serum
proteins, and most of the enzymes studied here progressively lose
activity when incubated in vitro at 37°C (Fig.51). This observation
makes it important to decide whether the specific activity pattern of
a labile enzyme of serum origin will differ from that of the amniotic
fluid protein concentration. Because of the difficulty of extra¬
polating from in vitro lability data to the in vivo situation, a
theoretical examination of enzyme lability xd.ll be made, and its
result will be compared with the pattern expected for a stable enzyme
of serum origin.
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Stable amniotic fluid enzymes of serum origin would have patterns
of specific activity per ml parallel to the protein concentration
(provided the enzyme levels in serum remain constant). However,
the phenomenon of enzyme lability will reduce the rate of accumulation
of measurable enzyme, so that the specific activity of a very labile
enzyme is controlled by its rate of influx into the amniotic fluid.
The rate of influx of the enzyme will be similar to that of the other
serum proteins, in proportions controlled by molecular weight and
other characteristics. Before about 25 weeks the rate of influx of
protein into the amniotic fluid will be in proportion to its rate of
accumulation (see Pig.49 line a), since removal of protein by fetal
swallowing is negligible at this time. (By 20 weeks of gestation
the fetus swallows less than 5 of the total volume of liquor in
twenty-four hours, Abramovitch, 1970).
Since the total specific activity of a highly labile enzyme will
be in proportion to the rate of influx of protein into the amniotic
fluid, division of the rate of influx of protein by the mean total
fluid volume and the mean total fluid protein content respectively
will provide patterns which are in proportion to a labile enzyme's
specific activity per ml amniotic fluid and per mg protein. The
results of this calculation are shown as histograms in Pig.49 lines
Jb and c, respectively. The influx of total protein on a volume basis
is maximum at about sixteen weeks whilst expression on a protein
basis results in a maximum between ten and eleven weeks of gestation.
This result suggests that in the case of labile enzymes early in
gestation, the mere demonstration of a difference between the
patterns of enzyme activity and of protein concentration in the
amniotic fluid is insufficient to allow the conclusion that the
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enzyme comes from a source other than serum. This conclusion applies
particularly to o-1,4-glucosidase, heat labile alkaline phosphatase,
and hexosaminidase, all of which show considerable increases between
ten and fifteen weeks of gestation. The analysis cannot however,
be extended beyond about twenty-five weeks of pregnancy because the
increasing rate of fetal swallowing (pritchard, 1965) will increase
the rate of protein offluz from the flui<\ and 30 prevent an accurate
assessment of influx.
iii. Analysis of concentration gradients
If an enzyme is primarily of serum origin, the ratio of its
specific activities between serum and amniotic fluid should be
similar to the concentration ratios of other proteins which are found
in amniotic fluid, and which are known to be exclusively of serum
origin. The group-3pecific component (3c) in amniotic fluid is
known to be of maternal serum origin throughout gestation (p.61-65)
and so can be used as an approximate measure of the maternal serum :
amniotic fluid protein concentration gradient. Similarly, a-feto-
protein may be used as a measure of the fetal serum : amniotic fluid
protein concentration gradient, since it is practically absent from
the maternal serum (kuoslahti and eppala, 1972). The mean concen¬
tration gradient for Gc has been found to increase during gestation
from 15 at between 13 and 18 weeks of gestation, to 32 at term (Table 5).
In the case of <a-fetoprotein the mean gradient between thirteen and
eighteen weeks has been found to be 206 (p. 77) : a magnitude which
is similar to that found earlier in gestation by Oitlin and
Boesman (1966).
Table 13 shows the mean specific activities observed for the
enzymes in amniotic fluid at term and bwtween thirteen and eighteen
TABLS 13
The mean specific activities observed for the amniotic fluid
enzymes, and those calculated from the maternal and fetal











hexosaminidase 36 1.06 0.20 0.01 5.0
acid phosphatase 35 0.06 0.03 <0.01 1.5
heat-labile alkaline
phosphatase
30 0.24 0.04 0.02 4.0
placental alkaline
phosphatase
29 0.09 0.02 < 0.01 3.0
a-1,4 glucosidase 30 0.54 0.01 < 0.01 27.0
Pregnancies at Term
hexosaminidase 25 1.72 0.26 - 6.6
acid phosphatase 25 0.23 0.02 - 11.5
heat-labile alkaline
phosphatase +
25 0.60 0.02 - 30.0
placental alkaline
phosphatase
25 0.65 0.37 - 1.8
pmole substrate hydrolysed/hr/ml amniotic fluid.
t using maternal serum data from thirteen to eighteen weeks gestation,
see Table II
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weeks of gestation. The expected specific activities have been
calculated from the maternal and fetal 3erum enzyme specific
activities (Table11 ^ and the maternal or fetal serum : amniotic fluid
protein gradients as outlined above. The term data has not been
tested on the hypothesis of a fetal serum origin since the a-feto-
protein gradient at term is very high (Gitlin and Boesman, 1966).
The results show that in all cases the specific activities observed
in amniotic fluid are in excess of those calculated on the hypothesis
of a serum origin for these enzymes. Particularly striking are the
low levels which should be expected on the hypothesis of a fetal
serum origin.
The validity of the analysis in 'Tabled must be examined, since
surface properties and molecular -./eight are of major importance in
determining the rate of diffusion of individual proteins. The
molecular weights of most of the enzymes studied are greater than
*
those of Gc and -fetoprotein. Thus the concentration gradients of
the latter proteins may be underestiaates of the expected specific
activity gradients of the enzymes. If this is so, the conclusion
that many of the enzymes are of non-serum origin is made more likely.
However, an independent line of evidence suggests that the analysis
is of value, at least in the case of placental alkaline phosphatase
at term, for which an expected to observed ratio of 1.8 was calculated.
Between thirty vreeks of gestation and term, the concentration of
major serum proteins in amniotic fluid falls by approximately half (Figs.
10-13,48). Therefore, if the amniotic fluid placental alkaline phos¬
phatase is of serum origin, its specific activity would not rise at
the sam ■ rate as in the maternal serum. Between thirty and forty
molecular weight of Gc = 50,000 (Schultz and Heremens, 1966)
of a-fetoprotein = 75,000 (p.79)
of enzymes : see p. 101
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weeks of gestation the specific activities of the enzyme in both
amniotic fluid (Fig.47a) and in maternal serum (Hunter, 1969) increase
by 3 to 3.5 fold. This suggests that there is approximately twice
the expected enzyme specific activity in term amniotic fluid, and
that the enzyme is therefore not in simple equilibrium with that in
maternal mixed venous serum. This bears out the conclusion from
Table 13.
To what extent do the calculations for placental alkaline
phosphatase provide an insight into the relationships between the
amniotic fluid and the placenta? Placental alkaline phosphatase is
located in the placental trophoblast (Ahmed and King, 1959? V/islocki
and I-'adykula, 1961; Hunter, 1969), so that in haemochorial placentae
it is not possible for the enzyme to diffuse directly from actively
exchanging trophoblast through the membrane into the amniotic fluid,
without passing into the maternal serum (see fig.3. p.7, and
Hamilton and Boyd, 1960). Thus placental alkaline phosphatase
might be expected to behave in amniotic fluid as a maternal serum
protein. However, as discussed above, the enzyme does not behave
in amniotic fluid as though it was simply of maternal serum origin.
There are two possible explanations for these findings. The
first is that the enzyme specific activity in mixed venous blood is
significantly less than that in the maternal placental blood. The
difference in the specific activity of placental alkaline phosphatase
between the arterial and venous 3ides of the maternal placental
circulation may be calculated from the in vivo decay of the enzyme
rate post-partum, and the rate of circulation of maternal blood
through the placenta. The post-partum clearance rate of placental
alkaline phosphatase is approximately 1 L/day (from Hunter, 1969).
Footnote to p. 106
c » Clearance = 1L/day
v = Blood volume = 5L
r = Rate of blood flow through placenta » 500 ml/min
7 = Specific activity of enzyme in placental venous blood
A = " " " " h " arterial blood
If there was only one complete circulation of blood through the placenta
in one day, then:
7 = A + cA
v
Total number of blood circulations through
the placenta in one day = r
v
For r circulations per day:
v
V = A + cA v
v x r
= A (1 + C, )
r
7 a 1 + C
A r
r = 0.5 x 60 x 24 L/day
= 720
• 1 = 1 + JJL. ~ < 0.002
A 720
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The maternal circulation rate through the term placenta is about
500 ml/min. (/Issali et al 1960). From this, the maternal veno¬
arterial ratio for placental alkaline phosphatase may be calculated
as being only of the order of 1.002 to maintain the specific
activity of the enzyme in serum. This small difference shows that
the mixed venous serum adequately reflects the enzyme activity of
circulating placental blood. Only in the event of maternal venous
pooling bonoath the chorionic plate might serious discrepancies arise,
Perhaps a more acceptable explanation for the excessive quantities
of placental alkaline phosphatase in amniotic fluid, is that parts
of the trophoblast are closely applied to the chorionic plate so
that an enzyrae diffusion pathway exists which is independent of
maternal serum. Such trophoblast would not be carrying out transport
functions as it would be 'starved' of maternal serum. The extent to
which the specific activity of placental alkaline phosphatase exceeds
that expected on the basis of the maternal gradient argument above may
therefore reflect the extent of trophoblast 'starvation',
iv. ■.Iternative tissue sources of enzyme
Having shown that maternal serum is neither a major source of
a-1,4-glucosidase, hexosaminidase or of placental or heat labile
alkaline phosphatase between 13 and 18 weeks, nor of hexosaminidase,
acid phosphatase, or heat-labile alkaline phosphatase towards term,
alternative tissue sources must be discussed. Any of the fetal or
maternal tissues which are adjacent to the amniotic fluid or which
are able to secrete protein into the fluid must be regarded as
potential sources. These include fetal serum, urine, skin and
respiratory and alimentary secretions, as well as umbilical cord




chorion and amniotic fluid cells. Ilaternal protein of non-serum
origin can only ontor the amniotic fluid from the uterine decidua
and myometrium.
It is possible that amniotic fluid cells contribute to the fluid
enzymes. However, it i3 difficult to understand how they could cause
the changes in enzyme activity observed between ten and twenty weeks
of gestation, since ifelson and dmery (1970) have shown that the
concentration of amniotic fluid cells is maximal at term. The
relationship between the enzyme specific activities in the cells and
the supernatants of three term amniotic fluids was therefore studied.
Table \2 shows that in one ml of amniotic fluid, there was more enzyme
activity in the supernatant fluid than in the cells. In the case of
heat-labile alkaline phosphatase there was between 29 and 56 times as
much enzyme in the supernatant as in the cells, whereas the ratio for
acid phosphatase was 4-10, and for hexosaminidase 2-4. Prom these
results it is clear that at term the minority of amniotic fluid enzymes
is cellular, and that the cells cannot be a major source of alkaline
phosphatase or acid phosphatase. It remains to be decided whether
the supernatant : cell ratio for hexosaminidase indicates that cellB
are a major source of this enzyme.
A similar supernatant : cell analysis has not been made on
amniotic fluid early in gestation. However, there are reasons to
suggest that amniotic fluid cells are an insignificant source of
supernatant enzyme between thirteen and eighteen weeks of gestation.
Firstly, the cell concentration is very low at the time of the
early specific activity peaks of hexosaminidase, U/-1,4-glucosidase,
and heat-labile alkaline phosphatase. Further, between twenty and
108.
thirty weeks, when the cell concentration i3 increasing at its
maximal rate (Nelson and mery, 1970) no obvious increase in enzyme
specific activity occurs.
The similarity between the early activity peaks of a-1,4-
glucosidase and heat-labile alkaline phosphatase suggests that the
same tissue is responsible for liberating both enzymes. However,
it is not known whether this tissue is maternal or fetal. Genetic
studies should provide the clearest answer to this question, yet
both successful (Nadler and Nessina, 1969) and unsuccessful
(Nadler et al 1970) prenatal diagnoses of Pompe's disease have
been reported using the measurement of supernatant a-1,4-glucosidase.
However, it is difficult to decide on the biological significance of
thi3 observation owing to the lack of extensive control data, and
possible complications due to unrecognised fetal heterozygosity.
Of considerable interest is the finding of Oalafsky and Nadler
(1971) that the majority of amniotic fluid --1,4-glucosidase at
sixteen weeks is bound to free cellular ogranelles. These
organelles must be of fetal origin which suggests that the enzyme is
also of fetal origin. Paradoxically, the same woikers (Salafsky
and Nadler, 1972) have also claimed that the <>-1,4-glucosidase in
amniotic fluid is not kinetically identical to that of fetal tissue
or amniotic fluid cells. At present, no firm conclusions can be
reached about the origin of the a-1,4-glucosidase of amniotic fluid.
However, it must be stressed that i£ the enzyme is of maternal origin,
then it must be synthesised within the uterus, since its diffusion
pathway into she amniotic sac must be independent of maternal serum.
In contrast to o>-1,4-glucosidase, heat-labile alkaline phos¬
phatase is found at high specific activities both early and late in
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gestation. tlectrophoresis of various human tissue extracts have
shown that at least four distinct forms of the phosphatase exist
(see Suzuki et 1969), so that it is unwise to regard the amniotic
fluid enzyme as a single entity, or to assume that the same entity
participates in both the early and late peaks of activity. Indeed,
since o-1,4-glucosidase is not elevated at term, it seems that the
phosphatase peal: at tern is not due to the same process of tissue
break-down as occurred earlier in gestation.
There is a lack of similarity between the patterns of o»t,4-
glucosidase, hexosaminidase and acid phosphatase during the last
eight weeks of gestation. Although all three enzymes are probably of
lysosomal origin and are ubiquitously distributed in body tissues,
acid phosphatase alone shows a marked increase in specific activity
toward term. this suggests that the increased levels of acid
phosphatase are not due to local tissue changes, and argues against
the suggestion of Aeelich and (Jomolka (1952) that the placenta is
a major source of amniotic fluid acid phosphatase. These -workers
claimed that th ratio of specific activityof acid phosphatase and
placental alkaline phosphatase in the amniotic fluid agreed well
with that in the placenta; however, Ahmed and King (1959) were
unable to confirm this. The absence of an elevation of acid
phosphatase in maternal or fetal serum in the last eight weeks of
pregnancy suggests that the placenta as a major source of acid
phosphatase.
It is of interest to note (see Table 11) that the specific
activity of acid phosphatase in fetal urine is considerably greater
than that of either hexosaminidase or a-1 ,4-glucosidase. Further,
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the specific activity of acid phosphatase in fetal urine is consider¬
ably greater than in most amniotic fluids, 30 that fetal urine may be
tentatively advanced as a major source of amniotic fluid acid phos¬
phatase during the last eight weeks of gestation.
e. Conclusion
This study shows that the majority of the enzymes investigated
are probably not of fetal or maternal serum origin. The complex
patterns of enzyme activity found between thirteen and eighteen
weeks of gestation, and during the last two months of pregnancy,
suggest that significant quantities of ti„sue protein are released
into the amniotic fluid. However, the sources of non-serum protein
in the amniotic fluid remain in doubt.
111.
Sr-Ifr/UL DIfflUh:-;iQN
i. The Nature and Origin of . .nniotlc Fluid rotein
It has been shown by ueenan et al (1970) and also in this thesis
(Fig. 48) that the soluble protein in amniotic fluid reaches maximal
concentrations at about twenty-five weeks of gestation. To under¬
stand the significance of the changes in amniotic fluid protein
concentration it was necessaiy to investigate the nature and origin
of the protein. .Ithough Derrington and hoothill (1961) had shown
th.it the majority of the soluble proteins in amniotic fluid at term
were typical serum proteins (e.g. albumin, transferrin), the nature
of the protein earlier in gestation had not been thoroughly examined,
and it was possible, for example, that the peak in protein concen¬
tration at twenty-five weeks was due to an influx of protein from
other sources. This question was investigated immunologically in
the present study, by raising rabbit antibodies against amniotic fluid
protein. It was found that/al^ffifttic fluid protein from various stages
of gestation was injected into rabbits, the majority of the immune
response was directed against serum proteins. -his confirmed the
preliminary findings of von Kleist et al (1968). The major proteins
were found to be albumin, -antitrypsin, group-3pecific component and
transferrin, and the changes in concentration of these proteins in
amniotic fluid were very similar to the changes in the concentration
of the total soluble protein. These observations showed that
throughout gestation the majority of the soluble protein in amniotic
fluid was of serum type, and experiments were therefore made to
investigate the origins of these serum proteins in amniotic fluid.
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Previous studies on amniotic fluid at term had shown that the
group-specific component (Gc), transferrin, and albumin are mainly
of maternal origin (luoslahti et al 1966; Tallberg et al 1966;
Usategui-Gomez and Morgan, 1966; Gitlin et al 1964). The present
study investigated the origin of Gc in amniotic fluids from earlier
stages of pregnancy, and showed that it was of maternal origin from
ten weeks of gestation onwards. A close similarity was found between
the concentration pattern of amniotic fluid Gc during pregnancy, and
the patterns of albumin, -antitrypsin and transferrin, and this
suggested that the other serum proteins .ere also mainly of maternal
origin throughout gestation. This possibility was supported by two
additional'facts. hirst, the concentration gradients of these
proteins between fetal serum and amniotic fluid -were much les3 than
that for a-fetoprotein (which comes from the fetus) both between 13
and 18 weeks of gestatioij and at tern. Secondly, when calculations
were made of the ratios of the concentration of Gc to the concentration
of either albumin, aantitrypsin, or transferrin in amniotic fluid and
maternal serum, there was a proportionality between the ratios which
suggested that in addition to Gc, the other serum proteins were also
of maternal origin (p.59. figs.14-16).
although these data suggest that the majority of amniotic fluid
serum protein is of maternal origin throughout pregnancy, there is
very likely to be a 3mall fetal contribution. The evidence for this
is the presence of small quantities of a-fetoprotein in amniotic fluid,
and the presence of albumin in fetal urine early in gestation
(Gitlin and Boesman, 1966; and Fig.33 ). Further support comes from
the presence of serum p.otein in umbilical cord matrix (see p*39)>.
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The presence of serum protein in the umbilical cord has been confirmed
in this laboratory by injecting thoroughly washed cord extracts into
rabbits and finding that the majority of the immune response was
directed toward serum protein. Similar experiments have shown the
presence of serum proteins in the tracheal aspirates of new born
babies, and these proteins will presumably enter the amniotic fluid
with the pulmonary surfactant lipids.
Previously, the only proteins of non-serum origin which have
been found in amniotic fluid were the amnion proteins described by
Lambotte and colleagues (p.22) and von Kleist et al (1968). In
the present study, immunological and enzymological evidence has been
advanced to show that other proteins present in amniotic fluid are of
non-3erum origin. Immunological investigations using adsorbed anti-
sera revealed an a^-protein which was consistently found in decidua and
which ras not detectable in serum, and whose concentration in amniotic
fluid changed in a similar way to the total protein and 3erum protein
concentrations. n p-mobility protein was also detected in amniotic
fluid by immunological methods. This protein was present at lower
concentrations in adult male serum than in fetal or maternal serum,
and it was al30 found in extracts of placenta and chorion. The
concentration gradients of this protein between amniotic fluid and
the maternal and fetal sera were found to be less than those of known
maternal serum (Gc) and fetal serum (a-feto-protein) markers at least
before thirty weeks of pregnancy, and this su -gested that much of this
protein enters the fluid independently of the maternal and fetal sera.
It is not clear whether the ci^-decidual protein has been
previously described in amniotic fluid, since the possibility of a
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decidual contribution to the protein in amniotic fluid had not been
considered by other workers. The absence of the protein in amnion
obtained at term strongly suggests that the decidual protein is not
the same as the amnion proteins described by other workers.
Furthermore, the amnion proteins described by von Kleist et al (1963)
were present in maximal concentrations in amniotic fluid at term,
whereas the decidual protein was at maximal concentrations at about
twenty-five weeks of pregnancy. Eo references have been found to a
protein similar to the ^-mobility protein described in this thesis.
\nother way of investigating protein contributions to amniotic
fluid is to study the specific activity patterns of amniotic fluid
enzymes. Many tissue enzymes are of course present in appreciable
concentrations in serum and it was expected that this would to some
extent obscure their route of entry into the amniotic fluid. But
there seemed a reasonable chance that a detailed study of the changes
in enzyme specific activities with advancing gestation both in
amniotic fluid and in serum would throw light on primary and secondary
origins. The specific activities of a group of amniotic fluid
enzymes were therefore measured from ten weeks of gestation until
terra and a number of rather distinctive specific activity patterns
were found. a,-1,4-Olucosidase showed a peak in specific activity
between thirteen and eighteen weeks of gestation. Heat-labile
alkaline phosphatase had an early peak of specific activity which
was similar to that of o-1,4-glucosidase and an additional specific
activity peak after thirty-seven weeks. Acid phosphatase showed a
peak of specific activity after thirty-two weeks, while the specific
activity of hexosaminidase remained unchanged during most of
pregnancy, although the lowest levels were found before fourteen weeks.
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The other enzyme studied was placental alkaline phosphatase, and it
showed a gradual increase in specific activity between ten and
thirty weeks, after which time a more rapid increase occurred.
The specific activity patterns of the amniotic fluid enzymes
contrasted sharply with the concentration patterns of the total
soluble protein and of the individual serum proteins in amniotic fluid.
Although this suggested that the enzymes were not of serum origin, it
was possible that amniotic fluid enzyme lability and changes in
specific activities of the enzymes in the serum might account in
part for the patterns which had been observed. Since a theoretical
treatment of enzyme lability (p.101 ) showed that a peak in amniotic
fluid enzyme specific activity before twenty weeks could conceivably
occur in an enzyme of serum origin, a quantitative comparison was
made of the enzyme specific activities in amniotic fluid and in the
maternal and fetal sera. The basis of this analysis was that
if the enzymes 'fere of serum origin, the ratios of their specific
activities between the amniotic fluid and the maternal and fetal sera
ifould be similar to the concentration ratios for proteins known to be
of maternal or fetal serum origin.
Amniotic fluid group-specific component and a-fetoprotein were
therefore chosen as marker proteins as these were known to be
respectively of maternal and fetal serum origin. The result of the
comparison strongly suggested that some of the enzymes mainly diffused
into the amniotic fluid independently of the serum. Between thirteen
and eighteen weeks of gestation, the specific activities of hexos¬
aminidase, a-1,4-glucosidase, and the placental and heat-labile
alkaline phosphatases in amniotic fluid were found to be in excess
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of those expected on the hypothesis of serum origin; although a
significant fraction of the acid phosphatase activity during this
period could be attributed to its influx from maternal serum. In
term amniotic fluid, hexosaminidase, heat-labile alkaline phosphatase
and acid phosphatase appeared to originate from the surrounding
tissues, whilst fetal urine was found to be a potential source of
acid phosphatase. The placental alkaline phosphatase in term
amniotic fluid had a mean specific activity which was the closest to
that expected on the hypothesis of a serum origin. However, there
was evidence to indicate that its specific activity was also in excess
of that expected for an enzyme of serum origin, and the possible
implications of thi3 was discussed in term3 of the relationships
between the placental trophoblast, the maternal serum, and the
chorionic plate.
It is clear that this attempt to enquire into the origin of
amniotic fluid enzymes rests upon the comparison of dissimilar
proteins, and that this could be misleading. Yet analysis of the
dissimilarities shows that the concentration gradients of He and
AFP are probably underestimates of the gradients of enzyme specific
activity which are predicted on the hypothesis that the enzymes are
of serum origin, since Gc and AFP are smaller and more stable than
the enzymes (see p. 104, and Figs. 34 and 51 ). Furthermore, there
was independent evidence available for placental alkaline phosphatase
which closely supported the gradient calculations. It is therefore
concluded that whilst this approach is very approximate, it is of value
in assessing the likelihood that a particular protein in amniotic fluid
is of serum origin. Clearly the approach is quite inapplicable to
small or non-protein solutes.
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Although the ensymological evidence suggested that there was a
release of tissue protein into the amniotic fluid between thirteen
and eighteen weeks of gestation and again at term, the only amniotic
fluid proteins which were found immunologically to be of tissue
origin had maximum concentrations at about twenty-five weeks. In
this context it must be added that the sensitivity of the immulogical
methods used is probably far below that of the enzymological assays
(in terms of fig protein detected). It is highly likely that other
proteins would be detected by the more sensitive complement fixation
test, and that these proteins would exhibit other concentration
patterns. Such experiments would be necessary to confirm the general
conclusions of the enzyme studies, and in particular to investigate
the tissues responsible for the contribution of a-1,4-glucosidase
and heat-labile alkaline phosphatase early in pregnancy.
A number of factors are likely to contribute to the changes in
the serum protein and total protein concentrations in amniotic fluid.
The fall in concentration between thirty and forty weeks of gestation
is probably due to increased rates of fetal swallowing, micturation
and umbilical cord transudation. The increase in protein concentrations
between ten and twenty weeks of gestation occurred for all the
proteins measured, with the exception of a-fetoprotein, 'which showed
a fall in concentration similar to that in fetal serum. The increase
in the concentration of Gc in amniotic fluid during this period suggests
that there is an increase in the protein permeability of the membrane
barrier between the maternal serum and the amniotic fluid, since Gc
has been shown to be mainly of maternal origin throughout pregnancy.
This increase in permeability would result in a more rapid entry of
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maternal serum proteins into the amniotic fluid.
To what extent could these changes in permeability have effects
on water fluxes between the maternal 3erum and the amniotic fluid?
The increase in the permeability of the placental membranes to macro-
molecules will result not only in an enhanced permeability to water,
but also in the water fluxes being increasingly controlled by hydro¬
static pressure gradients. Since the placenta lies between the
uterine de-cidua and the amniotic sac, it is probable that the
pressure of blood in the intervillous spaces and under the chorionic
plate will exceed the pressure in the amniotic fluid if the maternal
placental blood is to circulate. In this way a hydrostatic pressure
gradient would exist across the placental membranes which would bring
about a net flux of water from the maternal circulation into the
amniotic fluid. At present there is no evidence on this question,
although Lind and Hytten (1971) and Lind at al (1972) suggest that
the fetus controls the total volume of the amniotic fluid, and that
the amniotic fluid is an extension of the fetal extracellular space
during the second trimester of pregnancy (p. 18 )• This has been
partly disproved in the present study by demonstrating that Gc
and probably other major amniotic fluid antigens are mainly of
maternal origin. Yet, the finding of a-fetoprotein in amniotic
fluid shows that fetal serum does made some (probably small)
contribution. Certainly, the increase in volume between ten and
txirenty weeks cannot be due to a gross influx of fetal serum, since
the concentration of a-fetoprotein in amniotic fluid falls during




The point of immediate interest from this study is that
anencephaly and possibly spina bifida may be diagnosed antenatally
by amniotic fluid a-fetoprotein measurements, at a stage early enough
to permit therapeutic abortion. theoretical reasons have been
advanced to suggest that early diagnosis should be possible in
anencephaly, and the question can only now be resolved by studying
cases at risk early in pregnancy. In the case of spina bifida,
the usefulness of o-fetop^tein may be limited to those severe cases
in which the vertebral canal is exposed to the amniotic fluid. It
seems unlikely that the technique could be used to diagnose less
gross forms of spina bifida. This is a drawback, since it is these
latter cases which constitute the most serious and unhappy paediatric
problems and would therefore be best subjected to therapeutic abortion.
The use of o-fetoprotein for the diagnosis of some congenital
abnormalities of the central nervous system emphasises the value of
immunological studies on amniotic fluid. It should be possible to
assess the protein contribution of specific tissues to the amniotic
fluid by measuring tissue-specific antigens, as has been illustrated
by the work reported here on a^-decidual protein and by the work of
Lambotte et al (p.22) and of von Kleist et al (1968) on amnion proteins,
preliminary studies by Sutcliffe and Brock (unpublished) have shown
that tissue specific proteins are present in the aspirates of neonatal
tracheal secretions, and although these proteins were not detectable
in unconcentrated amniotic fluid at term by antibody-antigen crossed
electrophoresis, it seems quite possible that their presence will
be demonstrated by complement fixation tests. The measurement of
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specific lung components in amniotic fluid will help in further
investigating the origin of amniotic fluid lipids, and will perhaps
provide new ways of assessing pulmonary maturity.
It is possible that detailed description and measurement of the
non-3erum proteins in amniotic fluid will provide further tests of
fetal maturity. Indeed, in amniotic fluid, changes have been
observed toward term in the specific activities of some enzymes of
mainly non-serum origin, and it has been suggested that these may be
of value in estimating fetal maturity (pp. 81-94). This
possibility was further investigated by comparing the enzyme specific
activities in amniotic fluid with the maturity of the fetus as
estimated by menstrual history or paediatric examination (Sutcliffe
et al 1972). The results of this study were equivocal because of
the difficulty in assessing the significance of paediatric tests of
maturity, and possibly because the amniotic fluid samples were
obtained at artificial rupture of the membranes.
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Human serum normally contains only the conjugated bile salts, glycocholate, glyco-
chenodeoxycholate, taurocholate, and taurochenodeoxycholate (Sandberg et al., 1965;
Panveliwalla et al., 1970), with a total concentration below 5/xmol/l. In serum from
jaundiced patients the total bile salt concentration may rise to values exceeding 250fimol/1
(Panveliwalla et al., 1970). The conjugated chenodeoxycholates and free acids that we
have now shown to inhibit brain respiration in vitro often account for more than half of
the total bile salts and may perhaps exert an inhibitor action in vivo.
These observations may be relevant to the genesis of coma during hepatic failure, for
it is known that during hepatic coma the 02 uptake of human brain is below that of
normal subjects (Wechsler et al., 1954; Fazekas et al., 1956). Although several of the
metabolites that are retained in extracellular fluid during hepatic coma may inhibit
respiration by rat brain slices in vitro (Walshe et al., 1958; Lascelles & Taylor, 1968),
only bile salts do so at concentrations close to those found pathologically. Ammonia, for
example, will inhibit respiration by rat brain slices only when in a concentration of
approx. 1000 times that of plasma, even though the plasma ammonia concentration in
hepatic coma often parallels the degree of coma. These difficulties stand in the way of
accepting a role for bile salts in causing hepatic coma. First, it is not known whether bile
salts pass into cerebrospinal fluid; secondly, many jaundiced patients have raised plasma
concentrations of bile salts without coma supervening; thirdly, the correction of hepatic
coma by treatment with high-carbohydrate regimes cannot be easily explained if bile
salts are solely responsible for the fall of 02 uptake. For these reasons we are increasingly
attracted to the possibility that more than one factor is involved.
The inhibition of respiration achieved by the conjugated bile salts parallels their
detergent properties. Thus Hofmann (1963) has shown that for representative polar and
non-polar compounds the conjugated deoxycholates and chenodeoxycholates have a
lower critical micellar concentration and higher saturation ratio than the cholate.conju-
gates. It is possible that the bile salts in hepatic coma permit relatively easy access to the
brain of other respiratory toxins that would not themselves inhibit brain respiration in so
low a concentration. In this context it is noteworthy that Lascelles & Taylor (1968) were
able to show, with brain slices, potentiation of inhibition of 02 uptake by combinations
of metabolites each of which was present in a concentration known not to be inhibitory.
Finally, hepatic coma is often accompanied by acute renal failure. There can be no
doubt that bile salts can penetrate the glomeruli and be reabsorbed by the renal tubules.
If free chenodeoxycholate were formed in hepatic disease it might perhaps inhibit renal
02 uptake and contribute to the development of acute renal failure.
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Prenatal Diagnosis of Anencephaly
DAVID J. H. BROCK and ROGER G. SUTCLIFFE
University Department of Human Genetics, Western General Hospital,
Edinburgh EHA 2HU, U.K.
The prenatal diagnosis of a number of inborn errors of metabolism and chromosome
disorders is now possible through biochemical and cytogenetic assays on cultured
amniotic-fluid cells. These techniques do not allow recognition of most congenital mal-
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formations (unless associated with a chromosomal aberration), where both the
genetics and cause are obscure. The commonest of the congenital malformations of the
central nervous system are anencephaly and spina bifida, which have incidences of up to
3.6 ir. I COO in the U.K. (Elwood, 1970). Since the risk of either disorder increases drama¬
tically ... .a.:..lies where there are already affected sibs, a proportion of high-risk preg¬
nancies cur. .' j reuciiy identified (Carter et al., 1966; Carter & Fraser-Roberts, 1967).
In anencephaly there are some indications that vascular tissue on the floor of the skull
is exposed to the amniotic fluid (Willis, 1958). This might allow leakage of foetal blood
and could explain the reports of elevated amniotic-Suid bilirubin concentration in this
disorder (Cassady & Cailliteau, 1967; Lee & Wei, 1970). We therefore decided to measure
the concentration of a specifically foetal protein in the fluid. a-Fetoprotein was chosen
since it is an exclusive product of the conceptus, being synthesized in the yolk-sac, liver
and gastrointestinal tract from as early as 6 weeks of gestation (Gitlin et al., 1972). It is
known to reach maximum concentration in foetal serum at about 13-15 weeks and then
to decline towards term (Gitlin & Boesman, 1966). There have been contradictory re¬
ports about its presence in amniotic fluid (Gitlin & Boesman, 1966; Smith et al., 1971),
although by using a sensitive radioimmunoassay method Seppiila & Ruoslahti (1972)
were able to detect it at all stages of gestation.
In the present study, a-fetoprotein was measured by one-dimensional antibody-
antigen crossed electrophoresis (Brock & Sutcliffe, 1972). In normal pregnancies a-feto¬
protein concentration in amniotic fluid was maximal at 13 weeks of gestation, declined
rapidly between 15 and 20 weeks and then fell steadily towards term (Fig. 1). In 22
pregnancies leading to anencephaly or anencephaly combined with spina bifida, where
it was possible to get amniotic fluid in the third trimester, a-fetoprotein concentrations
were grossly elevated. All were above 12/xg/ml, and some ranged as high as 200/xg/ml
(Brock & Sutcliffe, 1972). When concentrations were expressed per mg of protein or per
mg of albumin the distinction between anencephalic and normal fluids remained clear.
In another nine 'anencephalic' pregnancies where fluid was obtained only after 35 weeks'
gestation the distinction was less clear, although five of the samples had strongly raised
a-fetoprotein concentrations.
Since many of the control samples used in this study were obtained from pregnancies
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Fig. 1. a-Fetoprotein concentrations in amniotic fluid at various stages ofgestation
c, Normal samples; a, samples obtained during monitoring of pregnancies at risk for
rhesus isoimmunization, but where bilirubin concentration was low; o, unexplained
hydramnios; x, unexplained stillbirth.
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Table 1. u-Fetoprotein concentrations in amnioticfluids frompregnancies leading to various
conditions






Rh isoimmunization necessitating three postnatal 28 0.5
exchange transfusions: live-born infant, 30 1.1




Rh isoimmunization necessitating two intrauterine 25 0.8
and three postnatal exchange transfusions: 26 1.3
live-born infant, progressing well 27 1.2
I 28 1.3
Rh isoimmunization necessitating intrauterine 24 2.2
exchange transfusion: stillbirth
Rh isoimmunization, hydrops fetalis: stillbirth 27 6.5
Rh isoimmunization: stillbirth 35 1.7
Rh isoimmunization (anti-E): stillbirth 29 0
Duodenal atresia: live birth 36 4.2
Renal hypoplasia: neonatal death 21 5.1
Stunted embryo: termination 12 34.2
Rubella contact: termination 22 4.9
Ectopia vesica: termination' 16 23.6
Exomphalos: termination 10 13.7
Diabetic mother, hydramnios: normal infant 35 2.0
Prediabetic mother, hydramnios: mongol infant 39 6.3
effect this had on amniotic-fluid a-fetoprotcin concentrations. Two pregnancies were
studied where at least four successive amniocenteses had been necessary to monitor foetal
status. In both the degree of isoimmunization was sufficient to require postnatal trans
fusions, and in one intrauterine transfusions had also been necessary. In neither case was
there any indication of a raised a-fetoprotein concentration (Table 1), nor was there in
four cases of rhesus isoimmunization leading to intrauterine death. A variety of other
conditions where there seemed a possibility of elevated amniotic fluid a fetoprotein
concentration were tested, but in none was an abnormal value found (Table 1).
The problem in the prenatal diagnosis of ancnccphaly is to detect it early enough to
allow termination of pregnancy. There are two reasons why this should now bo possible.
First, even though normal a fetoprotein concentrations in amniotic fluid are high before
20 weeks (Fig. 1), several of the anenccphalic fluids botweon 27 and 35 weeks' gestation
had ^-fetoprotein concentrations well above the entire normal range. Secondly, in a case
of myelocele spina bifida, fluid was obtained at. 13 weeks and had an a-fctoprotcin
concentration of 350p.g/ml (Brock & Sutcliffe, 1972). Since this condition resembles
anencephaly in that the neural plate is exposed, one would expect even higher
u.-fctoprotein concentrations in early amniotic fluids from anencephalic pregnancies.
Wc thank Mrs. M. Thompson for technical assistance, Dr. J. V. Clark for a gift of antiserum
and Professor A. Emery and Dr. M. Nelson for help with clinical details. Amniotic fluids have
been generously provided by Dr. J. G. Robertson, Dr. J. Scrimgeour, Dr. J. Monaghan, Dr. G.
Gordon and Dr. W. Paterson. The work was supported by grants from the Distillers' Co, and
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Dopamine ^-Hydroxylase Activity in Five Cases of Phaeochromocytoma
PH. TCHERDAKOFF, C. BOHUON, F. GUERINOT and M. BONNAY
Institut Gustave-Roussay, 94 Villejuif Val-de-Marne, France
Weinschilboum et al. (1971) have shown that dopamine (3,4-dihydroxyphenethylamine)
^-hydroxylase (EC 1.14.2.1) activity in blood correlates well with the activity in the
peripheral sympathetic nervous system and that the adrenal medulla plays no significant
part in maintaining the enzymic activity in the blood. We have now measured the
dopamine /3-hydroxylase activity (by a new and sensitive method) in the plasma and
tumour of five patients bearing phaeochromocytoma, as this tumour might be considered
as an accessory adrenal medulla.
All the tumors had been confirmed by biological, clinical and anatomo-pathological
observations. They were carried in ice from the operating room and frozen at —20°C
within lh. For assay of dopamine /^-hydroxylase activity they were thawed and
homogenized in 200vol. of tris buffer containing Triton X-100.
Heparinized blood samples were centrifuged and the plasma was stored at —20°C.
The dopamine ^-hydroxylase activity was stable for months under these conditions.
For the measurement of dopamine //-hydroxylase activity we used a new sensitive
radioassay method based on a double enzymic reaction (Bonnay et at., 1971). In the first
step dopamine //-hydroxylase hydroxylates the substrate (phenethylamine for tissue
and tyramine for blood; Weinschilboum & Axelrod, 1971; Molinolf et al., 1971), and
then the reaction- products are submitted to the action of the phenylethanolamine
7V-methyltransferase in the presence of »S-adenosyl(14C]methionine. The labelled
TV-methylated product is extracted and determined by measurement of its radioactivity
by liquid-scintillation counting.
Table 1 shows that a significant decrease in blood dopamine //-hydroxylase activity
appears 1 week after surgery. The possible exception (TYP) might be due to the unusual
character of this malignant phaeochromocytoma (FIVA secretant and hepatic
metastasis). However, there was no relation between tumour and plasma dopamine
//-hydroxylase activities, nor between dopamine //-hydroxylase activities and cate¬
cholamine concentrations.
It is now well established that the adrenal medulla does not participate in maintaining
dopamine //-hydroxylase activity in the blood. However, after the ablation of a
phaeochromocytoma, which might be considered as an accessory adrenal medulla, the
plasma enzyme activity falls significantly (by about 50%).
Several hypotheses may be advanced .to solve this apparent contradiction. First, a
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ENZYMES IN UNCULTURED AMNIOTIC FLUID CELLS
R. G. SUTCLIFFE and D. J. H. BROCK
University Department of Human Genetics, Western General Hospital, Edinburgh 4 (U.K.)
(Received August 8, 1970)
SUMMARY
The activities of five enzymes, isocitrate dehydrogenase, glucose-6-phosphate
dehydrogenase, 6-phosphogluconate dehydrogenase, phosphohexose isomerase and
lactate dehydrogenase have been measured in amniotic fluid cells at different stages
of pregnancy. With the exception of phosphohexose isomerase very low and highly
variable values were found and it was necessary to use spectrofluorometry to detect
activity. Contamination of samples by red cells was a frequent problem. The useful¬
ness of enzyme measurements in uncultured amniotic fluid cells for the antenatal
diagnosis of inborn errors of metabolism is discussed in the light of these experiences.
with TmdiluteA-ariBev-
The use of amniotic fluid cell studies for the antenatal diagnosis of inherited
disease has been increasingly exploited in the past three years1-4. Cultured and
uncultured cells have been used for a variety of diagnoses using enzymological
methods. The use of uncultured cells is attractive since it avoids the delay and
uncertainty of culture and also permits an earlier diagnosis3. Indeed, a therapeutic
abortion for Tay-Sachs disease has apparently been carried out entirely on the basis
of a low level of hexosaminidase A in uncultured cells4.
In this paper we report our experience with the measurement of five enzymes
in uncultured amniotic fluid cells. Specimens of amniotic fluid were obtained either
by transabdominal amniocentesis (5-10 ml) or at artificial rupture of the membranes
using an amnioscope (20-40 ml), or at hysterotomy (60, 150 ml). Specimens were
centrifuged at 1000 g for 10 min, and the cell-free supernatant was removed. The
cell buttons were washed twice in physiological saline and, if necessary, erythrocyte
contamination minimized by hypotonic shock. For enzyme measurements the cells
were disrupted ultrasonically in 0.1 M potassium phosphate buffer, containing 30 /rM
NADP and 1 mM mercaptoethanol, with the temperature maintained below io°.
Glucose-6-phosphate dehydrogenase (G6PDH), isocitrate dehydrogenase
(ICDH), 6-phosphogluconate dehydrogenase (6PGDH) and lactate dehydrogenase
(LDH) were assayed spectrofluorometrically by adding 20-100 //I of cell extract to
2.3 ml of a solution containing 90 mM potassium phosphate pH 7.95, 4.5 mM MgCl2
and 2 mg bovine serum albumin. 0.4 /rmoles of glucose-6-phosphate, 6-phospho-
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gluconate, isocitrate and 4 //moles of lactate were added separately for measurement
of the respective enzymes. The reaction was initiated by adding 0.5 //mole NADP
or 1 /tmole NAD. Protein determinations were made on soluble and insoluble protein
by Lowry's method5.
TABLE I








ICDH* G6PDH* 6PGDH* PHI* LDH** Number of Source
hypotonic
shocks
1 A 14 200 O.OI 0 0 37 0 1 H
1 B 14 560 0.08 0.02 O.OI NM 0.25 2 H
2 18 552 0.23 113 0 NM NM 12 H
3 18 20 1.22 115 0 <8 12.2 3 A
4 25 625 o-55 1.88 0 47 6.4 0 A
5 26 1890 <0.01 0.28 0 38 0.29 0 A
6 31 190 0.23 2-95 0 93 7-5 0 A
7 32 35o 0.21 11.0 0 99 3-9° 0 A
8 i?4 940 0.16 0.17 0 93 5-17 0 A
9 37 170 °-57 2-75 0 4r9 0.72 1 A
10 39 1610 0.67 2.0 0.60 136 I.OI 0 ARM
11 40 552 NM 0-33 0 NM 5.66 3 ARM
* //moles TPN converted per min per g total protein at 25°, except for PHI at 370.
** //moles DPN converted per min per g total protein at 25°.
H = Hysterotomy, A = Amniocentesis, ARM = Artificial Rupture of Membranes, NM = Not
measured.
The levels of enzyme activity found in amniotic fluid cells are shown in Table
I. ICDH, G6PDH and LDH were present in the cells in low concentrations and
6PGDH was detectable on two occasions only. However, PHI was present in ap¬
preciable quantities and could be confidently measured "both by spectrofiuorometry
and by ultraviolet spectrophotometry, which in our system had a sensitivity of about
io~4 //moles/min. The large variation in activities for each enzyme did not depend
on the volume of the amniotic fluid specimen, and was not diminished by expressing
in units per g soluble protein (as opposed to per g total protein). In the case of PHI
there may be an increase in specific activity with gestational age.
The most obvious feature of the results in Table I is the variability of the
values. A comparable range of activities for a-i,4-glucosidase has been recently
reported6. More important, however, are the extremely low activities of the enzymes
tested here. Preliminary experiments in which G6PDH was measured by ultraviolet
spectrophotometry indicated that only in a few cases could activity be confidently
detected. Subsequent measurements of all the enzymes except PHI was by spectro-
fluorometry, which increases sensitivity more than 100 fold. Even so, activities for
G6PDH, 6PGDH and ICDH were barely detectable. This is particularly true for
samples obtained by amniocentesis performed before the 20th week of pregnancy,
which rarely yielded more than 100 fig of cell protein. In our experience such samples
provide dubious material for precise enzymology, for there is always a chance of
significant contamination of amniotic fluid cells by red cells6, and also by enzymes
circulating in the amniotic fluid whose origin is at the moment unknown. These
considerations will have to be taken into account before a diagnosis of an inborn
error of metabolism is made on the basis of a measured activity.
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Summary
An enquiry has been made into the origins of a group of amniotic fluid enzymes
which have complex specific activity patterns during gestation. Between 13 and 18
weeks of gestation, the specific activities of hexosaminidase, a-l,4-glucosidase,
and the placental and heat-labile alkaline phosphatases in amniotic fluid were in
excess of those expected on the hypothesis of a serum origin. In contrast, a signifi¬
cant fraction of the acid phosphatase activity during this period could be attributed
to its influx from maternal serum. In amniotic fluid at term, hexosaminidase,
heat-labile alkaline phosphatase and acid phosphatase appeared to originate from
the surrounding tissues, although fetal urine was found to be an additional source
of acid phosphatase. The placental alkaline phosphatase in amniotic fluid at term
had a mean specific activity which was the closest to that expected on the
hypothesis of a serum origin. It is probable that tissue protein is released into the
amniotic fluid at term, and possibly also between 13 and 18 weeks of gestation.
The methods used to draw these conclusions may be of general use for examining
the origins of individual proteins in amniotic fluid.
A number of studies have suggested that the
majority of the protein in amniotic fluid is of
serum type. Using paper electrophoresis, McKay
et al. (1958), Abbas and Tovey (1960), Brzezinski
et al. (1964), Viergiver et al. (1962), and Heron
(1966) have all shown the similarity between the
amniotic fluid and serum proteins. Derrington
and Soothill (1961) immunized rabbits with
amniotic fluid obtained at term, and found by
immunoelectrophoresis that the antibody re-
ponse was directed solely toward serum protein.
Sutcliffe and Brock (1972) immunized rabbits
with amniotic fluid obtained at various stages of
gestation, and found that throughout gestation
most of the immune response was directed
towards serum protein.
Although proteins of non-serum origin must
constitute a minor fraction of the total amniotic
fluid protein, their study is of interest for a
number of reasons. Knowledge of the way in
which local tissues contribute to the fluid may
increase understanding of the formation and
maintenance of the amniotic fluid. Secondly, the
identification of proteins which come from tissues
of fetal origin should be of value in the antenatal
diagnosis of some genetic disease (O'Brien et al.,
1971; Friedland et al., 1971) and, finally, data
collected throughout pregnancy may be useful
in the assessment of fetal maturity.
Immunological and enzymological techniques
can be used in attempts to find tissue protein in
the amniotic fluid. In a previous paper Sutcliffe
et al. (1972a) reported the activity patterns of a
group ofamniotic fluid enzymes during gestation,
and raised the possibility of these measurements
being used for the assessment of fetal maturity.
In this paper the biological implications of the
results are considered from two stand-points.
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First the extent to which the enzymes are of
serum origin is discussed, and then their possible
tissue origins are considered.
Materials and Methods
The assay systems used have been described
by Sutcliffe et al. (1972a). Before assay the
maternal and fetal sera were diluted by up to 10
and 5 times respectively with physiological saline.
Extracts of amniotic fluid cells were made using
the methods of Sutcliffe and Brock (1971). In
order to follow the release of cellular enzyme
small serial samples of the supernatant were
collected during the course of sonication. The
maximum specific activities of released anzyme
were used to calculate the ratio of supernatant
to cellular enzyme in samples of amniotic fluid
at term.
Results
Amniotic fluid protein concentration
Figure 1 shows the distribution of protein
concentrations in amniotic fluid found through¬
out pregnancy. Although there was a consider¬
able scatter of results, there was a rise in mean
protein concentration between 10 and 25 weeks.
The quadratic curve of best fit was calculated for
this period by multiple regression analysis, and
is shown in Figure 1. Between 25 and 32 weeks
the protein concentration fell by half and re¬
mained at this level until term. Line a in Figure 2
shows the rate of accumulation of protein in the
amniotic fluid between 10 and 25 weeks of
gestation. Tt was constructed by taking the
product of the mean amniotic fluid volume for
each weekly period between 10 and 25 weeks of
gestation and the weekly protein concentration
as calculated from the quadratic curve of best
fit. The mean volumes were taken from the
combined data of Wagner and Fuchs (1962),
Gadd (1966), Rhodes (1966), Gillibrand (1969)
and Abramovitch (1970). The difference between
the products for consecutive weeks was taken as
the rate of protein accumulation per week.
Enzymes in serum and urine
The specific activities of hexosaminidase, acid
phosphatase, a-l,4-glucosidase and the heat-
labile and placental alkaline phosphatases were
measured in maternal and fetal sera, and in fetal
8-
Fig. 1
The protein concentration in amniotic fluid supernatant
measured by Lowry's method. The best fitting quadratic
curve for the data between 10 and 25 weeks of gestation
was plotted. It is of the form: P = 1-266G+0-026G2
— 9-822 where P = protein concentration, and G =
gestation in weeks.
■ = Hysterotomy. • = Amniocentesis. A = Artificial
rupture of membranes, normal pregnancy, x = Artificial
rupture of membranes, ancephaly.
urine. The results are shown in Table I. The
specific activity of heat-labile alkaline phos¬
phatase could not be measured in maternal
serum at term because of the exceedingly high
levels of placental alkaline phosphatase.
Enzymes in amniotic fluid cells
The liberation of enzyme from amniotic fluid
cells during the course of sonication is shown in
Figure 3. Between 40 and 150 seconds of sonica¬
tion were required for maximum enzyme
liberation. From the results the quantity of
cellular enzyme was calculated and expressed as
the specific activity of enzyme (moles per hour)
per precipitate from 1 ml. of amniotic fluid
(Table II). In each case the quantity of enzyme
present in 1 ml. of amniotic fluid supernatant was
20 30
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Table I
Enzymes in maternal and fetal serum and in fetal urine
Mean (and range) of enzyme specific activities, expressed in /zmole per hr. per ml.
Gestation No.




9-11 10 2-46 0-48 0-54 0-10 0-07
(1-72-3-42) (0-35-0-75) (0-42-0-81) (0-07-0-12)
13-18 11 3-00 0-5 0-65 0-33 0-08
(2-05-4-08) (0-34-0-79) (0-39-0-81) (0-12-0-82)
39-41 16 8-33 0-55 * 11-90 —
(5-21-13-0) (0-41-0-78) (4-60-22-6)
Fetal Serum
13-18 10 2-20 0-87 4-43 0-26 0-26
(1-2-7-23) (0-40-1-90) (2-65-6-7) (0-0-66) (0-13-0-42)
30-38 7 1 -28 0-60 2-33 0-3 —
(0-27-1-79) (0-44-0-79) (1-0-3-54) (0-0-45) 0-11,0-15
39-41 11 2-2 1-64 2-91 0-38 —•
(1-70-3-82) (0-70-2-51) (1 -31-5-23) (0-21-0-83)
Fetal Urine Total
13-18 11 0-47 0-56 0-08 0-03
(0-15-0-90) (0-28-1-10) (0-0-18) (0-0-07)
22-40 6 0-26 2-20 0-14 0-25
(0-05-0-37) (0-45^-38) (0-04—0-13) (0-10-0-45)
* Accurate measurement not possible due to high levels of placental alkaline phosphatase.
Table II
Ratio between the enzyme specific activities in the supernatant and cellular fractions ofamniotic fluid










Hexosaminidase D 1-44 0-67 2-15
E 2-00 0-56 3-57
T 1-45 0-64 2-27
Acid phosphatase D 0-21 0-02 10-5
E 0-24 0-03 8-00
T 0-13 0-03 4-33
Heat labile alkaline phosphatase* D 1-11 0-02 56-0
E 0-87 0-03 29-0
T 0-75 0-02 37-5
* Measured as heat labile alkaline phosphatase in supernatant, and total alkaline phosphatase in cells.




Histograms of amniotic fluid protein influx calculated
from the regression curve in Fig. 1 and the mean amniotic
fluid volumes in the literature. The graphs show the rate
of protein influx expressed (a) per week (b), per week per
ml. of amniotic fluid and (c) per week per mg. of amniotic
fluid protein.
measured as moles per hour per ml. of super¬
natant. The ratio of the supernatant to cellular
enzyme was then calculated. In each case the
quantity of enzyme in the supernatant exceeded
that in the cell fraction (Table II).
Discussion
Immunological methods have shown that
most of the protein in amniotic fluid is of serum
type (Derrington and Soothill, 1961; Sutcliffe
and Brock, 1972). Thus the protein concentra¬
tion determined by Lowry's method measures
the approximate concentration of serum protein
in the amniotic fluid. Figure 1 shows that this
protein concentration rose from 10 weeks of
gestation to reach a maximum between 20 and 30
weeks, and then declined until term. These
findings are in good agreement with the work of
Queenan et al. (1970), who used the biuret
method for protein measurement.
In contrast to the protein concentration, the
specific activities of some amniotic fluid enzymes
studied by Sutcliffe et al. (1972a) showed little
or no tendency to rise initially and reach a
maximum between 20 and 30 weeks. In most
cases they found maximal enzyme specific
activities at term and/or between 13 and 18
weeks of gestation. These obvious differences
lead one to question the extent to which serum
can be a major source of these enzymes in
amniotic fluid.
For an amniotic fluid enzyme to be of serum
origin, three conditions must be fulfilled. Firstly,
it must be able to pass into the amniotic sac
from the serum. Secondly, its specific activity
pattern during gestation should be predictable
from the concentration changes of other serum
proteins in the amniotic fluid. Finally, the
gradient of enzyme specific activity between the
serum and the amniotic fluid should be similar
to the concentration gradients of proteins which
are known to be of serum origin.
Molecular Weight
Previous studies (Usategui-Gomez et al.,
1966; Gitlin and Biasucci, 1969; Sutcliffe and
Brock, 1972) suggest that serum proteins which
have molecular weights of less than about
170 000 can permeate into the amniotic fluid.






0 50 100 150 200
SONICATION TIME IN SEC.
Fig. 3
The liberation of amniotic fluid cell enzymes during
sonication. The maximum specific activities were used to
calculate the enzyme specific activities in amniotic fluid.
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weights under 170 000. Robinson and Stirling
(1968) found the molecular weight of hexo¬
saminidase to be 100 000. Placental alkaline
phosphatase is dimeric at physiological pH, and
has a molecular weight of 116 000 (Sussman and
Gottlieb, 1969). The three forms of acid phos¬
phatase which have been found in human
placenta have molecular weights respectively of
35 000, 105 000 and over 200 000 (Di Pietro and
Zengerle, 1967). No data is available for human
a-l,4-glucosidase; however, the enzyme purified
from bovine and from rat liver have molecular
weights of 107 000 and 114 000 respectively
(Bruni et al., 1969; Jeffrey et al., 1970). Human
heat-labile alkaline phosphatase exists in a
number of distinct forms and has not yet been
purified.
The effect of lability on expected enzyme specific
activity patterns
Enzymatic proteins are more labile than the
majority of serum proteins, and most of the
enzymes studied here progressively lose activity
when incubated in vitro at 37 °C. (Fig. 4). This
observation makes it important to decide whether
the specific activity pattern of a labile enzyme of
serum origin will differ from that of the amniotic
fluid protein concentration. Because of the
difficulty of extrapolating from in vitro lability
DAYS AT 37 °C
Fig. 4
The decay of enzyme activity in an amniotic fluid obtained
at 16 weeks of pregnancy and incubated at 37 °C. The
enzymes are placental alkaline phosphatase (y), ceat-
labile alkaline phosphatase (■), acid phosphatase (•),
hexosaminidase (•) and a-l,4-glucosidase (a).
data to the in vivo situation, a theoretical
examination of enzyme lability will be made, and
its result will be compared with the pattern
expected for a stable enzyme of serum origin.
Stable amniotic fluid enzymes of serum origin
would have patterns of specific activity per ml.
parallel to the protein concentration (provided
the enzyme levels in serum remain constant).
However, the phenomenon of enzyme lability
will reduce the rate of accumulation of measure-
able enzyme, so that the specific activity of a
very labile enzyme is controlled by its rate of
influx into the amniotic fluid. The rate of influx
of the enzyme will be similar to that of the other
serum proteins, in proportions controlled by
molecular weight and other characteristics.
Before about 25 weeks the rate of influx of
protein into the amniotic fluid will be in propor¬
tion to its rate of accumulation (see Fig. 2, line a),
since removal of protein by fetal swallowing is
negligible at this time (Abramovitch, 1970).
Since the total specific activity of a highly
labile enzyme will be in proportion to the rate of
influx of protein into the amniotic fluid, division
of the rate of influx of protein by the mean total
fluid volume and the mean total fluid protein
content respectively will provide patterns which
are in proportion to a labile enzyme's specific
activity per ml. of amniotic fluid and per mg. of
protein. The results of this calculation are
shown as histogram lines b and c respectively in
Figure 2. The influx of total protein on a volume
basis is maximum at about 16 weeks whilst
expression on a protein basis results in a maxi¬
mum between 10 and 11 weeks of gestation. This
result suggests that in the case of labile enzymes
early in gestation, the mere demonstration of a
difference between the patterns of enzyme
activity and of protein concentration in the
amniotic fluid is insufficient to allow the conclu¬
sion that the enzyme comes from a source other
than serum. This conclusion applies particularly
to a-l,4-glucosidase, heat-labile alkaline phos¬
phatase, and hexosaminidase, all of which show
considerable increases between 10 and 15 weeks
of gestation. The analysis cannot, however, be
extended beyond about 25 weeks of pregnancy
because the increasing rate of fetal swallowing
(Pritchard, 1965) will increase the rate of protein
efflux from the fluid and so prevent an accurate
assessment of influx.
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Analysis of concentration gradients
If an enzyme is primarily of serum origin, the
ratio of its specific activities between serum and
amniotic fluid should be similar to the concen-
' tration ratios of other proteins which are found
in amniotic fluid, and which are known to be
exclusively of serum origin. The a2 group-
specific component (Gc) in amniotic fluid is
known to be of maternal serum origin through¬
out gestation (Ruoslahti et al., 1966; Sutcliffe et
al., 1972b), and so can be used as a measure of
the maternal serum: amniotic fluid protein con¬
centration gradient. Similarly, a-fetoprotein may
be used as a measure of the fetal serum: amniotic
fluid protein concentration gradient, since it is
practically absent from the maternal serum
(Ruoslahti and Seppala, 1972). The mean
concentration gradient for Gc has been found
to increase during gestation from 15 at between
13 and 18 weeks of gestation, to 32 at term
(Sutcliffe and Brock, 1972). In the case of
a-fetoprotein the mean gradient between 13 and
18 weeks has been found to be 206 (Sutcliffe and
Brock, 1972), a magnitude which is similar to
• that found earlier in gestation by Gitlin and
Boesman (1966).
Table III shows the mean specific activities
, observed for the enzymes in amniotic fluid at
term and between 13 and 18 weeks of gestation.
The expected specific activities have been
calculated from the maternal and fetal serum
enzyme specific activities (Table I) and the
maternal or fetal serum : amniotic fluid protein
gradients as outlined above. The term data has
not been tested on the hypothesis of a fetal
serum origin since the a-fetoprotein gradient at
term is very high (Gitlin and Boesman, 1966).
The results show that in all cases the specific
activities observed in amniotic fluid are in excess
of those calculated on the hypothesis of a serum
origin for these enzymes. Particularly striking
are the low levels which would be expected on
the hypothesis of a fetal serum origin.
The validity of the analysis in Table III must
be examined, since surface properties and
molecular weight are of major importance in
determining the rate of diffusion of individual
proteins. The molecular weights of most of the
enzymes studied are greater than those of Gc
and a-fetoprotein. Thus the concentration
gradients of the latter proteins may be under¬
estimates of the expected specific activity
gradients of the enzymes. If this is so, the
conclusion that many of the enzymes are of non-
serum origin is made more likely. However, an
independent line of evidence suggests that the
Table III
The mean specific activities observed for the amniotic fluid enzymes, and those calculated from the maternal










Gmoles of substrate hydrolyzed/ Ratio between
hr./ml. of amniotic fluid) observed and
total expected
Maternal Fetal values
serum origin serum origin
13-18 weeks gestation
Hexosaminidase 36 106 0-20 001 5-0
Acid phosphatase 35 006 003 <001 1 -5
Heat labile alkaline phosphatase 30 0-24 0-04 002 40
Placental alkaline phosphatase 29 0 09 0 02 <001 3-0
a-1,4 glucosidase 30 0-54 001 <001 270
Pregnancies at term
Hexosaminidase 25 1-72 0-26 — 6-6
Acid phosphatase 25 0-23 002 — 11 -5
Heat labile alkaline* phosphatase 25 0-60 002 — 300
Placental alkaline phosphatase 25 0-65 0-37 — 1-8
* Using data from maternal serum obtained between 13 and 18 weeks of gestation (see Table I).
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analysis is of value, at least in the case of
placental alkaline phosphatase at term, for
which an expected to observed ratio of 1 • 8 was
calculated. Between 30 weeks of gestation and
term, the concentration of major serum proteins
in amniotic fluid falls by approximately half
(Sutcliffe and Brock, 1972). Therefore, if the
amniotic fluid placental alkaline phosphatase is
of serum origin, its specific activity would not
rise at the same rate as in the maternal serum.
Between 30 and 40 weeks of gestation the
specific activities of the enzysme in both amniotic
fluid (Sutcliffe et al., 1972a) and in maternal
serum (Hunter, 1969) increase by 3 to 3-5 fold.
This suggests that there is approximately twice
the expected enzyme specific activity in amniotic
fluid at term, and that the enzyme is therefore
not in simple equilibrium with that in maternal
mixed venous serum. This bears out the con¬
clusion from Table III.
Alternative Tissue Sources of Enzyme
Having shown that serum is probably neither
a major source of a-l,4-glucosidase, hexo¬
saminidase or of placental or heat-labile alkaline
phosphatase between 13 and 18 weeks, nor of
hexosaminidase, acid phosphatase, or heat-
labile alkaline phosphatase towards term, alter¬
native tissue sources must be discussed. Maternal
protein of non-serum origin can only enter the
amniotic fetal from the uterine decidua and
myometrium. Potential fetal sources include
fetal urine, skin, respiratory and alimentary
secretions, as well as umbilical cord (a potential
source of mucopolysaccharide), placenta,
amnion, chorion and amniotic fluid cells.
Geyer (1970) has suggested that amnion is a
major source of some amniotic fluid enzymes at
term.
It is possible that amniotic fluid cells contri¬
bute to the fluid enzymes. However, it is difficult
to understand how they could cause the changes
in enzyme activity observed between 10 and 20
weeks of gestation, since Nelson and Emery
(1970) have shown that the concentration of
amniotic fluid cells is maximal at term. The
relationship between the enzyme specific activi¬
ties in the cells and the supernatants of three
samples of amniotic fluid obtained at term was
therefore studied. Table II shows that in one ml.
of amniotic fluid, there was more enzyme
activity in the supernatant fluid than in the cells.
In the case of heat-labile alkaline phosphatase
there was between 29 and 56 times as much
enzyme in the supernatant as in the cells,
whereas the ratio for acid phosphatase was
4 to 10, and for hexosaminidase 2 to 4. From
these results it is clear that at term the minority
of amniotic fluid enzymes is cellular, and that
the cells cannot be a major source of alkaline
phosphatase or acid phosphatase. It remains to
be decided whether the supernatant : cell ratio
for hexosaminidase indicates that cells are a
major source of this enzyme.
A similar supernatant : cell analysis has not
been made on amniotic fluid early in gestation.
However, there are reasons to suggest that
amniotic fluid cells are an insignificant source of
supernatant enzyme between 13 and 18 weeks of
gestation. Firstly, the cell concentration is very
low at the time of the early specific activity
peaks of hexosaminidase, a-l,4-glucosidase, and
heat-labile alkaline phosphatase. Further,
between 20 and 30 weeks, when the cell concen¬
tration is increasing at its maximal rate (Nelson «
and Emery, 1970) no obvious increase in
enzyme specific activity occurs.
The similarity between the early activity peaks •
of a-l,4-glucosidase and heat-labile alkaline
phosphatase suggests that the same tissue is
responsible for liberating both enzymes. How¬
ever, it is not known whether this tissue is
maternal or fetal. Genetic studies should provide
the clearest answer to this question, yet both
successful (Nadler and Messina, 1969) and
unsuccessful (Nadler et al., 1970) prenatal
diagnoses of Pompe's disease have been reported
using the measurement of supernatant a-1,4-
glucosidase. However, it is difficult to decide on
the biological significance of this observation
owing to the lack of extensive control data, and
possible complications due to unrecognized fetal
heterozygosity. Of considerable interest is the
finding of Salafsky and Nadler (1971) that the
majority of amniotic fluid a-l,4-glucosidase at
16 weeks is bound to free cellular organelles.
These organelles must be of fetal origin which
suggests that the enzyme is also of fetal origin.
Paradoxically, the same workers (Salafsky and
Nadler, 1972) have also claimed that the
a-l,4-glucosidase in amniotic fluid is not '
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kinetically identical to that of fetal tissue or
amniotic fluid cells. At present, no firm con¬
clusion can be reached about the origin of the
a-l,4-glucosidase of amniotic fluid. However, if
the enzyme is of maternal origin, then it must be
synthesized within the uterus, since its diffusion
pathway into the amniotic sac must be indepen¬
dent of maternal serum.
In contrast to a-l,4-glucosidase, heat-labile
alkaline phosphatase is found at high specific
activities both early and late in gestation.
Electrophoresis of various human tissue extracts
have shown that at least four distinct forms of
the phosphatase exist (see Suzuki et al., 1969),
so that it is unwise to regard the amniotic fluid
enzyme as a single entity, or to assume that the
same entity participates in both the early and
late peaks of activity. Indeed, since a-1,4-
glucosidase is not elevated at term, it seems that
the phosphatase peak at term is not due to the
same process of tissue break-down as occurred
earlier in gestation.
There is a lack of similarity between the
patterns of a-l,4-glucosidase, hexosaminidase
4 and acid phosphatase during the last eight
weeks of gestation. Although all three enzymes
are of lysosomal origin and are ubiquitously
« distributed in body tissues, acid phosphatase
alone shows a marked increase in specific
activity toward term. This suggests that he
increased levels of acid phosphatase are not due
to local tissue changes, and argues against the
suggestion of Seelich and Gomolka (1952) that
the placenta is a major source of amniotic fluid
acid phosphatase. These workers claimed that
the ratio of specific activity of acid phosphatase
and placental alkaline phosphatase in the
amniotic fluid agreed well with that in the
placenta; however, Ahmed and King (1959)
were unable to confirm this. The absence of an
elevation of acid phosphatase in maternal or
fetal serum in the last eight weeks of pregnancy
suggests that the placenta is not a major source
of acid phosphatase.
Table I shows that the specific activity of acid
phosphatase in fetal urine is considerably
greater than that of either hexosaminidase or
a-l,4-glucosidase. Further, the specific activity
of acid phosphatase in fetal urine is considerably
greater than in most amniotic fluids, so that fetal
i urine may be tentatively advanced as a major
source of amniotic fluid acid phosphatase
during the last eight weeks of gestation.
Conclusion
This paper shows that the majority of the
amniotic fluid enzymes studied are probably not
of fetal or maternal serum origin. The complex
patterns of enzyme activity found between 13
and 18 weeks of gestation, and during the last two
months of pregnancy, suggest that significant
quantities of tissue protein are released into the
amniotic fluid. However, the sources of non-
serum protein in the amniotic fluid remain in
doubt, and may possibly be identified by
immunological studies.
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Origin of Amniotic Fluid
Group-specific Component
The use of amniotic fluid for the prenatal diagnosis of genetic
disease has prompted investigations into the origin of amniotic
fluid protein. Several observations (refs. 1-5 and R. G. S. and
D. J. H. B., manuscript in preparation) have suggested that
the foetus contributes protein to the fluid early in pregnancy,
and it has also been claimed that during this time amniotic
fluid is an extension of the foetal extracellular space6,7. Con¬
versely, in term amniotic fluid, the serum proteins transferrin
and group-specific component (Gc) have been found to be
of maternal origin8-10. Serum proteins make up the great
majority of amniotic fluid protein at all stages of gestation,
but it is not known whether maternal or foetal serum is the
source early in gestation. In this study, Gc polymorphism
is used to investigate this point.
Polymorphism studies on Gc protein have shown that the
protein in foetal serum is synthesized by the foetus from
ten weeks of gestation onwards11. Thus, in cases where the
foetal phenotype is discordant with the mother's, the amniotic
fluid Gc would be concordant with the maternal phenotype if
it is of maternal origin, but discordant if it is of foetal origin.
In the latter case, the expected frequency of discordance
between the foetal and maternal phenotypes is equal to the
heterozygote frequency in the population12.
Antibody-antigen crossed electrophoresis (AACE) is known
to show Gc as a heterogeneous protein13, but has not been
previously used for Gc phenotyping. We used the method
as it allows a detailed examination of the amniotic fluid Gc
pattern without previous concentration of the fluid, and is
sensitive enough to show small contributions from one or
other allele. AACE was carried out using 1% agarose and
the buffer systems of Hirschfeld14. The first dimension was
run at 6 Vcm-1 for 3 h, and the second dimension at 1.5 V cm-1
for more than 15 h. The antiserum was raised in rabbits by
subcutaneous injection of x 10 concentrated amniotic fluid,
which was dispersed in Freund's complete adjuvant for the
first three injections. Amniotic fluid samples before 20 weeks
of gestation were obtained at terminations of pregnancy, and
thereafter at amniocentesis in cases of suspected rhesus iso¬
immunization. The Gc precipitate was identified in the gels
by its characteristic heterogeneity13,14, and also by the use of
a specific anti-Gc antiserum (Behringwerke).
Table 1 Concordance and Discordance for Maternal Gc Phenotype
Gestation Concordant pairs Discordant pairs
(weeks) Maternal Gc phenotype All phenotypes
1-1 2-1 2-2
10-18 11 8 2 0
19-27 5 5 2 0
28-38 14 8 1 0
Number of pairs studied in which concordance or discordance for
Gc phenotype was found between the amniotic fluid and maternal
serum, broken down according to gestational age and maternal Gc
phenotype. Phenotype frequencies: 0.54; 0.38; 0.09.
Table 1 shows that concordance of phenotype was found
in all of the fifty-six maternal serum-amniotic fluid pairs
studied. From the frequency of heterozygotes, approximately
38% discordance in at least one of the gestational groups
would be expected if there were a major foetal contribution
to the Gc of amniotic fluid. Among the cases summarized in
Table 1 were eleven in which a sample of foetal serum was
available for phenotyping. In four of these cases, discordance
was found between the foetal and maternal phenotypes and, in
each case, the phenotype of the amniotic fluid Gc was that
of the mother.
From these results we conclude that throughout gestation
the Gc in amniotic fluid is of maternal origin, and that it
enters the fluid by passing through the placental or reflected
membranes. This finding sounds a cautionary note for any
attempts to carry out prenatal diagnoses of genetic disease
either by direct screening of serum proteins or by linkage
analysis using serum protein polymorphisms.
We thank Mrs R. M. Clayton and Dr C. Smith for help and
advice, and Drs J. G. Robertson, J. Downie, J. M. Monaghan
and G. Gordon for providing us with material. R. G. S. holds
an MRC studentship. The work was supported by a grant
from the Distillers Company Limited.
R. G. Sutcliffe
D. J. H. Brock




Simpson Memorial Maternity Pavilion,
Lauriston Place,
Edinburgh EH3 9 EF
Received March 27; revised May 18, 1972.
1 O'Brien, J. S., Okada, S., Fillerup, D. L., Veath, M. L., Adornato,
B.,Brennar, P. H., and Leroy, J. G., Science, 172,61 (1971).
Friedland, J., Perle, G., Saifer, A., Schneck, L., and Volk, B. W.,
Proc. Soc. Exp. Biol. Med., 136, 1297 (1971).
Harper, P., Bias, W. B., Hutchinson, J. R., and McKusick, V. A.,
J. Med. Genet., 8, 438 (1971).
Gitlin, D., and Boesman, M., /. Clin. Invest., 45, 1826 (1966).
Brzezinski, A., Sadovsky, E., and Shafrir, E., Amer. J. Obstet.
Gynecol., 89, 488 (1964).
Lind, T., Parkin, F. M., and Cheyne, G. A., J. Obstet. Gynaecol.
Brit. Commonwealth, 76, 673 (1969).
Lind, T., and Hytten, F. E., Lancet, i, 1147 (1970).
Seppala, M., Ruoslahti, E., and Tallberg, T., Ann. Med. Exp.
Fenn., 44, 61 (1965).
Ruoslahti, E., Tallberg, T., and Seppala, M., Nature, 212, 841
(1966).
Usategui-Gomez, M., and Morgan, D. F., Nature, 212, 1600
(1966).
Melartin, L., Hirvonen, T., Kaarsalo, E., and Toinanan, P.,
Scand. J. Haematol., 3, 117 (1965).
Elandt-Johnson, R. C., Probability Models and Statistical Methods
in Genetics, 132 (Wiley, New York, 1971).
Weeke, B., Scand. J. Clin. Lab. Invest., 25, 269 (1970).
Hirschfeld, J., Science Tools, 7, 18 (1960).
Printed in Great Britain by Flarepath Printers Ltd.. St. Albans. Herts.
Reprinted from THE LANCET, ,/u/y 29, 1972, pp. 197-199
ALPHA-FETOPROTEIN IN THE
ANTENATAL DIAGNOSIS OF
ANENCEPHALY AND SPINA BIFIDA
D. J. H. Brock R. G. Sutcliffe
University Department of Human Genetics,
Western General Hospital,
Edinburgh 4
oc-fetoprotein (a.f.p.) has been measured
ummary -n ^ amnjotjc fluids Gf thirty-one
pregnancies leading to anencephaly (or anencephaly
and spina bifida), three leading to spina bifida, and
three leading to hydrocephaly (or hydrocephaly and
spina bifida). In the anencephalic cases all A.f.p.
concentrations were well above the normal range
between 25 and 35 weeks of gestation; after 35 weeks
five out of nine cases were clearly above normal. In a
single case of spina bifida, where amniotic fluid was ob¬
tained at 13 weeks, a.f.p. concentration was four times
greater than the highest normal level. After 30 weeks'
gestation amniotic fluids from pregnancies leading to
spina bifida and hydrocephaly could not be dis¬
tinguished from normal pregnancies. These results
suggest that amniotic-fluid-a.f.p. measurements will
be valuable in the early antenatal diagnosis of anen¬
cephaly and spina bifida and will enable termination
of these pregnancies.
Introduction
Anencephaly and spina bifida cystica are the most
common of the congenital malformations of the central
nervous system, with a combined incidence of up
to 7 in 1000 in the U.K.1'2 The risk of either disorder
is increased to 1 in 20 in a family where there is
already an affected sib 3 and to 1 in 10 or above in a
family where there are two affected sibs.4 One of the
prerequisites of antenatal diagnosis, the identification
of pregnancies at increased risk, is thus satisfied. The
other prerequisite, a marker molecule which will
indicate an affected fetus early enough to allow
termination of pregnancy, has so far not been found.
We suggest that a-fetoprotein (a.f.p.) could act as
such a marker molecule.
2
Materials and Methods
Amniotic fluids, obtained at delivery or by trans¬
abdominal amniocentesis, were centrifuged for 5 minutes
at 125 g and the clear supernatants removed. These
supernatants were stored at -25"C for up to 3 years.
Since the effect of protracted storage on a.f.p. is not
known, each sample from a pregnancy leading to a con¬
genital malformation was matched with a control sample
of the same approximate gestational age, which had been
stored for the same time. Congenital malformations were
classified as anencephaly (with or without spina bifida),
spina bifida, and hydrocephaly (with or without spina
bifida). Most of the control samples were obtained from
terminations of pregnancy or from amniocenteses carried
out during the management of rhesus-incompatible
pregnancies.
a.f.p. was measured by one-dimensional antibody-
antigen crossed electrophoresis using rabbit antiserum
provided by Dr. J. V. Clark and also bought from Behring-
werke. The monospecific antiserum was used at a final
concentration of 0-25% in a 1% agarose gel. Amniotic
fluid (5-15 pi.) was placed in the sample wells and elcctro-
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Fig. t—A.F.P. in amniotic fluid between 25 and 42 weeks of
pregnancy.
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Fig. 2—A.F.P. in amniotic fluid between 10 and 25 weeks of
pregnancy.
phoresis carried out overnight. The sensitivity limit of
the assay was about 1 ng. per ml., though values under
3 ng. per ml. were somewhat unreliable. Absolute values
of a.f.p. were calculated with reference to a standard
supplied by Prof. G. Abelev. If a Behringwerke standard
is used the values in figs. 1 and 2 must be multiplied
by 0-7. Protein was measured by the method of Lowry
et al.5 Norgaard-Pedersen has described a similar method
of measuring a.f.p.r>
Results
Concentrations of a.f.p. in the amniotic fluids of
pregnancies leading to anencephaly, spina bifida, and
hydrocephaly are shown in figs. 1 and 2. Fig. 1
covers the gestational range from 25 to 42 weeks when
most of the abnormal amniotic fluids were obtained.
From 25 to 35 weeks' gestation there is a distinction
between the anencephalic fluids and the normal
controls; even after 35 weeks' gestation most of the
anencephalic amniotic fluids have greatly raised a.f.p.
concentrations. The mean a.f.p. concentration of
the control fluids at 25-42 weeks' gestation was
3-1 pg. per ml. (range 0-10-5 p.g. per ml.), while only
four of the thirty-one anencephalic amniotic fluids
fell below 12 pg. per ml., all of these being from
pregnancies of 36 weeks' duration or longer.
In contrast, the concentration of A.f.p. in fluids
from cases of spina bifida and hydrocephaly were
not distinguishable from the normal controls between
32 and 41 weeks (fig. 1). However, a single ammotic-
fluid sample was obtained at 13 weeks' gestation from
a hysterotomy in which the fetus had a myelocele
spina bifida. In this case the concentration of a.f.p.
in the fluid was 350 jag. per ml., which was over four
times as great as the highest normal control value (fig.
4
2). In our experience a.f.p. levels are not very much
affected by severe rhesus isoimmunisation, by idio¬
pathic hydramnios, or by stillbirth (unless caused
by anencephaly).
Discussion
Attempts have been made to find marker molecules
in amniotic fluid which would indicate fetuses with
anencephaly and/or spina bifida.7-9 Several workers
have reported that bilirubin or a bilirubin-like molecule
with an extinction coefficient at 450 nm. is present
in the amniotic fluid surrounding anencephalic fetuses
at or near term.10-12 This suggested to us that enhanced
leakage or transudation of fetal-blood components
was occurring either directly into the fluid or into the
fluid via the cerebrospinal fluid (c.s.f.). If any of
these components were to be of diagnostic use it
would have to be unique to the fetus, and of sufficiently
high molecular weight not to equilibrate rapidly
with maternal fluid-spaces—i.e., a specifically fetal
protein, a.f.p.13 was an obvious candidate. It is
produced in the fetal liver as early as the 6th week of
gestation, reaches its highest concentrations in fetal
serum at about 13 weeks, and then falls steadily to
term.14 It may be found in amniotic fluid throughout
pregnancy with a highly sensitive radioimmuno¬
assay. 15 However, we have had no difficulty in detecting
a.f.p. in amniotic fluid at most stages of pregnancy
with a relatively insensitive method; only at term did
we sometimes fail to find a.f.p. (indicating a concentra¬
tion below 1 fig. per ml.). As in fetal serum, amniotic-
fluid-a.f.p. concentration is highest at about 13 weeks'
gestation and then falls. The concentration gradient
between fetal serum and amniotic fluid a.f.p. is about
200/1.16
Figs. 1 and 2 suggest that both anencephaly and
spina bifida may be detectable in utero early enough to
allow termination of pregnancy. In fig. 1 the difference
between anencephalic and normal a.f.p. levels is
greater in the 25 to 35 week period than it is after
35 weeks. Though the five spina bifida cases (three
associated with hydrocephaly) were indistinguishable
from controls after 32 weeks' gestation, the single
early case had greatly raised a.f.p. at 13 weeks' gesta¬
tion. There are different types of spina bifida, and
myelocele and total myeloschisis are more likely to
be associated with extrusion of fetal proteins into the
fluid than are meningomyelocele, meningocele, or
5
spina bifida occulta. The early case was a definite
myelocele, the later cases probably all meningo¬
myelocele or meningocele. This may indicate that
only unclosed neural-plate malformations can be
diagnosed antenatally.
Anencephalics seem to have a choroid plexus, and
this is a possible source of both the hydramnios and
high amniotic-fluid-a.f.p. levels. In spina bifida,
a.f.p. must presumably come from fetal c.s.f., though
its concentration there has not previously been
measured. We had some difficulty in obtaining fetal
c.s.f. entirely free of blood; two moderately clean
samples had a.f.p. levels of 0-96 and 0-86 mg. per ml.,
at 15 and 16 weeks' gestation respectively, though
with normal fetal serum levels of a.f.p. reaching
3 mg. per ml. at 15 weeks' gestation this could
be accounted for by contamination.
a.f.p. crosses the placental barrier and may be found
in maternal serum with a sensitive radioimmuno¬
assay.18 In cases of fetal distress maternal serum-
a.f.p. levels of up to 9 p.g. per ml. have been observed.
Possibly the raised amniotic-fluid a.f.p. that we have
found in anencephaly and myelocele spina bifida may
also find its way into the maternal serum. So far
we have not been able to test this, but we would not
regard as improbable the eventual antenatal diagnosis
of anencephaly and spina bifida through the monitoring
of a.f.p. levels in maternal serum.
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Summary
The specific activity patterns of a group of enzymes were studied in the super-
natants of amniotic fluid obtained between 10 weeks of gestation and term. A
number of different patterns were found. a-l,4-Glucosidase showed a peak in
specific activity between 13 and 18 weeks of gestation. Heat-labile alkaline
phosphatase had an early peak of specific activity which was similar to that of
a-l,4-glucosidase and, in addition, a specific activity peak after 37 weeks. Acid
phosphatase showed a peak of specific activity after 32 weeks. Hexosaminidase
remained unchanged during most of pregnancy, although the lowest levels were
found before 14 weeks. Finally, placental alkaline phosphatase showed a gradual
increase in specific activity between 10 and 30 weeks, after which time a more rapid
increase occurred. Expression of the results on a protein basis led to an exaggera¬
tion of the specific activity peaks in early and late gestation. The significance of
the results is discussed in the context of their possible use for the estimation of
fetal maturity.
Amniotic fluid analysis has been shown to be of
value in the prenatal diagnosis of both genetic
and non-genetic conditions. Tay-Sachs disease
can be diagnosed between 15 and 28 weeks of
gestation by measurement of hexosaminidase A
in amniotic fluid (O'Brien et al., 1971; Friedland
et al., 1971). Bilirubin measurement has become
routine for the diagnosis and assessment of
rhesus isoimmunization (see, for example,
Robertson, 1969), and the measurement of fluid
phospholipids has been claimed to be of value in
determining the liability of a fetus to respiratory
distress syndrome at birth (Gluck et al., 1971;
Bhagwanani et al., 1972).
A greater understanding of the origin and
quantitative behaviour of the proteins in
amniotic fluid would help in attempting to
extend the diagnostic potential of amniocentesis.
This paper reports the specific activity patterns
of a number of amniotic fluid enzymes during
pregnancy, and discusses their potential useful¬
ness in the diagnosis of fetal maturity. The
factors which contribute to the changes in
enzyme specific activity during gestation are
discussed in a subsequent paper (Sutcliffe and
Brock, 1972).
Materials and Methods
Amniotic fluid was obtained from three
sources. Samples obtained early in gestation
were taken from hysterotomy sacs, and those
from about 20 to 38 weeks were taken by
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amniocentesis at the clinic for patients with
rhesus iso-immunization. Collections of amniotic
fluid at term were made using an amnioscope
during artificial rupture of the membranes. In
all cases, the duration of pregnancy was measur¬
ed from the first day of the last menstrual period.
All samples which were visibly contaminated by
blood or meconium were excluded from the
series. In the patients having repeated amnio¬
centesis, only the initial specimen was collected.
Specimens with a AOD which fell outside the
Al, Bl, B2, CI and C2 zones of Robertson
(1969) were excluded.
The samples of amniotic fluid were centrifuged
for 45 minutes at 27 000 g. at 4 °C., and the clear
supernatant was removed. Enzyme assays were
carried out within two days of the sample being
collected, the material being stored at 4 °C.
during this period.
Hexosaminidase was assayed in a system of
0-1 M. citrate buffer pH 4-25, 5-3 mM.
p-nitrophenyl-2-acetamido-2-deoxy-{3-.D-gluco-
pyranoside and 5 pi. of amniotic fluid in a final
volume of 015 ml. Acid phosphatase was
assayed in a system of 0 • 1 M. citrate buffer pH
4-9, 10-5 mM. "Sigma 104" phosphatase
substrate (p-nitrophenyl phosphate), 0-4 per
cent formaldehyde and 20 to 40 pi. amniotic
fluid in a final volume of 0 -15 ml. The formalde¬
hyde inhibited any red cell acid phosphatase
present. cx-l,4-Glucosidase was assayed in a
system of 018 M. citrate pW 4-9, 12-8 mM.
p-nitrophenyl-a-Z)-glucopyranoside and 10 pi.
of amniotic fluid, in a final volume of 0-15 ml.
Alkaline phosphatase was assayed in a system of
62 mM. sodium carbonate buffer pW 10-75,
12-5 mM. magnesium chloride, 32-5 mM. "Sig¬
ma 104" phosphatase substrate and 5 to 20 pi. of
amniotic fluid in a final volume of 50 pi. To de¬
termine the specific activity of the placental
(heat-stable) alkaline phosphatase, an aliquot of
amniotic fluid was incubated at 65 °C. for 55
minutes after the method of Hunter (1969). The
difference in specific activity between the un-
heated and heated amniotic fluid aliquots repre¬
sented the heat-labile alkaline phosphatase. In all
assays a control without amniotic fluid and a
control without substrate were included.
The assay solutions were incubated for 2
hours at 37 °C. under saturated vapour pressure
to minimize evaporation. The reactions were
then stopped by the addition of 0-4 M. glycine-
sodium hydroxide buffer pW 10-3, to a final
volume of 1-0 ml. The optical density of the
solutions was measured spectrophotometrically
at 400 mp. The enzyme specific activities were
calculated by subtracting the sum of the controls
from the full systems, and using the molar
extinction coefficient of p-nitrophenol (1 -775x
104 under these conditions) to express the results
in /amoles substrate hydrolyzed per hour per ml.
of amniotic fluid. The protein concentration in
amniotic fluid was measured by Lowry's method
(Lowry et al., 1951), and it was used to calculate




Table I shows the pH optima and Km. values
for the enzymes studied. Routine assays were
carried out at optimal pH and at substrate
concentrations which were essentially saturating.
The exception to this was the hexosaminidase
assay where the sparing solubility of the substrate
precluded saturating conditions.
Table I
Michaelis constants (Km.) and pH optima of the
amniotic fluid enzymes studied
Enzyme Km.* pH optimum
Hexosaminidase 2-6 4-25
a-1,4-glucosidase 3-3 4-9
Acid phosphatase 0-8t 4-9
Total alkaline phosphatase 60 10-75
* expressed as mM substrate,
t substrate inhibition above 9mM substrate.
2. enzyme specific activity patterns
a-/,4-glucosidase (Figs, la and lb)
Figures la and lb show the patterns of specific
activity on volume and protein bases respectively.
A peak of activity was found between 13 and 18
weeks of gestation. After this period consistently
low specific activities were observed.
Heat-labile alkaline phosphatase
(Figs. 2a and 2b)
Figures 2a and 2b show the patterns of
specific activity on volume and protein bases
respectively. An initial peak in activity occurred
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Fig. I
Amniotic fluid a-l,4-glucosidase, expressed (a) per ml. of
amniotic fluid, and (b) per mg. of protein, plotted against
gestational age. ■: hysterotomy. •: amniocentesis.
A: artificial rupture of membranes, normal pregnancy.
x : artificial rupture of membranes, anencephaly.
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Amniotic fluid heat-labile alkaline phosphatase, expres¬
sed (a) per ml. of amniotic fluid, and (b) per g. of
protein, plotted against gestational age. Symbols as in
Fig. 1.
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between 13 and 18 weeks, and during this time a
close relationship was found between the specific
activities of heat-labile alkaline phosphatase and
a-l,4-glucosidase in individual amniotic fluids
(Fig. 3). Heat-labile alkaline phosphatase was
found at very low levels between 18 and 36
weeks of gestation, after which there was a
considerable rise (accompanied by a wide
scatter). When enzyme specific activity is
expressed on a protein basis (Fig. 2b) both peaks
of activity are exaggerated, and the rise toward
term occurred earlier.
1-0-
heat labile alkaline phosphatase
1-0
Fig. 3
The relationship between amniotic fluid a-l,4-glucosidase
and heat-labile alkaline phosphatase between 10 and 20
weeks ofgestation, expressed as /mnole/hr./ml. of amniotic
fluid.
Acid phosphatase (Figs. 4a and 4b)
Little change in specific activity per ml. of
amniotic fluid was observed before about 32
weeks. After this time there was an increase in
specific activity, together with considerable
variation between individual values. Figure 4b
shows that a minor peak in specific activity per
g. of protein occurred between 13 and 18 weeks




























Amniotic fluid acid phosphatase, expressed (a) per ml. of
amniotic fluid, and (b) per g. of protein, plotted against
gestational age. Symbols as in Fig. 1.
Hexosaminidase (Figs. 5a and 5b)
No clear pattern emerged from the enzyme
specific activity per ml. of amniotic fluid,
although the lowest specific activities are found
before 14 weeks of gestation. However, Figure
5b shows that the specific activity per mg. of
protein is minimal between 20 and 30 weeks.
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Amniotic fluid hexosami expressed (a) per ml. of Amniotic fluid placental alkaline phosphatase, expressed
amniotic fluid, and (b) per f protein, plotted against (a) per ml. of amniotic fluid, and (b) per g. of protein,
Fig. 6
alkaline
fl i , i
plotted against gestational age. Symbols as in Fig. I.
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Placental alkaline phosphatase
(Figs. 6a and 6b)
A gradual increase in specific activity was
observed between 10 and 30 weeks, after which
the specific activity rose more rapidly. Between
30 and 40 weeks, the specific activity of placental
alkaline phosphatase in amniotic fluid increased
by 3 to 3-5-fold. Expression of activity on a
protein basis led to an exaggeration of the rise in
the latter half of pregnancy.
Discussion
The results show that complex changes of
enzyme specific activity occur in the amniotic
fluid as gestation proceeds. Generally, hexo¬
saminidase had the highest specific activity in
amniotic fluid and, with the exception of
a-l,4-glucosidase, all the enzymes were at their
highest specific activities at term.
Between 13 and 18 weeks of gestation, there
was a peak in the specific activities of a-1,4-
glucosidase and heat-labile alkaline phosphatase.
The close correlation between the values for
these enzymes in individual amniotic fluids
(Fig. 3) suggests that their activity peaks are due
to the same developmental event. The effects of
this event are not limited to these two enzymes,
for there is a simultaneous increase in the specific
activity of hexosaminidase and also minor
activity peaks for the other enzymes.
Between 20 and 30 weeks of gestation, the
specific activities of a-l,4-glucosidase and heat-
labile alkaline phosphatase fell to their lowest
levels, whilst those of the other enzymes remain
unchanged. After 30 weeks, the specific activities
of hexosaminidase and a-l,4-glucosidase re¬
mained unchanged, whilst those of acid phos¬
phatase, placental alkaline phosphatase, and
(somewhat later) heat-labile alkaline phosphatase
rose to their maximal levels. Roopnarinesingh
et al. (1972) also found that the specific activity
of placental alkaline phosphatase increased
during this time, though these workers used
56 °C. as their inactivation temperature and so
may also have been measuring a labile fraction
of alkaline phosphatse. The considerable scatter
of the specific activities of the phosphatases at
term may be partially due to errors in estimating
gestational age, or to the varying proximity of
the onset of labour. Such errors would have their
greatest effect upon enzymes undergoing rapid
changes in specific activity. The lack of correla¬
tion between the levels of the three enzymes in
the individual amniotic fluids after 37 weeks
does not seem to be due to technical problems.
Meconium-stained amniotic fluids were excluded
from the series as they contain excessive quanti¬
ties of heat-labile alkaline phosphatase (Geyer
and Schneider, 1970). It was possible that the
samples of amniotic fluid obtained at artificial
rupture of the membranes were not typical of
the rest of the fluid. This point was investigated
in three patients at induction of labour. In these
patients, ten consecutive 20 ml. samples of
amniotic fluid were taken for analysis while it
drained from the amnioscope. In no case was
significant variation found in the protein
concentration or in any of the enzyme specific
activities.
In this study no significant correlations were
found between the amniotic fluid protein con¬
centration and the enzyme specific activities.
Flowever, the specific activities on a protein basis
were plotted against gestational age because
this caused an exaggeration of the early and late
peaks of enzyme specific activity. This occurs
because the protein concentration reaches a
maximum at approximately 25 weeks of gestation
(Queenan et al., 1970; Sutcliffeand Brock, 1972).
Although the biological basis of this expression
of specific activity is questionable, the exaggera¬
tion it brings about may be valuable if the
measurements are to be used for maturity testing
or other studies during the last trimester of
pregnancy.
The patterns of enzyme specific activity
reported here show that complex factors control
the composition of amniotic fluid, and the
possible nature of these factors is dealt with in a
subsequent paper (Sutcliffe and Brock, 1972).
Yet, whatever the biological implications of
these findings, the trends observed during the
latter half of pregnancy suggest that the measure¬
ment of enzymes in amniotic fluid may be of use
in the assessment of fetal maturity. In particular,
the changes in phosphatase activity, on both
volume and protein bases, appear to merit
further investigation.
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